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Abstract 
Pathogenic Escherichia coli (E. coli) bacteria are responsible for a number of infectious diseases, 
such as neonatal meningitis, urinary tract infections, and gastroenteritis. Initiated by adhesion of 
bacteria to the surface of human cells, type 1 fimbriated E. coli utilize a mannose-specific lectin, 
namely FimH, at the tip of adhesive organelles, the fimbriae, for attachment to cells with high-
mannose surface glycans. Therefore, the synthesis of potent inhibitors of bacterial adhesion and 
the development of innovative techniques for investigation of this matter are of utmost scientific 
as well as medicinal value and motivate the research described herein. 
At first, the Amadori rearrangement was applied in the synthesis of ligands for the bacterial lectin 
FimH, which were further validated by performance of docking studies and biological tests. It 
turned out that complexation of Amadori products in the lectin binding site is compromised, which 
limits the activity towards inhibition of FimH-mediated bacterial adhesion. Supplementary to this 
work, it was interesting to utilize the Amadori rearrangement for the synthesis of colored products 
in order to facilitate and accelerate the purification of the highly polar Amadori products. 
The preparation of a carbohydrate-centered scaffold with an AB4-type functionalization was 
discussed by retrosynthetic analysis and could eventually be realized after thorough investigation. 
Based on this target scaffold compound, various useful glycoconjugates were synthesized, such as 
a tetravalent glycocluster. By testing this cluster in adhesion-inhibition assays, a multivalency 
effect, albeit of weak nature, was observed and conjugation with a biorepulsive OEG linker paved 
the way towards further studies on functional surfaces. 
Furthermore, the property of cyclodextrins to undergo inclusion of hydrophobic guest molecules 
was utilized for developing a novel bacterial adhesion assay. Therefore, several cyclodextrin hosts 
and carbohydrate- as well as azobenzene-based guest molecules were synthesized and tested in 
different approaches in respect of the new assay. In the most successful approach, mannose 
cyclodextrin conjugates served as host molecules for inclusion of azobenzene units on 
photoresponsive PEG beads. It was demonstrated that UV light-induced isomerization of the 
azobenzene units resulted in a reduced bacterial adhesion to the functional beads. In this regard, 
the extent of this effect showed a high dependence on the molecular structure of the applied 
azobenzene derivative. Further development of this system gives rise to a broad spectrum of 
applications, such as the extraction or accumulation of pathogens from fluid samples. 
  
  
Kurzfassung 
Pathogene Escherichia coli (E. coli)-Bakterien sind verantwortlich für eine Reihe von Entzün-
dungskrankheiten wie z. B. neonatale Meningitis, Harnwegsinfektionen und Gastroenteritis, 
welche durch Adhäsion von Bakterien an die Oberfläche menschlicher Zellen ausgelöst werden. 
Typ-1-fimbriierte E. coli-Bakterien nutzen dabei ein Mannose-spezifisches Lektin, FimH, an der 
Spitze adhäsiver Organellen, den Fimbrien, um an Zellen mit hochmannosidischen Oberflächen-
sacchariden zu binden. Die Synthese von potenten Inhibitoren und die Entwicklung innovativer 
Techniken zur Untersuchung dieser Form der bakteriellen Adhäsion sind daher sowohl von 
großer wissenschaftlicher als auch medizinischer Bedeutung und motivieren die hier beschriebe-
nen Forschungsarbeiten. 
Zunächst wurden unter Anwendung der sogenannten Amadori-Umlagerung Liganden des bakte-
riellen Lektins FimH synthetisiert und im Anschluss durch Dockingstudien sowie biologische 
Tests validiert. Wie sich herausstellte, ist die Komplexierung dieser Amadori-Produkte in der 
Lektin-Bindungstasche beeinträchtigt und dadurch die inhibitorische Aktivität gegenüber FimH-
vermittelter bakterieller Adhäsion eingeschränkt. Ergänzend zu diesen Arbeiten war es interes-
sant, die Amadori-Umlagerung für die Synthese farbiger Produkte einzusetzen, um die chromato-
graphische Reinigung der sehr polaren Amadori-Produkte zu vereinfachen und zu beschleunigen. 
In einer Synthese-orientierten Studie wurde die Präparation eines AB4-funktionalisierten Kohlen-
hydrat-Scaffoldmoleküls anhand einer retrosynthetischen Analyse diskutiert und nach sorgfälti-
ger Untersuchung realisiert. Ausgehend von dieser Zielverbindung war es möglich, weitere nützli-
che Glykokonjugate zu synthetisieren wie z. B. einen tetravalenten Glykocluster. Dieser führte in 
Inhibitionsassays einen – wenn auch schwach ausgeprägten – Multivalenzeffekt und wurde an-
schließend durch Konjugation mit einem OEG-Linker für weitere Studien auf funktionalen Ober-
flächen vorbereitet.  
Weiterhin wurde ein neuer Assay zur Untersuchung bakterieller Adhäsion entwickelt, der sich die 
Eigenschaft von Cyclodextrinen zu Nutze macht, hydrophobe Gastmoleküle einzulagern. Hierzu 
wurden verschiedene Cyclodextrin-Wirtsmoleküle sowie Kohlenhydrat- und Azobenzol-basierte 
Gastmoleküle hergestellt und in unterschiedlichen Ansätzen in Verbindung mit dem neuen Assay 
untersucht. Im erfolgreichsten Ansatz dienten Mannose-Cyclodextrinkonjugate als Wirtsmoleküle 
für die Einlagerung von Azobenzol-Einheiten auf photoaktiven PEG-Beads. Es konnte gezeigt 
werden, dass die Isomerisierung der Azobenzol-Einheiten durch UV-Licht eine Reduktion der 
bakteriellen Adhäsion an die funktionalen Beads zur Folge hat. Die Ausprägung dieses Effektes ist 
dabei stark von der molekularen Struktur der Azobenzol-Derivate abhängig. Die Weiterentwick-
lung dieses Systems verspricht eine Vielzahl von Anwendungsmöglichkeiten wie z. B. die Extrak-
tion oder Anreicherung von Pathogenen aus Flüssigkeiten. 
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How to Read This Thesis 
This thesis is comprised of seven chapters with different contents, regarding the information 
and the research presented therein: 
The general introduction (Chapter 1) of this thesis provides basic information about the field 
of glycobiology and bacterial adhesion. This chapter is especially important for readers that 
are not familiar with this kind of matter in order to fully understand the research presented 
herein. While Chapter 2 describes the objectives of the research embodied in this work, 
Chapter 3-5 comprise the actual results of the performed studies as well as their discussion. 
Each of these chapters includes a detailed introduction, which focuses on the respective 
theoretical background of the research presented in the corresponding chapter. Furthermore, 
Chapters 3-5 contain a published article, a submitted manuscript (and the corresponding 
Supporting Information), as well as unpublished results. Chapter 6 contains conclusions in 
form of a detailed summary of the obtained results. All experimental data as well as synthetic 
procedures are presented in the experimental section (Chapter 7). The appendix features 
UV/Vis spectra and chromatograms of selected compounds as well as abbreviations and lists 
of figures, schemes, and tables. 
In order to prevent possible confusion, page numbers are not shown in sections that present 
published articles or manuscripts since these have their own page numbers. 
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1. General Introduction 
1.1 Carbohydrates and Their Role in Nature 
One of the most abundant classes of compounds found in nature are carbohydrates. These so-
called glycans occur in various forms and have earlier been considered solely as a source of 
energy or as structural material. After the progress of analytical technology and research on 
the field of glycobiology, however, they have increasingly been recognized as part of other 
biomolecules, such as glycoproteins or glycolipids. Depending greatly on their molecular 
structure, their conformation as well as the presentation, these glycoconjugates mediate a 
variety of different functions that are essential to most biological systems including living 
organisms. 
Structural Diversity of Carbohydrates 
The term carbohydrate originates from the general chemical formula CnH2nOn (with n ≥ 3) 
which describes their molecular composition as a combination of carbon and water. While 
basic monosaccharides consist of just one carbohydrate unit, oligo- and polysaccharides 
contain several moieties that are connected with each other through glycosidic linkages. In 
this regard, a large number of connection possibilities arise due to the number of hydroxyl 
groups available for intermolecular condensation, resulting in a high structural diversity of 
the oligosaccharides. Homopolysaccharides, such as cellulose, can be comprised of hundreds 
to thousands of D-glucose units joined through β(1→4) glycosidic bonds. While linear 
cellulose forms fibers, amylose has a helical shape comprised of D-glucose units, which, in 
contrast to cellulose, are connected through α(1→4) glycosidic linkages. Amylopectin has an 
even more complex structure, which is due to additional branching by α(1→6) glycosidic 
bonds every 24 to 30 glucose units (Scheme 1.1). Glycogen, a polysaccharide similar to 
amylopectin, has a much higher degree of branching and, thus, forms even bigger 
supramolecular structures. 
Cellulose can be found in green plants as a main component of the cell wall and, therefore, is 
regarded as the most abundant organic compound in nature. Amylose and amylopectin occur 
as a mixture in starch, which is produced in plants as a form of energy storage and is a very 
common carbohydrate in food such as wheat, potatoes or rice. Glycogen serves the same 
purpose as starch but can be found exclusively in animals and fungi, where it functions as a 
long-term energy storage next to fats.1  
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Scheme 1.1: Molecular structures of linear cellulose (top left), helical amylose (top right) and branched 
amylopectin (bottom). The supramolecular structure is illustrated next to the respective molecule. 
Carbohydrates in Biological Systems 
An intriguing fact about glycans is that they make up a large part of the membrane of all cells. 
In eukaryotic cells, the membrane consists of different lipids, which form a bilayer 
surrounding the cell, thus protecting it from external influences, such as pH changes or salts. 
Additionally, a variety of integral and peripheral membrane proteins are incorporated into 
the bilayer acting as receptors, ion channels or carrier proteins, for example (Figure 1.1A). 
All proteins and lipids that are incorporated into the cellular membrane are functionalized 
with highly complex glycans at specific glycosylation sites, resulting in a thick layer of 
carbohydrates, which surrounds the whole cell. Due to its location at the outer part of the cell, 
this so-called glycocalyx (cf. Figure 1.1B) interacts with a broad spectrum of binding partners 
that induces different biological processes, which depend greatly on the particular 
interaction.2 Many of these interactions have been investigated, showing that glycans as part 
of glycoproteins and glycolipids modulate cellular processes, such as signaling,3 molecular 
recognition4 and cell adhesion.5 
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Figure 1.1: A) Schematic illustration of a cellular membrane with various incorporated proteins and 
lipids, which are functionalized with glycans at particular glycosylation sites.2 B) Electron microscopic 
view of the glycocalyx of an endothelial cell.6 
N-Glycans 
There are two main types of glycans that are presented at protein glycosylation sites: N-linked 
and O-linked oligosaccharides. N-Glycans, being the most common kind of glycans, are bound 
to the amide group in the side chain of asparagine whereas the sequon (the sequence of 
consecutive amino acids) for N-glycosylation is Asn-X-Ser or Asn-X-Thr with X being any 
amino acid except proline. All N-glycans share a common core sequence of Manα1–6(Manα1–
3)Manβ1–4GlcNAcβ1–4GlcNAcβ1-Asn and are subdivided into three types: high-mannose, in 
which exclusively mannose units are attached to the core sequence; complex, in which two to 
seven highly variable “antennae” are attached to N-acetylglucosamine (GlcNAc) units at the  
beginning of the core; and hybrid, in which mannose units are attached only to the Manα1–6 
arm and one or two antennae to the Manα1–3 arm of the core (Figure 1.2).7 
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Figure 1.2: Types of N-glycans: high-mannose, complex and hybrid. Each N-glycan contains the 
common core Man3GlcNAc2Asn (blue square: GlcNAc; green circle: Man; yellow circle: Gal; purple 
square: Neu5Ac; purple triangle: fucose).8 
O-Glycans 
O-Glycans mainly occur in mucins, which are heavily O-glycosylated glycoproteins, acting as 
transmembrane proteins of cell surfaces, and can additionally be found in mucous secretions. 
In contrast to N-glycans, mucin O-glycans begin with an α-linked N-acetylgalactosamine 
(GalNAc) unit at the reducing end, which is linked to the side chain of serine or threonine. The 
GalNAc unit is often extended with other carbohydrates, such as N-acetylglucosamine 
(GlcNAc), galactose, fucose, or sialic acid, but most importantly not mannose, glucose, or 
xylose units. Mucin O-glycans can be branched and modified by O-acetylation of sialic acid and 
O-sulfation of galactose and GlcNAc.9 
Glycolipids 
Despite the sometimes heavy glycosylation of glycoproteins, the majority of carbohydrates on 
the cell surface are part of glycolipids. Glycans of this complex and diverse family of 
glycoconjugates are connected to a hydrophobic portion, which is most of the times 
incorporated into the cell membrane so that the carbohydrate is located in the extracellular 
matrix. But not all glycolipids are located at the cell surface and, for example, occur in the 
lumen of the endoplasmic reticulum (ER). Subfamilies of glycolipids are glycoglycerolipids, 
glycophosphoglycerolipids, glycosylated sterols, glycosylated prenols, lipopolysaccharides, 
and glycosphingolipids. The latter subfamily, including gangliosides, is one of the most 
frequently researched since it is involved in important cell signaling processes and occurs 
mainly in the nervous system. Glycosphingolipids are defined as glycolipids in which the 
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carbohydrate residue is connected to a ceramide backbone comprised of a sphingoid base, 
which is N-acylated with a long-chain fatty acid (Scheme 1.2).10 
 
Scheme 1.2: Representative molecular structures of the glycosphingolipids lactosylceramide (top) and 
ganglioside GM3 (bottom). 
 
1.2 Lectins and Their Relevance for Bacterial Adhesion 
Glycans present in biological systems (whether at cell surfaces or in solution) are recognized 
and bound by specific carbohydrate binding proteins, which are called lectins. The specificity 
of the interaction with a particular carbohydrate can be as high as that between a substrate 
and an enzyme, or an antigen and an antibody.11 However, the strength of a single lectin-
monosaccharide interaction is relatively weak with dissociation constants in the micromolar 
to millimolar range.12 
The first lectin was discovered and isolated in 1888 from the seeds of the castor oil plant by 
Herrmann Stillmark who described the agglutination of erythrocytes (red blood cells) by 
ricin.13 At that time, this hemagglutination behavior, however, was not connected to the 
binding of carbohydrates by the isolated protein. This relation was drawn later by isolation of 
the well-known plant lectin concanavalin A (Con A) from the jack bean, being the first lectin 
which was identified to have a preference for binding of carbohydrates.14 Although lectins 
were first discovered in plants, numerous lectins have been isolated from microorganisms 
and animals as well. Elucidation of the structures of various lectins from different sources has 
shown that their primary sequences mostly lack similarities, although they often share 
similarities in their tertiary structures. Further investigations, however, have revealed that 
the carbohydrate specificity of each lectin is caused by a conserved amino acid sequence 
forming the so-called carbohydrate recognition domain (CRD). Recognizing the terminal non-
reducing carbohydrate moiety of glycan ligands, the CRD particularly discriminates between 
the α- and β-anomers, resulting in different binding affinities.15  
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Lectins in Bacteria 
Like in the case of ricin, the ability to agglutinate erythrocytes has also been identified for 
bacteria, especially of the Enterobacteriaceae family. This hemagglutination activity is linked 
to the interaction of filamentous protein appendages on the bacterial surface, so-called 
fimbriae, with the glycosylated erythrocytes. Lectin subunits on the fimbriae mediate this 
carbohydrate-specific adhesion of the bacteria to the cell surface and, hence, the subsequent 
agglutination. This phenomenon of bacterial colonizing of cell surfaces by recognition and 
binding of the sugar decoration on cells has also been observed, for example, in the case of 
epithelial cells.16 
 
1.3 Type 1 Fimbriae-mediated Bacterial Adhesion 
Pathogenic Escherichia coli (E. coli) bacteria are responsible for a number of infectious 
diseases, such as neonatal meningitis, urinary tract infections, and gastroenteritis, which are 
triggered by adhesion of the bacteria to human cells. Adhesion occurs mainly via different 
types of fimbriae on the bacteria’s surface (Figure 1.3A).17 One important class of these 
adhesive organelles are type 1 fimbriae, which have been found to be responsible for specific 
adhesion to cells bearing glycans with a high mannose content.18 
This special type of fimbriae is composed of the main structural pilus subunit FimA forming 
the pilus rod, subunits FimF, FimG, and the mannose-specific adhesin FimH, which form the 
distal tip fibrillum. Assembly of the fimbriae proceeds by a chaperone-usher pathway in the 
periplasm. Here, the fimbrial subunits (FimA, FimF, FimG, and FimH) enter in an unfolded 
conformation and form complexes with the chaperone FimC. Upon interaction with the usher 
FimD, which forms a pore in the outer membrane of the cell, the chaperone-subunit 
complexes again dissociate and the chaperone remains in the periplasm. The subunits then 
cross the outer membrane through the FimD pore and become incorporated into the growing 
pilus (Figure 1.3B).19 
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Figure 1.3: (A) TEM image of an E. coli cell, showing fimbriae on the cell surface.20 (B) Assembly of 
type 1 fimbriae according to the chaperone-usher pathway inside the periplasm. IM: inner membrane; 
OM: outer membrane; FimH: fimbrial lectin; FimC: periplasmic chaperone; FimD: fimbrial usher 
protein; FimA, FimD, FimF, and FimG: other fimbrial subunits.19 
The Bacterial Lectin FimH 
Examination of the crystal structure of a FimH-FimC chaperone complex has revealed that the 
adhesin FimH actually consists of two domains, a FimHP pilus domain and a FimHL lectin 
domain.21 Therein, the C-terminal FimHP domain functions as a sort of anchor, attaching the 
N-terminal mannose-binding FimHL domain to the pilus. At the tip of this domain, the CRD of 
FimH can be found, which is capable of binding a mannose moiety in its α-configuration. Later, 
an X-ray structure of FimH containing a mannose molecule inside the CRD was analyzed.22 It 
was found that the hydroxyl groups of the mannose (excluding the anomeric hydroxyl group) 
interact with amino acids inside the FimH CRD through hydrogen bonds, especially with 
residues Phe1, Asn46, Asp47, Asp54, Gln133, Asn135, Asp140, and Phe142. Interestingly, 
mannosides which contain an aromatic portion, such as p-nitrophenyl α-D-mannoside 
(pNPMan), have been found to exhibit increased affinities for the CRD of FimH. Two distinct 
tyrosine residues Tyr48 and Tyr137, which form the so-called “tyrosine gate”, near the 
entrance of the CRD (cf. Figure 1.4) undergo π-π interactions with the glycoconjugate’s 
aromatic system, thus, improving the overall complexation within the CRD.23 
A B 
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Figure 1.4: (Left) Molecular structure of an aromatic α-D-mannoside containing a squaric acid ester 
attached to the chloro-substituted phenyl ring in the aglycone. (Middle) Amino acid residues located at 
the entrance of the CRD of FimH. The “tyrosine gate” is formed at the entrance of the CRD by tyrosine 
residues Tyr48 and Tyr137. (Right): The CRD depicted as a Connolly surface, complexing the aromatic 
mannoside, which is presented as a CPK model. The aromatic system interacts with the “tyrosine gate” 
at the rim of the CRD.24 
1.4 Investigation and Control of Bacterial Adhesion 
Bioconjugation of Carbohydrates 
For investigation of type 1 fimbriae-mediated bacterial adhesion, the synthesis of appropriate 
glycoconjugates by utilization of efficient chemical reactions is an unavoidable step. The field 
of bioconjugation is concerned with the research of selective reactions that allow for synthesis 
of glycoconjugates without involving protecting group manipulations, resulting in a high 
product yield and minor to no by-product formation. This methodology is an essential tool 
not only for investigation of bacterial adhesion, but also for the discovery of new drugs against 
diseases that are mediated through protein-carbohydrate interactions. Fields of application 
for bioconjugation concern the fabrication of glycoarrays on different surfaces (e. g. gold, 
polystyrene, glass), the preparation of oligovalent glycoconjugates, such as glycoclusters and 
glycodendrimers, and labeling of carbohydrates with fluorescent markers or other tags like 
biotin, for example.25 Several reactions have been successfully employed in this regard, such 
as native chemical ligation,26 Staudinger ligation,27 thiol-maleimide ligation,28 Diels-Alder 
reaction29 and so-called “click chemistry”.30 Within the click chemistry concept, the copper(I)-
catalyzed azide alkyne cycloaddition (CuAAC) has become the most prominent reaction.30b, c 
It is an advanced variant of the azide-alkyne Huisgen cycloaddition as first elaborated by 
Huisgen31 in the 1960s. 
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The Cluster Effect 
Since a single lectin-carbohydrate interaction is rather weak, optimization of the aglycone in 
order to increase the strength of interaction has been extensively performed over recent 
years. Another approach to improve these interactions is the investigation of multivalent 
glycoconjugates, which contain several mannose residues for the interaction with the lectin. 
It has been observed that a linear increase of ligand valency often results in a logarithmic 
increase of the avidity (the overall strength of all lectin-carbohydrate interactions).32 For this 
phenomenon, the term “cluster effect” was coined, which is especially pronounced in lectins 
having multiple CRDs.33 However, this effect has also been observed in the case of the bacterial 
lectin FimH, which was proven to be monomeric and having just one CRD. It was suggested 
that the observed cluster effect, in this case, is a result of an increased effective concentration 
of mannosyl residues in close proximity to the CRD of FimH. Therefore, quick rebinding of a 
mannose residue is statistically favored in multivalent ligands after release of a previously 
bound mannoside from the CRD.16 
Control of Bacterial Adhesion by Photoresponsive Glycoconjugates 
As described above, the extent of bacterial binding to glycoconjugates depends strongly on 
the molecular structure of the employed glycoconjugate, concerning the chemical nature of 
its aglycone as well as its valency. However, also the spatial arrangement of the presented 
carbohydrate residues, for example, on a surface has been found to be quite critical for the 
efficiency of bacterial adhesion. Approaches that are based on the control of the spatial 
arrangement of carbohydrates and, thus, the extent of bacterial adhesion, involved particular 
mannosides containing a photoresponsive azobenzene portion.34 
Azobenzene35 is a well-known photoresponsive molecule, which has been widely studied with 
regard to its properties towards photoisomerization.36 When the planar and more stable E 
isomer is irradiated with UV light (λ ≈ 365 nm), isomerization to the bent Z form is induced.37 
In case of exposure to visible light or upon thermal relaxation, back-isomerization to the E 
isomer takes place. The half-time (τ1/2) of thermal Z→E relaxation can vary significantly 
depending i. a. on the substitution of the aromatic system (Scheme 1.3).38 
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Scheme 1.3: Irradiation with UV light induces reversible E/Z photoisomerization of azobenzene. Z→E 
back-isomerization can be effected by exposure with visible light or thermal energy. 
The first contribution which demonstrated that the photoisomerization of azobenzene 
glycosides and the resulting change in spatial orientation of carbohydrate moieties affects 
type 1 fimbriae-mediated bacterial adhesion was made by Weber et al. in 2014. Therein, the 
specific adhesion of type 1 fimbriated E. coli to azobenzene mannoside ligands, with a given 
orientation by the configuration of an azobenzene monolayer on a non-physiological surface, 
was investigated. Changing the orientation of the ligands by means of photoisomerization is 
thought to influence the recognition behavior of E. coli bacteria, resulting in greatly decreased 
adhesion. Furthermore, it was demonstrated that Z→E back-photoisomerization led to the 
original orientation of the carbohydrate moieties and thus restored bacterial adhesion (Figure 
1.5).34a 
 
Figure 1.5: The adhesion of type 1 fimbriated E. coli cells is mediated by the lectin FimH at the fimbrial 
tip. Cellular recognition is depending on the spatial orientation of azobenzene mannosides immobilized 
on the surface, which can be changed by reversible E/Z photoisomerization with two different 
wavelengths.34a 
In another approach, the methodology described above was applied to the surface of HMEC-1 
human cells. Azobenzene glycosides were attached to the cell surface via click chemistry and 
the cells were subsequently irradiated with UV light. Investigation of type 1 fimbriae-
mediated bacterial adhesion under static as well as flow conditions demonstrated that 
 General Introduction 11 
adhesion to the azobenzene glycoside-modified cell surface is higher in the E than in the Z-
state (Figure 1.6).34b 
 
Figure 1.6: Reversible E/Z isomerization employing UV or visible light, respectively, allows to change 
the orientation of the azobenzene-conjugated sugar and to manipulate sugar-specific bacterial 
adhesion in parallel.34b 
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2. Objectives 
Adhesion of bacteria to human cells is a crucial step in the initiation of several infectious 
diseases. With the rise of bacterial strains that have become resistant to previously effective 
antibiotics, fighting these diseases is getting more difficult. This emphasizes the importance 
of research on bacterial adhesion for the further understanding of this process and the 
development of efficient strategies for the treatment of bacterial infections. 
In the scope of this thesis, variable methodological approaches were studied in order to 
support and facilitate research in the field of bacterial adhesion. Since bioconjugation is an 
essential tool for the synthesis of glycoconjugates needed for investigation of bacterial 
adhesion, new ligation methods according to the bioconjugation methodology are of special 
interest. Chapter 3 focuses on the exploration of the Amadori rearrangement as a potential 
candidate for bioconjugation of carbohydrates. In this chapter, the synthesis of different 
Amadori products is presented as well as their examination by molecular modeling and 
biological testing. Furthermore, colored Amadori products are applied in order to facilitate 
their chromatographic purification. 
Glycoclusters as well as carbohydrate scaffold compounds, which can be utilized as 
precursors for carbohydrate-centered glycoclusters, are valuable tools for investigation of 
multivalency effects in bacterial adhesion. Chapter 4 involves the synthesis of various AB4-
type carbohydrate scaffolds and a tetravalent glycocluster. Additionally, biological testing of 
the glycocluster is presented in respect of the investigation of multivalency effects in bacterial 
adhesion. 
In order to enhance and facilitate research in the field of bacterial adhesion, developing new 
assay systems is an important step. In Chapter 5, different approaches for the development of 
a new assay format, which allows for “switchable” cell adhesion, are presented. Based on 
inclusion of azobenzene guest molecules into cyclodextrin hosts, this assay system allows for 
attenuation of bacterial binding to certain glycoconjugates, which are either connected to the 
host or the guest molecule. Switching of cell adhesion is initiated by photoisomerization of the 
respective azobenzene unit, disrupting the host-guest-complexes.
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3. Exploration of the Amadori Rearrangement for Bioconjugation 
of Carbohydrates 
3.1 Introduction 
In general terms, the Amadori rearrangement is the acid-catalyzed reaction between α-
hydroxy aldehydes and amines, leading to α-amino ketones. When applied to carbohydrates, 
aldoses like D-glucose (1) also undergo this rearrangement upon reaction with suitable 
amines, forming the respective C-glycosyl type 1-amino-1-deoxyketoses, such as 2 (Scheme 
3.1).  
 
Scheme 3.1: Amadori rearrangement between an amine and D-glucose (1). The rearrangement product 
is the respective 1-amino-1-deoxyketose 2. 
The history of the Amadori rearrangement goes back to the year 1925 when the Italian 
chemist M. Amadori39 claimed to have isolated two compounds by reacting D-glucose (1) with 
different aromatic amines, defining the products as a mixture of the respective glucosyl 
amines as well as the related Schiff bases. In the mid-1930s, Kuhn and Dansi40 revised 
Amadori’s experiments and concluded that the compounds he obtained were actually 
products of a new type of rearrangement reaction. In continuation, Kuhn and Weygand41 
described the mechanism of this reaction (Scheme 3.2), which they named the Amadori 
rearrangement. The initial step therein is the nucleophilic attack of an amino group at the 
anomeric carbon of an aldose like 1, forming a glycosylamine 3. Protonation induces ring 
opening and creates a Schiff base 4 which is in equilibrium with its enol form 5 due to 
enamine-imine tautomerism. Thus, tautomerization turns the enol 5 into the more stable 
ketone, namely 1-amino-1-deoxyketose 6, which cyclizes to the respective hemiketal upon 
attack of the primary hydroxyl group at the carbonyl carbon. 
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Scheme 3.2: Mechanism of the Amadori rearrangement, exemplified with D-glucose (1). Nucleophilic 
attack of an amine at the anomeric position of 1 creates a glycosylamine 3. After protonation and ring 
opening, the Schiff base 4 is formed, which is in equilibrium with its enol form 5. Keto-enol tautomerism 
results in 1-amino-1-deoxyketose 6, undergoing ring closure to the corresponding hemiketal. 
The Amadori rearrangement, together with the Heyns42 rearrangement, is known as the initial 
step of the Maillard43 reaction cascade, as a form of non-enzymatic browning of food. Being of 
great importance for flavor, taste, and color, it is a result of food processing under the 
influence of heat.44 In this highly complex cascade of parallel and subsequently proceeding 
reactions, amino groups in amino acids, peptides, and proteins, respectively, react with 
reducing sugars. This affects the nutritional quality and, in some cases, also involves the 
formation of hazardous substances, such as the potentially cancerogenous acrylamide.45 
Application of the Amadori Rearrangement in Organic Synthesis 
Besides its occurrence in nature, the Amadori rearrangement has also found several 
applications in carbohydrate chemistry. In 1959, Kuhn et al. reported an attractive procedure 
for the synthesis of lactulose from lactose by employing the Amadori rearrangement as a key 
step.46 This contribution is a sophisticated alternative to the previous synthesis of lactulose, 
which has been accomplished by application of the Lobry de Bruyn–Alberda van Ekenstein 
rearrangement.47 Later, Paulsen et al. applied an intramolecular Amadori rearrangement in 
the synthesis of an iminosugar.48 Iminosugars are carbohydrate analogs, where the endocyclic 
ring oxygen is substituted by a nitrogen atom. This important class of compounds has been 
identified as powerful glycosidase inhibitors.49 
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Despite its successful application in complex synthesis, the Amadori rearrangement suffers 
from a number of preparative drawbacks. The products arising from the reaction are prone 
to enter the Maillard cascade, leading to formation of unwanted by-products. These can act as 
initiators of subsequent reactions, such as dehydration, cyclization, oxidation, or 
fragmentation, resulting in a variety of secondary products. In addition, the products are often 
not very stable and may decompose during prolonged reaction times.50 
Four main factors significantly influence the efficiency of the Amadori rearrangement: the 
nature of the employed amine and carbohydrate, the temperature, the reaction time, and the 
acid catalyst. In this regard, the Wrodnigg group was able to optimize the reaction conditions 
for the introduction of various amines onto the C-1 position of different carbohydrates 
without the requirement of any protecting group manipulations.51 Three potent analogs of 
glycosidase inhibitor 2,5-dideoxy-2,5-imino-D-mannitol52 were prepared by starting from a 
glucofuranose 7 (Scheme 3.3). Three different amines were then utilized for the Amadori 
rearrangement, giving products 8, 9, and 10, respectively, in remarkably high yields. Final 
cyclization by means of intramolecular reductive amination gave inhibitors 11, 12, and 13, 
respectively. 
 
Scheme 3.3: Application of the Amadori rearrangement in the synthesis of glycosidase inhibitors 11, 12 
and 13. a) Dibenzylamine, AcOH, EtOH, 40 °C, 1 h, 90%; b) 3-(benzylamino)propionitrile, 40 °C, 1 h, 
83%; c) aminohexanol, AcOH, 40 °C, 1 h, 96%; d) H2, Pd(OH)2/C, MeOH, 4 d, 52%; e) H2, Pd(OH)2/C, 
MeOH, 24 h, 31%; f) H2, Pd(OH)2/C, MeOH, 2 h, 26%. 
Each final step in the synthesis of 11, 12, and 13 involves the cyclization of the respective 
Amadori products 8, 9, and 10 through a sequence of successive reactions. Although a precise 
mechanism of this cyclization has not been published so far, a conceivable mechanism is 
presented by the example of Amadori product 8 (Scheme 3.4). Therein, initial hydrogenation 
of Amadori product 8 results in both reduction of the azide at the C-5 position as well as 
debenzylation of the C-1 amino group. Intramolecular attack of the C-5 amine at the anomeric 
18 Exploration of the Amadori Rearrangement for Bioconjugation of Carbohydrates  
carbon of 8a induces ring closure, forming the corresponding Schiff base 13a, which is 
subsequently reduced to the glycosidase inhibitor 13. 
 
Scheme 3.4: A conceivable mechanism for the cyclization of Amadori product 8, resulting in glycosidase 
inhibitor 13.  
As demonstrated by the examples described above, the Amadori rearrangement can be 
utilized as a powerful glycoconjugation method. However, it is important to stress that the 
reactants as well as the reaction conditions have to be adapted for every individual example 
in order to minimize side reactions and, hence, the amount of formed by-products. If these 
criteria are met, this glycoconjugation reaction may be suited for certain applications in the 
field of bioconjugation (cf. Chapter 1.4). The rearrangement products as C-glycosyl type 
glycoconjugates are of special interest for biological investigations since the glycosidic linkage 
of such compounds has a higher stability towards physiological hydrolysis, compared to the 
natural occurring O- as well as N-glycosides.53 Even enzymatic deglycation of Amadori 
products does not occur in the presence of regular glycosidases, which catalyze O-glycoside 
hydrolysis. The most frequently researched deglycating enzymes are fructosyl amine 
oxidases, which catalyze the oxygen-mediated oxidation of Amadori compounds through 
cleavage at the ketoamine bond followed by release of the amine, glucosone, and H2O2. 
Although this class of enzymes mostly occurs in fungi and bacteria but not in mammals, 
however, only fructose-derived Amadori products are recognized and oxidized.54 
This chapter covers the investigation of the Amadori rearrangement as a potential 
bioconjugation method. Research on this project was performed in collaboration with the 
Glycogroup at the TU Graz, owing to their enormous experience in this field, in the frame of a 
DFG project.55 While the Glycogroup investigated different types of mono- but also 
multivalent Amadori rearrangement reactions,56 I focused on biological testing of particular 
compounds in connection with the published manuscript in Chapter 3.2, which involves 
Amadori products as FimH ligands. Furthermore, I conducted special applications of the 
Amadori rearrangement in terms of chromophore-assisted purification57 (cf. Chapter 3.3). 
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3.2 Are D-manno-configured Amadori Products Ligands of the Bacterial Lectin 
FimH? 
T.-E. Gloe*, I. Stamer*, C. Hojnik*, T. M. Wrodnigg, T. K. Lindhorst, Beilstein J. Org. Chem. 2015, 
11, 1096–1104. 
* These authors contributed equally 
The Lindhorst research group has outstanding experience in the investigation of type 1 
fimbriae-mediated bacterial adhesion. In the course of this research, a wide range of different 
mono- but also multivalent glycoconjugates have been synthesized and tested as inhibitors in 
bacterial adhesion studies. Concerning the synthesis, the group has often made use of efficient 
and selective ligation reactions, such as thiourea coupling, native chemical ligation, or click 
chemistry in order to realize their syntheses. Therefore, the investigation of chemoselective 
ligation methods, particularly for the synthesis of new FimH ligands, is of high interest. 
In the following article we applied the Amadori rearrangement in the synthesis of two C-
glycosyl type D-mannoside analogues and investigated both glycoconjugates as ligands of 
type 1 fimbriated E. coli in molecular modelling studies and biological tests. It was found that 
both ligands have a reduced potency as inhibitors of bacterial adhesion, which was supported 
by molecular modelling studies, revealing that the complexation inside the carbohydrate 
binding site of FimH is hampered by the β-C-glycosidically linked aglycone. 
 
Figure 3.1: Using the Amadori rearrangement, D-manno-configured hexoses can be synthesized from 
appropriate heptoses and amines. Since the aglycone in these compounds is connected through a β-C-
glycosidic linkage to the anomeric carbon, the complexation in the FimH carbohydrate binding site 
requires a different binding mode as for regular α-D-mannosides.
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For this project, C. Hojnik synthesized and characterized the tested substances, I. Stamer 
performed and interpreted the molecular modelling studies and I conducted the biological 
tests and evaluated the obtained data. All authors contributed in writing the article as well as 
the Supporting Information (SI).
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3.3 Synthesis of Colored Amadori Rearrangement Products 
Whereas the Amadori rearrangement has been applied in complex carbohydrate chemistry, 
Amadori products are prone to undergo subsequent reactions, forming complex mixtures of 
unwanted by-products. Depending on the structure of the amine as well as the carbohydrate 
utilized for the reaction, purification of rearrangement products can be demanding and, in 
some cases, form the main challenge of the method.50 Due to the high polarity of both the 
unprotected carbohydrate moiety and the amino group at the C-1 position of the Amadori 
product, purification by preparative silica gel column chromatography can be sometimes 
restricted as it requires highly polar solvent mixtures, risking contamination with silica by 
column bleeding. 
A conceivable way to overcome the problem of high product polarity is acetylation of the 
carbohydrate since this derivatization substantially increases the hydrophobicity of the 
compound. Nevertheless, acetylation of an Amadori product would not only effect the 
hydroxyl groups of the sugar ring but also the amino group at the C-1 position. Consequently, 
in a final deprotection step, cleavage of the N-acetyl group would be necessary besides O-
deacetylation. This, however, often requires harsh reaction conditions,58 implying the risk of 
decomposition. 
A different approach, which facilitates and accelerates chromatographic purification of 
organic compounds, is the use of chromophore-tagged reaction products. In this regard, the 
Lindhorst group has established a methodology that allows for visual tracking of the 
separation process during chromatographic purification (Figure 3.2). For this strategy, the 
term “chromophore-supported purification” (CSP)57 was coined and it has been 
demonstrated in the parallel synthesis and purification of different carbohydrate derivatives. 
The color labels used in CSP are based on guaiazulene, an azulene derivative which is much 
cheaper compared to plain azulene but has the same intense blue color, making it ideal for 
visualization of organic compounds. In earlier work, tagging of alcohols as well as amines was 
addressed by application of different guaiazulene-derived reagents.57, 59 In a similar approach, 
Timmer et al. have employed azulen-1-yl-dicarbonyl as a protecting group for alcohols. Using 
this azulene-derived reagent, the protection as well as deprotection of various carbohydrate 
derivatives has been demonstrated.60 
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Figure 3.2: Application of the CSP methodology allows for visual tracking of the separation process 
during preparative column chromatography and, additionally, the isolation of target compounds is 
facilitated.61 
Employing the CSP methodology in connection with the Amadori rearrangement may be of 
great use in order to facilitate the chromatographic purification of Amadori products. Not only 
does the introduction of a guaiazulene moiety result in visualization of the Amadori product 
as well as the formed side products, but it also increases the hydrophobicity of the molecule 
so that less polar solvent mixtures can be used in chromatography. For this reason, a 
guaiazulene-tagged amine 18 was chosen, which is accessible from the well-known 
guaiazulene carbonate derivative 17.59 
 
Results and Discussion 
The guaiazulene carbonate derivative 17 was prepared following a known procedure, which 
was first described by Aumüller et al.59 Here, plain guaiazulene (14) was deprotonated by 
lithium diisopropylamide (LDA), resulting in the resonance stabilized anion 15, which was 
further converted to alcohol 16 by treatment with paraformaldehyde. The targeted 
carbonate 17 was obtained by a reaction with N,N´-disuccinimidyl carbonate (DSC) and was 
subsequently treated with ethylenediamine to give the guaiazulene-tagged amine 18 in a very 
good yield. 
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Scheme 3.5: Synthesis of guaiazulene-tagged amine 18. a) LDA, Et2O, -35 °C, 40 min; b) (CH2O)n, -35 °C 
→ rt, 16 h, 54 %; c) DSC, pyridine, DMF, 40 °C, 16 h, 91%; d) ethylenediamine, 0 °C → rt, 16 h, 95%. 
The guaiazulene-tagged amine 18 and aminomethylazobenzene 19 (synthesis is described in 
Chapter 5.3.1) were used as chromophores for CSP of Amadori products. In order to obtain D-
manno- or D-gluco-configured Amadori rearrangement products, D-glycero-D-talo-
heptopyranose (20) and D-glycero-D-gulo-heptopyranose (21) were needed. While 20 was 
obtained commercially, instead of pure heptose 21a an epimeric mixture of D-glycero-D-
galacto/D-talo heptopyranose (21a/b)62 was provided by Cornelia Hojnik from the Glyco 
Group at the TU Graz. This mixture is equally suited for Amadori rearrangement reactions 
(compared to pure heptose 21a) since the C-2 stereocenter is converted to a keto group 
during the course of the reaction. 
For preparation of the gluco-configured Amadori products, guaiazulene-tagged amine 18 and 
azobenzene hydrochloride 19, respectively, were reacted with heptopyranose 20 (Scheme 
3.6) by application of optimized reaction conditions previously reported.62a, 63 The reaction of 
guaiazulene-tagged amine 18 was first carried out at a temperature of 40 °C applying acetic 
acid as the catalyst. However, thin layer chromatography (TLC) control revealed that the 
reaction did not proceed at first so that the temperature was successively raised to 70 °C. This 
drastically accelerated the reaction but at the same time induced the formation of several side 
products. Nevertheless, the intense color of the guaiazulene moiety greatly facilitated the 
chromatographic purification so that the product 22 could be obtained in an acceptable yield 
of 52% (66% based on conversion, 14% starting material reisolated). 
For the reaction of aminomethylazobenzene 19, triethylamine was used instead of acetic acid 
since, in this case, the respective triethylammonium chloride salt acts as the acid catalyst. The 
reaction proceeded very slowly so that almost no conversion could be observed. Therefore, 
an excess of 1.5 eq of the amine and an extended reaction time was applied, which eventually 
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gave the desired rearrangement product 23, however, in a low yield of 6% with slight 
contaminations. Here again, the formation of various side products was observed, though not 
to the same extent as for Amadori product 22 due to the low conversion of azobenzene 
derivative 19. 
 
Scheme 3.6: Amadori rearrangement of heptopyranoses 20 and 21a/b with guaiazulene-tagged 
amine 18 and azobenzene derivative 19, respectively. a) For product 22: EtOH, 1,4-dioxane, H2O, AcOH, 
70 °C, 5 h, 51%; for prouct 24: EtOH, 1,4-dioxane, H2O, AcOH, 70 °C, 7 h, 54%; b) for product 23: EtOH, 
1,4-dioxane, H2O, TEA, 70 °C, 10 h, 6%; The azobenzene Amadori compound 25 was obtained 
contaminated with side products. 
For preparation of manno-configured Amadori products, heptopyranoses 21a/b were 
reacted with amines 18 and 19, respectively, by applying the same reaction conditions as in 
the synthesis of the gluco-configured Amadori products (Scheme 3.6). As described above, the 
reaction of heptoses 21a/b with guaiazulene-tagged amine 18 also did not proceed at first 
and the temperature was raised to 70 °C. The formation of side products was similar as in the 
case of the gluco-configured compound and the manno-configured Amadori product 24 was 
obtained in a similar yield of 54% (59% based on conversion, 5% starting material 
reisolated). The rearrangement reaction of azobenzene derivative 19 and heptoses 21a/b 
proceeded very slowly so that also in this case an excess of the amine and an extended 
reaction time was applied. In contrast to the preparation of the respective gluco-configured 
compound, however, the desired Amadori product 25 was only obtained in heavily 
contaminated form together with side products, which were not further characterized. 
Comparison of the Amadori rearrangement reaction in the manno- and gluco-series, 
respectively, demonstrates that the configuration at the C-3 carbon of the respective heptose 
does not have a significant influence on the result of the reaction. Rather, it was the reactivity 
of the employed amine that played a key role for the success of the reaction. While application 
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of the guaiazulene-tagged amine 18 resulted in a good conversion in both cases (gluco and 
manno), the preparation of azobenzene Amadori compounds 23 and 25 was considerably 
hampered by the amine’s low reactivity. 
Despite the good conversion of guaiazulene-tagged amine 18, the formation of the observed 
side products undeniably influenced the yield of the reaction. It seems as if the carbamate 
group in the Amadori products 22 and 24 is not sufficiently stable under the conditions 
applied. The relatively high temperatures combined with the presence of acid may have 
resulted in partial cleavage of this functional group or induced other decomposition reactions. 
Nevertheless, the intense blue color of the guaiazulene moiety considerably facilitated the 
chromatographic purification of Amadori products 22 and 24 so that all impurities could be 
efficiently separated. 
Amadori reactions carried out with azobenzene derivative 19 were critically hampered and 
only resulted in very low formation of the corresponding products 23 and 25. Due to the 
insufficient conversion it can be speculated that the pH value resulting from the applied amine 
hydrochloride-triethylamine system may be unfavorable for the rearrangement reaction. In 
the future, the corresponding free amine may be preferably utilized for this particular 
reaction. As demonstrated above, the CSP method could be successfully applied in the 
synthesis of guaiazulene-derived Amadori products 22 and 24. Using the azobenzene moiety 
as a chromophore for CSP of Amadori products 23 and 25, however, turned out to be less 
efficient and resulted in pronounced tailing, which significantly affected the purity of the 
obtained products.
 Carbohydrate Scaffold-based Glycoclusters for Investigation of Bacterial Adhesion 43 
4. Carbohydrate Scaffold-based Glycoclusters for Investigation of 
Bacterial Adhesion 
4.1 Introduction 
Various kinds of scaffold molecules have been frequently utilized for the construction of 
complex dendritic glycostructures and glycoclusters. The synthesis of these branched 
compounds is of high interest for the establishment of new methods in combinatorial 
chemistry. In particular, multivalent carbohydrate-containing structures can be employed for 
the investigation of multivalency effects in lectin or bacterial binding.64 
A scaffold compound can be defined as a multifunctional molecule, which allows for 
(orthogonal) attachment of various moieties with different spatial orientations (Scheme 4.1). 
Benzene derivatives such as 1,3,5-tris(bromomethyl)benzene, for example, can be utilized as 
planar scaffolds while a tetraol allows for functionalization in a type of tetrahedral manner. 
More elaborate supramolecular compounds have been prepared by scaffolds derived from 
biomolecules, such as amino acids, peptides, and carbohydrates.65 The fixed stereochemistry 
of these compounds allows a three-dimensionally directed functionalization. Furthermore, 
each functional group can be addressed selectively based on their different reactivities or 
orthogonal functionalization. 
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Scheme 4.1: Examples of scaffold molecules allowing for further functionalization, resulting in a 
different spatial orientation of the attached moieties. 
The molecular rigidity and fixed stereochemistry of carbohydrates qualifies them as excellent 
scaffolds for the preparation of carbohydrate-centered glycomimetics. Especially their 
multifunctionality paves the way for interesting applications. For instance, it allows for direct 
introduction of five equal functional groups, which can be used to create carbohydrate-
centered octopus glycosides.66 Further branching of the introduced functionalities has also 
been employed in the preparation of dendrimers and larger glycoclusters.67 Additionally, 
functional groups can be introduced in an orthogonal manner based on an appropriate 
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protection group strategy. In this way, heteroglycoclusters have been prepared, which mimic 
glycans as present in native biological systems more closely than common homoglycocluster. 
This makes them valuable tools for the investigation of multivalent protein-carbohydrate 
interactions, which resemble those occurring in biological systems.68 
Uniformly derivatized glucoside scaffolds have been synthesized by alkylation of the well-
known β-propargyl glucoside 26 and of α-allyl glucoside 28 with either propargyl bromide or 
allyl chloride, respectively. While the propargylated scaffold 2769 has been employed earlier 
for further functionalization according to the click chemistry methodology, the allylated 
scaffold 2966a, c offers many other possibilities for further derivatization. 
 
Scheme 4.2: Synthesis of uniformly functionalized glucoside scaffold molecules. a) propargyl bromide, 
NaH, DMF, 54%; b) allyl chloride, NaH, TBABr, DMF, 76%. 
Many articles have been published involving the derivatization of allylated scaffold 29α and 
29β, respectively, to create glycoclusters or branched dendritic molecules (Scheme 4.3). 
Ozonolysis of 29α, for example, was utilized to prepare the pentaaldehyde 30,66a which was 
further derivatized to a valuable pentaamine via reductive amination. Another useful 
transformation is the epoxidation of the pentaalkene with m-chloroperoxybenzoic acid (m-
CPBA), giving pentaepoxide 31,70 which can be used, for example, as a starting material for 
ring opening reactions with nucleophiles. According to the concept of click chemistry, a 
photolytic thiol-ene reaction with cysteamine hydrochloride has been employed in the 
synthesis of pentaammonium hydrochloride 3266a in excellent yield. On the other hand, the 
hydroboration of pentaalkene 29β by 9-borabicyclo[3.3.1]nonane (9-BBN) was utilized to 
prepare pentaalcohol 33. Subsequently, multiple glycosylation reactions were applied to 
create a pentavalent glycocluster from this compound.71 
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Scheme 4.3: Derivatization of pentavalent scaffold 29α/β. a) 29α, O3, NaHCO3, CH2Cl2, MeOH, then PPh3, 
75%; b) 29β, m-CPBA, CHCl3, 70%; c) 29α, cysteamine hydrochloride, MeOH, h.ν (254 nm), 97%; 
d) 1. 29β, 9-BBN, THF, 2. NaOH, H2O2, 62%. 
A special class of carbohydrate scaffolds are those bearing an AB4-type functionalization. 
These scaffolds are synthesized mostly by an early introduction of the ‘A’ functional group in 
the aglycone, for instance, by a glycosylation reaction while the remaining hydroxyl groups 
are subsequently derivatized with a second ‘B’ functional group in a uniform manner. In this 
way, highly versatile scaffolds with an orthogonal functionality become available, which give 
rise to tetravalent glycoclusters, for example.64 Further applications involve labelling with 
tags, such as biotin, or immobilization on appropriate surfaces to form glycoarrays.72 
A variety of this kind of carbohydrate scaffolds has been synthesized and employed in 
different applications (Scheme 4.4). In analogy to the pentaalkene 29 described above, a 
tetraalkene 3473 was prepared, which bears an alkyl bromide chain in the aglycone. Later the 
same compound was employed in the synthesis of a tetravalent glycocluster 35.74 A different 
scaffold was prepared by propargylation from galactoside 36,75 which, on the other hand, was 
obtained from the respective allyl galactoside by a thiol-ene reaction with Boc-protected 
cysteamine. This scaffold 37 was efficiently transformed via CuAAC reaction into a 
biotinylated tetravalent glycocluster as a carbohydrate probe for coating of magnetic beads. 
In analogy, scaffold 4076 was prepared by propargylation of glucoside 38 and subsequent 
ester cleavage to yield 39. Further transformation via CuAAC reaction and peptide coupling 
yielded a potent lipopeptide vaccine. 
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Scheme 4.4: Synthesis of different AB4-type carbohydrate scaffolds and a tetravalent glycocluster. 
a) MeOH, h.ν (254 nm), 40%; b) 1. NaOMe, MeOH, 89%, 2. propargyl bromide, NaH, THF, 51%; 
c) 1. propargyl bromide, NaH, THF, 2. NaOH (2 M), 31% overall yield (starting from 38). 
This chapter covers different research topics involving the synthesis of carbohydrate-scaffold 
compounds and tetravalent glycoclusters as well as their biological testing towards inhibition 
of bacterial adhesion. While Chapter 4.2 presents a submitted manuscript, which includes the 
synthesis of carbohydrate-centered scaffold compounds, unpublished results from biological 
tests of a tetravalent glycocluster as well as the preparation of an OEG glycocluster conjugate 
are presented in Chapter 4.3. All syntheses in this chapter were performed by myself (unless 
indicated otherwise). 
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4.2 Synthesis of AB4 Carbohydrate Scaffolds as Branching Units in the 
Glycosciences 
T.-E. Gloe, A. Müller, A. Ciuk, T. M. Wrodnigg, T. K. Lindhorst, Carbohydr. Res. 2015, submitted. 
Carbohydrates are excellent scaffolds for the synthesis of carbohydrate-centered 
glycomimetics due to their molecular rigidity, fixed stereochemistry as well as their 
multifunctionality. Especially carbohydrate scaffolds containing functional groups that can be 
addressed in an orthogonal manner (such as AB4-type scaffolds) are valuable tools for the 
investigation of multivalency effects in lectin binding. Their orthogonal functionalization 
allows for both the introduction of several carbohydrate moieties but also attachment of the 
resulting glycocluster (or dendrimer) to a surface, for example. 
In the following manuscript, we report on the preparation of AB4-type carbohydrate scaffolds 
containing various ethyl aglycone moieties, functionalized with ‘A’ and four functional groups 
‘B’ at positions 2, 3, 4, and 6 of the sugar ring. Following a retrosynthetic approach, different 
synthetic pathways were evaluated to achieve AB4-type derivatization. Even unsuccessful 
routes, nevertheless, provided valuable precursor scaffold compounds for other applications. 
The final sequence was demonstrated in the synthesis of the targeted azido-functionalized 
N3(NHBoc)4-type scaffold, from which an isothiocyanate scaffold compound as well as a 
tetravalent glycocluster were prepared. Additionally, a photoresponsive scaffold compound 
containing an azobenzene moiety was synthesized. 
 
Scheme 4.5: Azide or isothiocyanate functionalized carbohydrate scaffolds can be transformed into the 
corresponding tetravalent glycocluster containing the ‘A’ portion as an orthogonal functional group for 
further derivatization.
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For this project, A. Müller prepared a propargylated azobenzene derivative for the synthesis 
of a photoresponsive scaffold compound and A. Ciuk prepared an allylated scaffold as a 
precursor molecule. All other compounds found in this manuscript were synthesized by 
myself. The manuscript was written by T. M. Wrodnigg, T. K. Lindhorst and myself, I prepared 
the supporting information.
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4.3 Investigation of Type 1 Fimbriae-mediated Bacterial Adhesion to 
Tetravalent Glycoclusters 
In Chapter 4.2, the synthesis of a tetravalent homoglycocluster 41 was reported, which bears 
four mannose portions and, in addition, an azido group in its aglycone. This functional group 
can be addressed for further functionalization by either conversion of the azide group, 
cycloaddition of an appropriate carbohydrate moiety, or by coupling to an activated surface 
for adhesion studies (Scheme 4.6). The latter approach is of particular interest because it 
allows for tests with tetravalent carbohydrate-centered glycoclusters. 
 
Scheme 4.6: The azide group (circle) in glycocluster 41 can be addressed in three different 
functionalization pathways: conversion to an isothiocyanate or amino group (A), cycloaddition of an 
appropriate carbohydrate moiety (B) or immobilization onto a suitable prefunctionalized surface (C). 
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Closer inspection of the azido function in the cluster 41 reveals that it is rather shielded by 
the surrounding carbohydrate moieties due to the relatively short ethyl linker connecting it 
to the carbohydrate scaffold. Its concealed position might hamper the immobilization process 
so that it was decided to attach a biorepulsive oligo ethylene glycol (OEG) linker to the cluster. 
The linker consists of an amino group for the actual surface coupling as well as an alkyne 
portion for attachment with the glycoclusters azido group by a CuAAC cycloaddition reaction. 
In addition to the facilitation of the immobilization process, attachment of such a biorepulsive 
linker is expected to decrease or eliminate unspecific adhesion of bacteria to, for example, 
polystyrene surfaces functionalized with this glycocluster. 
 
Results and Discussion 
4.3.1 Synthesis of OEG Linker 46 and Attachment to Glycocluster 41 
OEG linker 4677 was synthesized following a procedure of Norberg et al.77b starting from plain 
triethylene glycol (42), which in the initial step was alkylated with propargyl bromide. The 
remaining hydroxyl group of the resulting alkyne 43 was then converted into the respective 
tosylate 44 in order to serve as a leaving group in the next step. Treatment with sodium azide 
resulted in substitution of the tosylate, giving azide 45, which was finally reduced to the 
targeted amine 46 under the conditions of Staudinger reduction (Scheme 4.7). 
 
Scheme 4.7: Synthesis of OEG linker 46. a) KOH, propargyl bromide, 60 °C, 3 h, 34%; b) TsCl, KOH, 
CH2Cl2, 0 °C, 2 h, 84%; c) NaN3, TBAI, DMF, 70 °C, 4 h, 76%; d) PPh3, NH4OH, THF, rt, 16 h, 82%. 
For conjugation of the OEG linker 46 with the azido-functionalized glycocluster 41, CuAAC 
reaction conditions were applied according to a variant that generates the required copper(I) 
species in situ by reduction of copper(II) with sodium ascorbate.30b Although this variant of 
the click reaction is frequently used in complex organic synthesis due to its efficiency and, 
most importantly, its specificity, problems were encountered when applied to the 
glycocluster 41. It was found that the reaction was always incomplete (irrespective of the 
conditions applied), even when an excess of the linker 46 and/or the copper catalyst was 
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added after the initial reaction. Additionally, the highly polar nature of the click product 
precluded the separation from the high amount of remaining starting material. Finally the 
desired product 47 was obtained by utilization of copper(I) bromide and N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (PMDTA) as a complexing agent, which stabilizes the 
copper(I) species (Scheme 4.8). Although the conversion of 41 was still incomplete, it was 
significantly higher than in the previous method, thus, enabling purification of the product 47 
by reverse phase (RP) chromatography. Since it was necessary to use formic acid as a solvent 
additive, the product was obtained as the respective formic acid salt 47 in a yield of 50% (71% 
based on conversion, 21% starting material reisolated). 
 
Scheme 4.8: Synthesis of glycocluster OEG conjugate 47 by means of CuAAC reaction conditions. a) 46, 
CuBr, PMDTA, DMF, rt, 16 h, 50%. 
4.3.2 Adhesion-Inhibition Assay with Glycocluster 41 
In order to pave the way towards adhesion studies on glycoarrays fabricated from 
glycocluster 47, the inhibitory potency of glycocluster 41 towards type 1 fimbriae-mediated 
bacterial adhesion was investigated by performance of an adhesion-inhibition assay. For this, 
microtiter plates were coated with mannan, incubated with GFP-transfected E. coli 
(pPKL1162) and serial dilutions of glycocluster 41 and methyl α-D-mannoside (MeMan) were 
employed on the plates. After washing, fluorescence of adhering bacteria was detected, 
delivering inhibition curves, from which IC50 values were deduced (Figure 4.1). 
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Figure 4.1: Inhibition curves obtained with glycocluster 41 from inhibition of type 1 fimbriae-mediated 
bacterial adhesion to mannan. The depicted inhibition curves are representative examples from three 
independent experiments. MeMan was tested on the same microtiter plate. Error bars are standard 
deviations from three testing results on one plate. 
An inhibitor’s IC50 value represents the concentration at which it prevents 50% of bacterial 
adhesion. Comparison to the IC50 value of a standard inhibitor (in this case MeMan), which is 
tested on the same microtiter plate, allows for direct correlation of different inhibitors by 
comparing their so-called relative inhibitory potencies (RIP values), even if they were not 
tested on the same plate. In case of multivalent inhibitors, such as the glycocluster 41, a 
multivalency-corrected RIP value, RIPvc, has to be taken into account in order to receive its 
“true” inhibitory potency. The results obtained from the adhesion-inhibition assay are listed 
in Table 4.1. 
In the performed adhesion-inhibition assay, the RIP (based on MeMan) of glycocluster 41 was 
determined as approximately 26 and the RIPvc as 6.4. When the RIPvc value equals 1, no 
multivalency effect is observed so that the higher relative inhibitory potency results from a 
purely statistical advantage by the presence of multiple mannose residues available for lectin 
binding (cf. Chapter 1.4). Thus, in the case of glycocluster 41, a small multivalency effect was 
determined. However, this effect is not as pronounced as for similar carbohydrate-centered 
glycoclusters that have been reported, showing RIPvc values in the range of 16 to 36.66b, 78 
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Table 4.1: Inhibition of bacterial adhesion (E. coli) to a mannan-coated surface. The inhibitory potency 
of glycocluster 41 is compared to the standard inhibitor MeMan.a 
 MeMan Glycocluster 41 
IC50 ± SD (mM) 2.357 ± 1.032 0.0920 ± 0.0489 
RIP (MeMan) 1.0 25.6 
RIPvc – 6.4 
aSD: standard deviation (from three independent assays); RIP: relative inhibitory 
potency referenced to MeMan (tested on the same microtiter plate); RIPvc: valency-
corrected RIP. 
 
Thiourea-bridged glycoclusters containing a non-carbohydrate core have been found to 
provide significantly higher binding affinities of FimH in haemagglutination assays with 
type 1 fimbriated E. coli when compared to their natural glycoside counterparts. 
Furthermore, comparison of big glycoclusters (tetra-, hexa- and octavalent) with smaller 
clusters (di- and trivalent) revealed that the latter delivered higher relative inhibition titres 
(RITs).79 At first glance, these findings seem to be in contradiction to the results gathered from 
the testing of cluster 41. However, carbohydrate-centered clusters containing thiourea-
bridged mannose moieties have not been tested so far as inhibitors of type 1 fimbriae-
mediated bacterial adhesion. Therefore, it can only be speculated what may be the reason for 
the cluster’s reduced inhibitory potency compared to those reported containing natural 
glycosidic bonds. The most likely explanation seems to be a combination of both the radial 
arrangement of the mannose moieties fixed by the rigid mannose scaffold and the electronic 
and conformational properties of the thiourea groups. Furthermore, intramolecular 
interactions of these groups may evoke a geometric arrangement that is unfavorable for the 
preorganization of the presented mannose moieties as well as the recognition by the bacterial 
lectin. Interestingly, anomeric thiourea groups seem to mediate a strong dependence of the 
glycocluster-lectin recognition properties in regard to the geometrical shape of the 
investigated multivalent compound. This has been demonstrated by studies with the 
mannose-specific lectin Con A, revealing dramatic differences between thioglycoside- and 
glycosylthioureido- or glycosylamido-coated glycoclusters based on a cyclodextrin core80 but 
also by investigation of carbohydrate-centered thioglycoside- and glycosylthioureido-
glycoclusters.74
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5. Cyclodextrin Conjugates to Control Bacterial Adhesion 
5.1 Introduction 
Cyclodextrins (CDs) are cyclic oligosaccharides that are often referred to as cycloamyloses, 
cyclomaltoses, or Schardinger dextrins. As non-natural compounds they are obtained through 
enzymatic degradation of starch, one of the most essential and abundant polysaccharides 
found in nature. As part of the family of cage molecules, CDs have a hydrophobic cavity, which 
is available for inclusion or encapsulation of suitable molecules. This host-guest type 
relationship is often exploited in order to modify the properties of encapsulated guest 
molecules with regard to their biological, chemical, and physical characteristics. Besides their 
commercial breakthrough in the 1980s mainly in the food and pharmaceutical industry, other 
important fields for applications of CDs are chromatography, catalysis, biotechnology, 
cosmetics, agriculture, medicine, hygiene, textiles, and the environment.81 
 
5.1.1 The Discovery of Cyclodextrins and Elucidation of their Structure and 
Properties 
CDs were first discovered in the late 19th century by the French chemist Antoine Villiers when 
he described the fermentation of potato starch with Bacillus amylobacter, which under certain 
conditions resulted in the formation of so-called dextrins.82 While their structure at that time 
was unknown, the term “dextrins” had been used to generally describe (intermediate) 
degradation and/or decomposition products of starch.83 In the same year, Villiers proposed 
the name “cellulosine” due to the similar properties compared to cellulose, which – like 
cellulosine – is also resistant to acid hydrolysis and lacks reducing sugars.84 
In the early 20th century, the Austrian chemist and bacteriologist Franz Schardinger 
rediscovered the cellulosines reported by Villiers as crystalline side products of starch 
ingestion with a heat-resistant microorganism.85 He investigated the polysaccharides 
employing a colorimetric iodine test and was able to distinguish between two crystalline 
dextrins A and B,86 which he later named α- and β-dextrin.87 Although Villiers is known as the 
discoverer of CDs, Schardinger is acknowledged as being the “Founding Father” of CD 
chemistry, which is why they were called Schardinger dextrins until the 1970s. One of his 
most remarkable achievements, however, was the isolation of the microorganism that 
expresses the enzyme responsible for CD synthesis by degradation of starch. This novel 
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microorganism, namely Bacillus macerans, gave the same dextrins as before but in contrast to 
Villiers’ Bacillus amylobacter produced the crystalline polysaccharides in a 10-fold higher 
yield.88 Astonished about this result, Schardinger identified an explanation for his findings in 
the work of Robert Koch, a German physician and microbiologist, who had already stated that 
the bacillus Villiers employed for starch digestion was probably contaminated with Bacillus 
macerans due to the sterilization conditions he applied.89  
Although Schardinger never elucidated the structure of α- and β-dextrin, his hypothesis that 
they are cyclic polysaccharides was later confirmed by Karl Johann Freudenberg,90 who used 
a cryoscopic method for the determination of their molecular weights, being five glucose units 
for α- and six for β-dextrin.91 His findings, however, were placed in doubt by Dexter French, 
claiming that the method used by Freudenberg would have been inappropriate for 
determination of high molecular weights due to interference of impurities that have low 
molecular weights. Together with Robert E. Rundle, French determined the correct molecular 
weights of α- and β-dextrin by applying X-ray diffraction and crystal density measurements, 
revealing the numbers of glucose units as six for α- and seven for β-dextrin.92 Furthermore, 
he isolated γ-dextrin and determined its molecular size and structure using X-ray experiments 
and paper chromatography after partial acid hydrolysis and enzyme digestion. French’s 
experiments revealed eight joined glucose units for this dextrin.93 
Although French was the first to correctly describe the molecular composition of α-, β-, and 
γ-CD, it was Freudenberg who initially reported their molecular structure by studying the 
chemical as well as enzymatic hydrolysis and acetolysis of permethylated dextrins. As a result 
of his experiments, he could demonstrate that the investigated dextrins had a cyclic structure 
composed of glucose units joined by α-(1→4) glycosidic linkages.94 This type of connection 
forces the glucose units to arrange in a cone shape. While the conus contains an apolar cavity 
due to the carbohydrate carbon skeleton, the hydroxyl groups are located at the rims of the 
conus, giving these areas hydrophilic properties. In this context, a distinction can be drawn 
between the narrow edge (primary face) at which the primary hydroxyl groups are located, 
and the wide edge (secondary face, cf. Figure 5.1A) carrying the secondary hydroxyl groups. 
With increasing number of glucose units, the diameter of the conus increases from α- 
(0.57 nm) over β- (0.78 nm) to γ-CD (0.95 nm), giving rise to encapsulation of different guest 
molecules with varying sizes (Figure 5.1B).  
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Figure 5.1: (A) Arrangement of glucose units in a circular fashion due to α-(1→4) glycosidic linkages 
results in the cone-shaped molecular structure of CDs. The narrow edge contains the primary hydroxyl 
groups (primary face) while the secondary hydroxyl groups are located at the wide edge (secondary 
face). (B) Geometric dimensions of α-CD (n = 6), β-CD (n = 7), and γ-CD (n = 8).81 Modified from 
reference 81. 
An outstanding feature of CDs is their ability to encapsulate various (mainly) hydrophobic 
guest molecules. Already hypothesized by Schardinger in the early 20th century, this property 
was extensively researched later by Friedrich Cramer, who performed studies in solution as 
well as in the solid state. He discovered that the CDs toroidal form allows them to complex a 
variety of guest molecules in their apolar cavity (Figure 5.2).95 Moreover, Cramer reported 
that the inclusion of guest molecules is a reversible process based on an equilibrium between 
the association and dissociation of host and guest.96 The reason for the reversibility of this 
process are the rather weak forces involved in encapsulation, such as hydrophobic 
interactions, van der Waals forces, and hydrogen bonding. Using kinetic, spectroscopic and 
competitive inhibition methods, Cramer determined the dissociation constants of CD 
complexes with various guests and showed that not only highly apolar, aliphatic and aromatic 
hydrocarbons can be complexed but also polar substances, such as acids, amines, halogens, 
and, interestingly, even (noble) gases.95-97  
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Figure 5.2: (A) Inclusion of guest molecules into the CD cavity is a reversible process based on an 
equilibrium between the association and dissociation of host and guest. (B) Inclusion complexes exist 
in different stoichiometric proportions depending on the size and structure of the guest as well as the 
host.81 
5.1.2 Cyclodextrins and Their Applications 
Cramer’s investigations about CD inclusion complexes are acknowledged as the origin from 
which various applications resulted in research as well as in the chemical and pharmaceutical 
industry. The first patent for CD application was filed in 1953 as a collaboration of Karl 
Freudenberg, Friedrich Cramer, and Hans Plieninger, comprising the most important 
characteristics of CDs as protective agents for air-sensitive substances and for enhancing the 
water-solubility of hydrophobic substances.98 With this patent, the foundation stone for the 
pharmaceutical application of CDs was laid, which, however, did not start until the 1970s 
because of their suspected toxicity French reported on.99 Interestingly, this issue was resolved 
in the mid-1960s by reports revealing that the true toxicity was due to impurities trapped 
inside the CDs.100 After the non-toxicity of CDs was progressively accepted by the 
pharmaceutical and chemical industry, high-scale production led to a significant price drop of 
CDs and increased their further application until today. 
In the chemical industry, CDs have been produced, for instance, as stationary phases for high 
performance liquid chromatography (HPLC) and gas chromatography (GC). As immobilized 
chiral architectures, they offer the possibility to separate enantiomers and diastereomers, 
which is quite demanding and often impossible by the use of standard column materials.101 
Another interesting application of CDs lies in their utilization as catalysts of chemical 
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reactions in a similar manner as enzymes. Although Cramer had already given the base for 
supramolecular catalysis through CDs,102 this field was extensively researched by Myron Lee 
Bender, who, for example, studied the influence of CDs on the cleavage of functional groups, 
such as esters, amides, phosphates, carbonates, and sulfates, but also other chemical reactions 
like acyl migration and decarboxylation.103 CDs also play an important role in environmental 
sciences, where they find application as solubilization agents for organic pollutants but also 
in accumulation and removal of organic contaminants and heavy metals from water, soil, and 
atmosphere.104 
There is a large number of pharmaceutical applications for CDs. In most cases, they are 
utilized as drug carriers when the water solubility of a drug is restricted. In this aspect, the 
drug’s inclusion into the CD cavity enhances the transport through the cellular membrane, 
which it has to cross in order to develop its effect. Importantly, the lipophilic membrane only 
has a low affinity for the hydrophilic CD105 so that it remains outside of the cell while the drug 
passes the membrane. Not only does the complexation of a drug improve its delivery, it also 
facilitates the administration of volatile compounds, for instance, in the form of tablets.106 
Moreover, CDs are often applied to mask the bitter or irritant taste of drugs and, in some cases, 
can also reduce their unpleasant odors.107 
The latter example especially points out the accessibility of CDs for general consumers in 
everyday life. Here, they are frequently applied for stabilization, odor control, and conversion 
of liquid ingredients into a solid form. Preventing unpleasant odors, for example, in diapers, 
female hygiene products, or paper towels is often achieved by dry CD powder, which reduces 
the volatility of smelly mercaptans, and addition of a hydroxypropyl β-CD surfactant provides 
antimicrobial activity.108 Long-lasting fragrances have been produced by complexation with 
CDs, increasing the energy barrier for evaporation of volatile compounds so that they are 
slowly released over a long period of time.109 Other interesting sectors of application are foods 
and flavors, where CDs are often utilized for flavor protection and flavor delivery but they 
have also become popular in food processing for removal of cholesterol from animal products 
and masking of bitter components in citrus fruit juices.107 
Furthermore, azobenzene derivatives have been widely investigated as guest molecules, 
which form stable inclusion complexes with CDs. Interestingly, encapsulation of these guests 
preferentially occurs in the E form while the Z isomer is not capable of entering the CD cavity 
or is expelled after photoisomerization of the encapsulated E form.110 This property has been 
exploited in many studies in order to influence supramolecular assembly processes but also 
gated-ion channels have been created, whose function relies on CD-azobenzene inclusion 
complexes.111 
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Samanta et al. reported on a dynamic supramolecular system, which is able to capture and 
release different lectins in response to irradiation with UV light.112 Here, vesicles that have 
been created from amphiphilic CDs acted as hosts for cross-linkers with an azobenzene and a 
carbohydrate moiety. After inclusion of the azobenzene present in the E form, binding of an 
azobenzene lactoside by peanut agglutinin (PNA) resulted in crosslinking of the complexes. 
Exposing the dense multilamellar complexes to UV light effected photoisomerization of the 
azobenzene moiety and, consequently, led to the transition from a high-affinity, multivalent 
state to a low-affinity, monovalent state (Figure 5.3). 
 
Figure 5.3: Assembly of amphiphilic CD vesicles, noncovalent cross-linkers with an azobenzene and a 
carbohydrate moiety (G1), and the lectin PNA leads to dense multilamellar complexes. Irradiation with 
UV light results in isomerization of the azobenzene units, causing the transition from a high-affinity, 
multivalent state to a low-affinity, monovalent state.112 Modified from reference 112. 
In another example, the Harada group reported a thermo- and light-responsive azobenzene 
CD complex, which consists of a CD host covalently bound to a hydrocinnamoyl linker via a 
polyethylene glycol spacer, which is terminated with an azobenzene guest moiety (6-Az-
PEG600-HyCiO-β-CD, cf. Figure 5.4 left).113 The group performed 2D ROESY NMR experiments 
to study the conjugate’s complexation behavior and observed a strong temperature and 
concentration dependence. Recording NMR spectra at 30 °C revealed that a self-inclusion 
complex was formed, where the CD cavity alternatively encapsulates the aromatic part of the 
hydrocinnamoyl linker and the azobenzene moiety. However, when measured at 1 °C, only 
the aromatic part of the linker was included while exclusive inclusion of the azobenzene unit 
occurred at 60 °C. Furthermore, it was reported that the complex existed in a dethreaded form 
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at 80 °C and intermolecular complexes preferentially formed at high concentrations. 
Interestingly, UV light irradiation caused a conformational change to a self-inclusion complex, 
in which the CD cavity includes the azobenzene part irrespective of the concentration applied. 
 
Figure 5.4: Molecular structure and schematic depiction of the CD complex (6-Az-PEG600-HyCiO-β-CD, 
left). Proposed conformational changes of the CD complex in aqueous solution by external stimuli 
(right).113 Modified from reference 113. 
This chapter covers different approaches for the development of a novel assay system, which 
enables investigation of switchable cell adhesion based on CD inclusion complexes. Research 
presented in Chapter 5.2 involves initial approaches concerning the assay system whereas the 
results mentioned in Chapter 5.2.1 are part of the bachelor thesis of V. Thoms.114 Chapter 5.2.2 
contains results gathered from a short term scientific mission at the CSIC – University of 
Seville. Advanced research on the assay system is described in Chapter 5.3 while parts of this 
chapter are reported in the bachelor thesis of S. O. Jaeschke.115 The preparation of compounds 
and performance of biological tests described in Chapter 5.3 was done in collaboration with 
A. Müller.  
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5.2 Covalent and Non-covalent Immobilization of Cyclodextrin Derivatives for 
Investigation of Bacterial Adhesion 
Due to their remarkable ability to form inclusion complexes with suitable, mainly 
hydrophobic guest molecules, CDs can not only be utilized for this purpose in solution but also 
when assembled on surfaces.116 While this property has been researched particularly in the 
field of supramolecular chemistry, it has also become an important issue for biochemistry and 
bioorganic chemistry. As mentioned in Chapter 5.1.2, CDs have been successfully employed 
for inclusion of azobenzene glycoconjugates in order to achieve switching of processes such 
as lectin binding. In analogy, switching of bacterial adhesion may be a feasible approach as 
well. Therefore, I designed a new type of binding assay, which allows for switchable cell 
adhesion to photoresponsive ligands that are assembled on supramolecular surfaces. 
For the development of the assay system, two approaches were pursued, which differ in the 
nature of the employed CD hosts as well as the glycoconjugate guest molecules. While the first 
approach involved covalent immobilization of amino-functionalized CD derivatives onto 
activated microtiter plates (cf. Chapter 5.2.1), in the second approach, supramolecular 
surfaces were created by non-covalent immobilization of amphiphilic CD derivatives (cf. 
Chapter 5.2.2). In order to effect inclusion complex formation, the fabricated CD surfaces were 
subsequently treated with the respective guest molecule, which, besides the mannose moiety, 
bears a hydrophobic portion (azobenzene or adamantane; detailed molecular structures are 
discussed in the respective chapter), allowing for inclusion into the CD cavity. As a result, 
mannose moieties are presented on the supramolecular surface and are available for binding 
by the bacterial lectin FimH. 
There are two ways to achieve reversible adhesion of bacteria to the supramolecular surface. 
One is the competitive displacement of the encapsulated guest molecule with a guest which 
undergoes stronger interactions with the CD cavity. Since inclusion complex formation is a 
reversible process, which is influenced by an equilibrium, competitive displacement can be 
controlled by adjusting the concentration of the competing guest molecule (in case both 
guests have a similar molecular structure). The other possibility, which is also more elaborate 
since a competitive guest is not needed, is photo-switchable displacement of the encapsulated 
guest molecule. For this, a photoresponsive azobenzene guest is required. As described in the 
introduction, exclusively the E isomer can insert into the CD cavity while the bulkier, more 
hydrophilic Z isomer does only show weak inclusion properties. This, of course, offers the 
opportunity to convert an already included azobenzene glycoconjugate into its Z isomer by 
photoirradiation, resulting in disruption of the inclusion complex. As a consequence, adhesion 
 Cyclodextrin Conjugates to Control Bacterial Adhesion 99 
of bacteria to the supramolecular surface is attenuated, as no mannose moieties are available 
for binding (Figure 5.5). 
 
Figure 5.5: Outline for CD-based adhesive surfaces. CD derivatives that are covalently or non-covalently 
immobilized onto a polystyrene surface are capable of forming inclusion complexes with carbohydrate-
ligands containing a hydrophobic residue. Once inclusion complexes are formed, the carbohydrate can 
be bound by type 1 fimbriated E. coli. Competitive or photo-switchable displacement of the guest 
encapsulated in the CD cavity results in attenuation of bacterial binding. 
5.2.1 Bacterial Adhesion by Application of Covalently Immobilized Cyclodextrins 
 
5.2.1.1 Synthesis of Cyclodextrin Derivatives and Azobenzene Guest Molecules 
For proper functionalization of activated microtiter plates with CDs, an appropriate CD 
precursor was needed. The well-known mono-6-azido-6-deoxy-β-CD (50)117 was chosen for 
this purpose. Applying this CD derivative in a 1,3-dipolar cycloaddition with propargylamine 
creates a suitable compound for surface immobilization via the amino group. The synthesis of 
this amino-functionalized CD 51 is not only straight-forward but can also be commenced from 
inexpensive β-CD (48). 
First, one of the primary hydroxyl groups of β-CD (48) was tosylated by utilization of 1-(p-
toluenesulfonyl)imidazole,118 giving the corresponding tosylate 49.119 The azido-β-CD 50 was 
then obtained by simple nucleophilic substitution with sodium azide. Copper catalyzed 1,3-
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dipolar cycloaddition with propargylamine gave the amino-functionalized CD 51, which was 
used for immobilization without further purification (Scheme 5.1A). 
In order to compare the immobilization of CD 51 with that of a standard mannoside, an amino 
functionalized mannoside 53 was prepared. Therefore, 2-azidoethyl α-D-mannoside (52)120 
and propargylamine were reacted in a copper-catalyzed cycloaddition, giving mannoside 53, 
which was also used without further purification for the immobilization process (Scheme 
5.1B). 
 
Scheme 5.1: A) Synthesis of CD derivative 51. a) 1-(p-toluenesulfonyl)imidazole, H2O, rt, 2 h, 32%; b) 
NaN3, H2O, 120 °C, 16 h, 42%; c) propargylamine, CuSO4 . 5 H2O, sodium ascorbate, DMF/H2O (3:1), rt, 
2 h, crude product. B) Synthesis of mannoside 53. a) propargylamine, CuSO4 . 5 H2O, sodium ascorbate, 
DMF/H2O (3:1), rt, 2 h, crude product. 
After synthesis of CD 51 and mannoside 53, an appropriate photoresponsive guest molecule 
was synthesized. Here, the choice fell upon a simple azobenzene mannoside 59, which 
contains a triethylene glycol spacer between the mannose moiety and the azobenzene. This 
spacer was added to the glycoconjugate in order to improve its water solubility since it has 
been found earlier that plain azobenzene mannosides tend to show decreased water 
solubility.121 
The synthesis was started with the preparation of the azobenzene triethylene glycol ether 56 
by a nucleophilic substitution reaction with p-phenylazophenol (55) and chloride 54. The 
resulting alcohol 56 was then glycosylated with trichloroacetimidate 57122 employing BF3-
etherate as a promoter, yielding the unprotected mannoside 59 after subsequent Zemplén123 
deacetylation of mannoside 58 (Scheme 5.2). 
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Scheme 5.2: Synthesis of azobenzene mannoside 59. a) KOH, n-BuOH, 140 °C, 3 d, 70%; b) BF3 . Et2O, 
CH2Cl2, rt, 16 h, 42%; c) NaOMe, MeOH, rt, 16 h, 92%. 
5.2.1.2 Validating Surface Functionalization 
Before the biological testing, the immobilization of CD 51 was validated and compared to that 
of mannoside 53. For this purpose, a phenol-sulfuric acid assay124 was performed after both 
compounds had been covalently immobilized onto activated microtiter plates. This assay 
offers the possibility to determine the concentration of immobilized glycoconjugates on the 
surface via photometric detection of the absorbance at 490 nm. Therefore, calibration lines 
were deduced from dilution series of azido CD 50 as well as 2-azidoethyl α-D-mannoside (52) 
(Figure 5.6).  
Figure 5.6: Phenol-sulfuric acid assay. Calibration lines were deduced from dilution series of 2-
azidoethyl α-D-mannoside (52, left) and azido-CD 50 (right).  
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Using the functional equation of the CD 50 calibration line considers the 7-fold valency of the 
CD. In this way, the concentrations of both immobilized compounds 51 and 53, as calculated 
from the calibration lines, can be directly compared (Table 5.1). 
Table 5.1: Results from the phenol-sulfuric acid assay of mannoside 53 and CD 51 immobilized onto 
polystyrene.  
 Average value of absorbance 
Calculated concentration 
[mmol/L] 
Mannoside 53 0.164 ± 0.043 0.598 ± 0.162 
CD 51 0.151 ± 0.030 0.208 ± 0.058 
 
Comparing the calculated concentrations reveals that immobilization of mannoside 53 is 
more efficient than that of CD 51, resulting in a higher concentration on the surface. Despite 
the limited sensibility of the phenol-sulfuric acid assay, the results show a successful 
immobilization of CD 51. 
 
5.2.1.3 Biological Testing 
Before testing the inclusion of the synthesized azobenzene guest molecule 59, followed by 
bacterial adhesion to the mannose moieties presented, the functional surface itself was first 
investigated towards type 1 fimbriae-mediated bacterial adhesion in order to preclude 
unspecific interactions of bacteria with the CD surface. Therefore, mannoside 53, CD 51 as 
well as propargylamine were immobilized on activated microtiter plates by application of 
10 mM solutions of the respective compound. Then, the plates were incubated with GFP-
transfected E. coli (pPKL1162) and after washing, bacterial adhesion was measured by 
readout of the fluorescence intensity (Figure 5.7). 
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Figure 5.7: Bacterial adhesion to microtiter plates functionalized with propargylamine (left), 
mannoside 53 (middle) and CD 51 (right). The fluorescence values shown resulted from incubation 
with a bacteria suspension of 2 mg/mL. 
The adhesion studies show that immobilization of propargylamine alone resulted in more 
than 50% of bacterial binding when compared to CD 51 which gave the highest fluorescence 
value. Unfortunately, both values for mannoside 53 and CD 51, respectively, are in the same 
range. It can be speculated that the E. coli strain used for the experiments is not only capable 
of specific binding to mannose residues but also shows similar adhesion properties towards 
glucose units of the β-CD derivatives. 
For further investigation of bacterial binding, plain β-CD (48) was used as an inhibitor of 
type 1 fimbriae-mediated bacterial adhesion. Performance of an adhesion-inhibition assay 
was very important at this point since the previously observed binding behavior could also 
be a result of unspecific binding to the supramolecular surface. Thus, mannan-coated 
microtiter plates were prepared, incubated with fluorescent E. coli and subsequently, serial 
dilutions of β-CD (48) and MeMan were employed on the plate. After washing, fluorescence 
was detected, delivering inhibition curves from which IC50 values were deduced where 
possible (Figure 5.8). 
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Figure 5.8: Inhibition curves obtained with MeMan (left) and β-CD (48, right) from inhibition of type 1 
fimbriae-mediated bacterial adhesion to mannan-coated microtiter plates. Non-linear regression gave 
the sigmoidal concentration-response curve for MeMan while this was not possible for β-CD (48). Error 
bars result from triplicate values on one plate. 
While the inhibition curve of MeMan shows a sigmoidal shape and delivers an IC50 value of 
4.20 mM, non-linear regression was not possible for the inhibition curve of β-CD (48). 
Presumably, a sigmoidal shape might be observed when testing higher concentrations, though 
this was not possible due to the restricted water solubility of β-CD (48). 
Although inhibition of bacterial adhesion by β-CD (48) did not result in a sigmoidal curve and 
the respective IC50 value could not be deduced, it is apparent that MeMan is a better inhibitor. 
This raises the question, why bacterial adhesion to the supramolecular surface was observed 
in the previous experiments. The results gathered from the adhesion-inhibition assay suggest 
that a possible affinity of FimH for glucose (as in CD 51) can be ruled out as a reason for this 
adhesion behavior. More likely, the observed adhesion could be a result of unspecific 
interactions of the lectin with the supramolecular surface or with unfunctionalized parts of 
the polystyrene surface, resulting from incomplete immobilization.  
To conclude, the approach described in this chapter turned out to be not as promising as 
expected. In order to further investigate this assay system, the nature of the supramolecular 
surface needs to be modified so that unspecific binding of bacteria to the surface can be 
precluded. Therefore, a different approach, which involves the non-covalent immobilization 
of amphiphilic CD derivatives, will be discussed in the following chapter. Furthermore, 
application of the azobenzene guest molecule 59 will be demonstrated as well. 
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5.2.2 Application of Amphiphilic Cyclodextrins for Non-covalent Immobilization 
It was described earlier that substrates with long alkyl chains can be immobilized on 
polystyrene microtiter plates due to their ability of undergoing hydrophobic interactions with 
the surface. Using this approach, glycoSAMs were fabricated by non-covalent immobilization 
of amphiphilic substrates.125 Furthermore, SAMs of amphiphilic CDs on hydrophobic and 
hydrophilic substrates have been established.126 Applying this approach to the investigated 
assay system will be discussed in this chapter. Thus, not only the targeted CDs were modified 
but also two different mannosides were chosen as guest molecules for inclusion complex 
formation. Furthermore, it was decided to perform an ELLA-type (enzyme-linked lectin assay) 
variation of the assay by using an HRP (horseradish peroxidase) conjugate of the mannose-
specific lectin Con A before investigating type 1 fimbriae-mediated bacterial adhesion. 
The CD derivatives chosen for immobilization were modified with either C6, C12, or C14 alkyl 
chains on the primary face and were compared towards their applicability in the binding 
assay. While one of the guest molecules employed was azobenzene glycoconjugate 59 (cf. 
Chapter 5.2.1), a different guest molecule in this chapter consists of three portions, which each 
serve a different purpose: a hydrophobic adamantane residue, a guaiazulene moiety and a 
mannose portion. 
Adamantane derivatives are known to form very stable inclusion complexes with CDs and 
have been widely used in the field of supramolecular chemistry as guest molecules.127 
Therefore, this portion was incorporated into the guest molecule for undergoing strong 
interactions with the hydrophobic CD cavity. While the mannose portion will be used for the 
actual binding of the mannose-specific lectin Con A, the guaiazulene portion serves a 
completely different purpose. As already described in Chapter 3.3, guaiazulene – as an azulene 
derivative – has a strong blue color and was previously used in the CSP methodology as a color 
tag. In this approach, however, the color of the guaiazulene tag is exploited for photometric 
determination of the actual concentration of ligands on the supramolecular surface. 
With these components at hand, the concept can be understood as explained in Chapter 5.2, 
considering investigation of lectin binding instead of bacterial adhesion (Figure 5.9). 
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Figure 5.9: Amphiphilic CD derivatives that are non-covalently immobilized to a polystyrene surface 
are capable of forming inclusion complexes with carbohydrate-ligands containing a hydrophobic 
residue. The extent of host-guest-complex formation can be monitored by guaiazulene supported 
photometric read-out. Once inclusion complexes are formed, the carbohydrate can be bound by lectin 
Con A. Depending on its chemical structure the ligand can be removed from the CD cavity by 
competitive or photo-switchable (in case of an azobenzene guest molecule) displacement, thus, 
attenuating lectin binding. 
The following work was done in collaboration with the research group of Jose Manuel García 
Fernández during a short term scientific mission at the CSIC – University of Seville.128 
 
Results and Discussion 
5.2.2.1 Synthesis of Cyclodextrin Derivatives and Mannoside Guest Molecule 64 
For non-covalent immobilization on polystyrene microtiter plates, three amphiphilic CD 
derivatives 61,129 62, and 63 were synthesized, which differ in the length of the alkyl chains 
that are connected to the primary face of the CD. For better comparison of how different 
lengths affect the immobilization, C6, C12, and C14 alkyl chains were chosen. 
The synthesis of the amphiphilic CD derivatives was started from plain β-CD (48) in an Appel-
analogous reaction with triphenylphosphine and N-bromosuccinimide, which furnished 
heptakisbromo CD 60.130 Then, a nucleophilic substitution reaction with carboxylates of the 
respective fatty acids hexanoic, dodecanoic, and tetradecanoic acid, respectively, was 
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performed, giving the targeted amphiphilic CD derivatives 61-63 in moderate to low yields. 
Since long alkyl chains promote micelle formation, precipitation and filtration of the products 
was getting more problematic when heading towards higher chain lengths, resulting in a 
significant drop in yield. 
HO OH
(OH)14 (OH)14
O O
(OH)14
a b
48 60
4 3
Br Br
4 3
OO
34
n n
61, n = 1; 62, n = 7; 63, n = 9  
Scheme 5.3: Synthesis of amphiphilic CD derivatives 61-63. a) 1. PPh3, NBS, DMF, 80 °C, 16 h; 2. NaOMe, 
MeOH, rt, 2 h, 96%; b) n = 1, hexanoic acid, Cs2CO3, DMF, 50 °C, 72 h, 60%; n = 7, dodecanoic acid, Cs2CO3, 
DMF, 50 °C, 72 h, 38%; n = 9, tetradecanoic acid, Cs2CO3, DMF, 50 °C, 72 h, 9%. 
Next, the synthesis of mannoside guest molecule 64 was performed. Retrosynthetic analysis 
reveals that all three portions can be easily connected through a branching unit that contains 
three different functional groups (Scheme 5.4).  
 
Scheme 5.4: Retrosynthetic analysis of mannoside guest molecule 64. Disconnection results in three 
precursor molecules 17, 65 and 67 that can be joined with each other through O-propargyl-L-serine 
hydrochloride 66 as the branching unit. 
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For this, O-propargyl-L-serine hydrochloride 66131 is perfectly suited since the alkyne can be 
addressed for cycloaddition with mannose conjugated azide 65,132 the amino group can form 
a carbamate by reaction with guaiazulene carbonate 17 (cf. Chapter 3.3) and the carboxylic 
acid can be joined with adamantylamine (67). The synthesis of O-propargyl-L-serine 
hydrochloride 66 was commenced by base promoted alkylation of Boc-protected L-serine 68 
with sodium hydride and propargyl bromide, giving alkyne 69 in excellent yield. O-propargyl-
L-serine hydrochloride 66 was then obtained in good yield by Boc-deprotection with 
hydrochloric acid (Scheme 5.5). 
 
Scheme 5.5: Synthesis of O-propargyl-L-serine hydrochloride 66. a) propargyl bromide, NaH, DMF, rt, 
16 h, 96%; b) HCl (aq.), EE, rt, 1 h, 84%. 
Next, the well-known mannoside 65 was prepared for further linkage with the branching 
element. Lewis-acid promoted glycosylation of triethylene glycol 54 with pentaacetyl α-D-
mannose (70)133 was performed, giving chloride 71134 in moderate yield. Then, by 
nucleophilic substitution with sodium azide, azide 72 was obtained in good yield and 
subsequent Zemplén deacetylation furnished mannoside 65. 
 
Scheme 5.6: Synthesis of mannoside 65. a) 54, BF3.Et2O, CH2Cl2, rt, 16 h, 63%; b) NaN3, TBAI, DMF, 60 °C, 
16 h, 89%; c) NaOMe, MeOH, rt, 16 h, 96%. 
In order to facilitate and accelerate the further synthesis of guest molecule 64 by taking 
advantage of the intense blue color of guaiazulene, carbonate 17 (cf. Chapter 3.3) was first 
coupled to the branching unit before the other required portions. Then, the adamantyl residue 
was introduced by HBTU- and HOBt-promoted amide coupling of adamantylamine (68) and 
carboxylic acid 73, giving amide 74 in good yield. The last step in this pathway was the 
connection of unprotected mannoside 65 to the branching element in a 1,3-dipolar 
cycloaddition. However, experiments revealed that this reaction resulted in formation of side 
products, which were not separable from the desired product 64. Therefore, it was preferred 
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to couple the acetyl-protected mannoside 72 instead, giving the acetylated product 75 in a 
moderate yield of 50% (55% based on conversion, 5% starting material reisolated). Since the 
reaction was accommodated by formation of diversely colored side products, the guaiazulene 
portion may have suffered from decomposition or substitution, which explains the drop in 
yield. The mannoside guest molecule 64 was then finally obtained by employing Zemplén 
conditions for deacetylation of precursor 75. 
 
Scheme 5.7: Synthesis of mannoside guest molecule 64. a) 17, NaHCO3, THF/H2O (1:1), rt, 16 h, 90%; 
b) 67, HBTU, HOBt, DIPEA, DMF, rt, 16 h, 89%; c) 72, CuSO4 . 5 H2O, sodium L-ascorbate, DMF/H2O (3:1), 
rt, 16 h, 50%; d) NaOMe, MeOH, rt, 16 h, 88%. 
5.2.2.2 Lectin Binding Assay 
For investigation of the previously synthesized compounds in the ELLA-type assay, the initial 
step performed was employing amphiphilic CDs 61-63 on polystyrene microtiter plates in 
order to achieve non-covalent immobilization onto the surface. Since the solubility of these 
compounds in PBS (phosphate buffered saline) dropped significantly with increasing alkyl 
chain length, CD solutions were prepared from respective DMSO stock solutions with a 
maximum DMSO content of 1%. The standard procedure reported by Lindhorst et al. for 
immobilization of amphiphilic substrates on polystyrene surfaces125 is desiccation of the 
substrate solution on the plate. Due to the DMSO content, however, this procedure could not 
be applied since immobilized CDs could possibly redissolve in DMSO and, thus, be removed 
by washing afterwards. Instead, the plates were incubated overnight and subsequently 
washed several times to remove excess CD solution. At this point it was essential to avoid 
buffers containing detergents in order to ensure that already immobilized CDs were not 
removed from the surface. 
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Then, inclusion of mannoside guest 64 as well as azobenzene mannoside 59 (cf. Chapter 
5.2.1.1), respectively, into the CD cavity was performed. Therefore, serial dilutions of ligand 
solutions were applied on the CD-covered plates. Due to the poor water solubility of 
mannoside 64, respective ligand solutions were prepared from DMSO stock solutions as 
explained earlier. After washing and blocking with bovine serum albumin (BSA), absorbance 
at 600 nm was measured for photometric determination of the ligand concentration on the 
surface of the plates that were incubated with guaiazulene derivative 64. Interestingly, no 
absorbance could be detected at this wavelength, indicating that the concentration of ligand 
was below the limit of detection. Nevertheless, the plates were finally incubated with 
peroxidase-labeled Con A and after washing, ABTS (2,2´-azino-bis(3-ethylbenzo-thiazoline-6-
sulphonic acid) was added, resulting in a color reaction. In this way, the extent of lectin bound 
to the ligands on the surface could be monitored by measuring the absorbance at 405 nm, 
giving the respective binding curves (Figure 5.10). 
 
Figure 5.10: Lectin binding to microtiter plates covered with CDs 61 (black), 62 (red), and 63 (blue). 
While the concentration for CD immobilization was kept at 5 µM, the concentration of ligand 64 for 
inclusion complex formation was varied. Error bars result from duplicate values on one plate. 
The binding curves obtained from the plates incubated with mannoside 64 show an increase 
of absorbance with increasing concentrations of ligand. This confirms that the inclusion of 
ligands into the immobilized CDs was successful and, hence, the actual immobilization process 
as well. On closer inspection, it becomes evident that the functionalization of the surfaces was 
differently efficient depending on which CD was used. CDs 62 and 63, which both have 
relatively long alkyl chains in comparison to 61, show similar curves. However, the curve of 
CD 61 has a higher absorbance value at the highest ligand concentration, indicating that 
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immobilization seems to be more effective in this case. Nevertheless, the ligand 
concentrations used for testing were too low because the rising absorbance had not yet 
reached a plateau. Therefore, higher concentrations were to be tested in the following 
experiments. 
In order to investigate if photo-induced isomerization of azobenzene mannoside 59 results in 
disruption of the inclusion complex and, thus, switches lectin binding, the plates were treated 
with this ligand as well. However, this did not result in observable lectin binding, no matter 
which CD derivative was used for immobilization. It appears that inclusion of the azobenzene 
residue is not as efficient as that of the adamantane residue in 64. However, application of 
higher ligand concentrations may result in better inclusion and detectable lectin binding. 
Although it was planned to perform further experiments concerning the improvement of the 
assay as well as investigation of bacterial adhesion in this format, future research on this topic 
was terminated. The reason for this was a publication by Jonkheijm et al.135, which was 
published shortly after the initial experiments were performed. In this publication, an assay 
system is described which is similar to the one discussed here and involves switching of lectin 
and bacterial binding to azobenzene glycoconjugates that are assembled on a supramolecular 
surface. Jonkheijm and coworkers succeeded in fabricating a surface of amphiphilic CDs and 
induced inclusion complex formation with azobenzene mannosides. Lectin as well as bacterial 
binding to the surface was then measured and later attenuated by irradiation with UV light, 
causing isomerization of the azobenzene moiety and, thus, disruption of the previously 
formed inclusion complexes. Jonkheijm employed an imprinting technique for immobilizing 
the amphiphilic CD derivatives onto different surfaces, which presumably facilitated and 
enhanced this process. 
Although Jonkheijm succeeded in an early publication of his results, the feasibility of this 
approach could be confirmed and investigation of this assay format from a different point of 
view may be promising. Therefore, A. Müller and I initiated another project, which deals with 
a variation of the assay described in this chapter.  
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5.3 Switching Bacterial Adhesion by Means of Cyclodextrin Inclusion 
Complexes on Photoresponsive Surfaces 
In another approach, a reversed variant of the binding assay that was discussed in the 
previous chapters was investigated. The basic concept therein is the same, however, the 
inclusion scenario between the azobenzene and the CD takes place on a photoresponsive 
surface of covalently immobilized azobenzene derivatives either on polystyrene microtiter 
plates or magnetic polyethylene glycol (PEG) beads. For this purpose, two azobenzene 
derivatives were employed, which, despite their similar molecular structure, greatly differ in 
their photochemical properties, giving rise to two different types of photoresponsive surfaces. 
For inclusion complex formation, two CD conjugates are employed, which contain an alkyl or 
an aromatic mannoside connected to the β-CD via a triazole linkage. Once the azobenzene 
moiety is encapsulated, the mannose unit of the respective CD conjugate is presented on the 
surface and accessible for type 1 fimbriae-mediated bacterial adhesion. In order to prove the 
switching of bacterial binding, the surface can be exposed to UV light prior to incubation with 
the fluorescent bacteria. In this way, disruption of the inclusion complexes is induced and the 
CD conjugate is released, thus, making the surface inadhesive (Figure 5.11). 
 
Figure 5.11: Inclusion of a mannose CD conjugate occurs on a photoresponsive surface of a covalently 
immobilized azobenzene derivative. Binding of the mannose moiety of the CD conjugate by the 
bacterial lectin FimH results in bacterial adhesion to the supramolecular surface. Exposure to UV light 
leads to disruption of the inclusion complexes, thus, making the surface non adhesive.  
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The procedure described above proves the inclusion complex formation as well as the 
switching process just in an indirect way since the fluorescence measurement is not possible 
until the performance of bacterial binding. To overcome this hurdle and directly prove the 
inclusion on the surface, a fluorescein-tagged CD derivative was prepared and employed as a 
host. In this way, the inclusion complex formation as well as the UV light mediated disruption 
of the complex can be directly validated through fluorescence read-out. 
For this project, A. Müller synthesized precursor mannoside 89 and azobenzene derivative 82 
while I performed the synthesis of all CD-derived compounds (for precursors cf. Chapter 5.2) 
and azobenzene derivative 83. Both of us performed the biological tests and interpreted the 
obtained data. 
 
Results and Discussion 
5.3.1 Synthesis of Azobenzene Guest Molecules and CD Hosts 
Since the surfaces used for the assays were prefunctionalized with either carboxylate groups 
or activated functional groups, such as active esters, azobenzene derivatives that bear an alkyl 
amino group were needed for covalent immobilization. Therefore, two different azobenzene 
derivatives 82 and 83 were synthesized, which differ in the substitution of the aromatic 
system but have both a methylene amino group available for coupling with the respective 
surface. 
The first step in the synthesis of azobenzene derivative 82 was the condensation of 4-[N-Boc-
aminomethyl]aniline (76) with nitrosobenzene (77) employing Mills reaction136 conditions, 
giving the Boc-protected product 80 in good yield. Final deprotection with trifluoroacetic acid 
gave the target compound 82 quantitatively. For the synthesis of azobenzene derivative 83, 
nitroso compound 78137 was prepared from 4-[N-Boc-aminomethyl]aniline (76) by oxidation 
with Oxone®. The crude product was obtained as a mixture of the nitroso compound 78 and 
the respective nitro derivative, which, however, was unproblematic for direct use in the next 
step. Condensation of crude 78 and p-anisidine (79) was performed also by employing Mills 
reaction conditions, giving the product 81 in a moderate yield. The target compound 82 was 
then obtained by quantitative deprotection with trifluoroacetic acid (Scheme 5.8). 
Additionally, the Boc-group of 80 was cleaved with concentrated aqueous hydrochloric acid, 
giving the respective ammonium hydrochloride 20 in a quantitative yield. This azobenzene 
derivative was, however, not used for surface immobilization but as a reactant for an Amadori 
rearrangement reaction (cf. Chapter 3.3). 
114 Cyclodextrin Conjugates to Control Bacterial Adhesion  
 
Scheme 5.8: Synthesis of azobenzene derivatives 82 and 83. a) DMSO, AcOH, rt 16 h, 75%; b) Oxone®, 
H2O, CH2Cl2, rt, 16 h, 48%; c) DMSO, AcOH, rt, 16 h, 82%; d) TFA, CH2Cl2, rt, 1 h, R = H, quant., R = OMe, 
quant; e) CH2Cl2, HClaq, rt, 4 h, quant. 
For the synthesis of CD conjugates 85 and 90 it was decided to couple azido-β-CD 50 (cf. 
Chapter 5.2.1.1) with two precursor mannosides in a simple CuAAC reaction. Therefore, it was 
required that both mannosides contain a propargyl function accessible for the cycloaddition. 
The choice herein fell upon propargyl α-D-mannoside (84)138 and an aromatic mannoside 89, 
in which the propargyl function is located at the opposite side of the phenyl ring. 
CD conjugate 85 was prepared by directly coupling propargyl α-D-mannoside (84) with azido-
β-CD 50 under CuAAC conditions. The pure product 85 could be isolated after purification by 
gel permeation chromatography in a very good yield (Scheme 5.9A). 
The first step of the synthesis of aromatic CD conjugate 90 was Lewis acid-promoted 
glycosylation of mannose pentaacetate (70) with hydroquinone (86), giving the aromatic 
mannoside 87 in a good yield. In the next step, the propargyl function was introduced at the 
phenolic position by alkylation with propargyl bromide. The resulting acetyl-protected 
mannoside 88 was obtained in a fair yield and was then deacetylated. Final coupling of azido-
β-CD 50 with mannoside 89 by means of CuAAC gave the targeted CD conjugate 90 in a good 
yield after purification through RP chromatography (Scheme 5.9B). 
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Scheme 5.9: A) Synthesis of CD conjugate 85: a) CuSO4 . 5 H2O, sodium ascorbate, DMF/H2O (3:1), rt, 
16 h, 92%; B) Synthesis of CD conjugate 90: a) BF3 . Et2O, CH2Cl2, MeCN, rt, 48 h, 71%; b) propargyl 
bromide, K2CO3, KI, MeCN, 70 °C, 16 h, 65%; c) NaOMe, MeOH, rt, 16 h, 81%; d) CuSO4 . 5 H2O, sodium 
ascorbate, DMF/H2O (3:1), rt, 16 h, 78%. 
As a precursor for the CD derivative 93, amino-β-CD 91139 was prepared by reducing azido-β-
CD 50 under Staudinger reduction conditions following a procedure from Tang et al.140 
Thiourea bridging with fluorescein isothiocyanate 92 finally gave the fluorescein-tagged CD 
derivative as the corresponding spiro form 93 in a fair yield (Scheme 5.10). 
 
Scheme 5.10: Synthesis of fluorescein-tagged CD derivative 93. a) 1. PPh3, DMF, rt, 2 h; 2. H2O, 90 °C, 
2 h, 91%; b) DIPEA, DMF, rt, 16 h, 64%.  
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5.3.2 Biological Testing on Polystyrene Microtiter Plates 
For investigation of bacterial adhesion to the CD conjugates, the photoresponsive surface of 
azobenzene guest molecules had to be fabricated. In the initial experiments only azobenzene 
derivative 82 was tested while testing of azobenzene derivative 83 as well as the validation 
of inclusion complex formation with fluorescein-tagged CD derivative 93 will be discussed in 
Chapter 5.3.3. 
For fabrication of the photoresponsive surface, a 10 mM solution of azobenzene derivative 82 
in carbonate buffer (pH 9.6) was incubated on polystyrene microtiter plates. Subsequently, 
the plates were washed for removal of unreacted azobenzene and deactivated with an 
ethanolamine solution. To induce inclusion complex formation on the surface, the microtiter 
plates were incubated with CD conjugates 85 and 90, respectively, and excess CD conjugate 
was removed by washing. After incubation with fluorescent E. coli (PKL1162), fluorescence 
was measured for quantification of bacterial adhesion. As a reference, p-aminophenyl α-D-
mannoside (pAPMan) was always tested on the same plate. The obtained adhesion curves are 
shown in Figure 5.12. 
 
Figure 5.12: Bacterial adhesion to microtiter plates immobilized with azobenzene derivative 82. While 
the concentration for immobilization was kept at 10 mM, the concentration of CD conjugates 85 and 90 
for inclusion complex formation was varied. Error bars result from duplicate values on one plate. 
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The adhesion curves obtained from the initial experiments reveal that bacterial binding 
occurs in varying degrees depending on the inclusion complex present on the surface. 
Application of the aliphatic CD conjugate 85 resulted in low bacterial binding, which only 
moderately increases towards higher CD concentrations. The binding curve obtained from 
aromatic CD conjugate 90, on the other hand, shows much higher bacterial binding and in its 
maximum even surpasses the binding curve of pAPMan. As described in the general 
introduction (cf. Chapter 1.3), aromatic mannosides show a stronger binding to the bacterial 
lectin FimH due to additional interactions with the tyrosine gate near the CRD. These 
interactions also seem to be responsible for the stronger adhesion obtained from surfaces that 
were treated with the aromatic CD conjugate 90. Furthermore, bacterial binding decreases 
substantially at higher CD concentrations, suggesting an increase of steric hindrance on the 
surface so that either inclusion complex formation is hampered or the bacterial adhesion 
itself. 
These binding assays confirm that the overall concept is feasible and provides a solid 
foundation for further experiments involving irradiation with UV light for switching the 
surface’s adhesive properties. Due to the low bacterial binding resulting from the aliphatic CD 
conjugate 85, only the aromatic CD conjugate 90 was utilized in the following experiments. 
In order to switch the adhesive properties of the photoresponsive surface, azobenzene-
covered microtiter plates were fabricated according to the protocol described above. The 
microtiter plate was then divided into two parts whereby one part was exposed to UV light 
and the other was kept covered so that no irradiation could take place. Incubation with GFP-
transfected E. coli was followed by fluorescence measurement. pAPMan was immobilized on 
both parts of the plate as a control to ensure that the UV light does not influence the surface’s 
integrity. 
The obtained data (not shown) revealed that the part of the plate exposed to UV light 
irradiation showed decreased bacterial binding but had very strong internal fluctuations. It 
appears that photoisomerization of the azobenzene molecules on the surface indeed lead to 
disruption of the formed inclusion complexes and, hence, less bacterial binding. The 
fluctuations, however, indicate that the irradiation process is not optimal, which may be due 
to the experimental setup. Since the UV lamp is located above the microtiter plate, shadows 
are casted from the wall of each well resulting in an uneven distribution of radiation and 
therefore incomplete photoisomerization (Figure 5.13). 
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Figure 5.13: Schematic depiction of the experimental setup applied for irradiation of microtiter plates. 
Due to the location of the UV lamp above the plate, the walls cast a shadow on each well. As a result, not 
every well receives the same amount of radiation leading to incomplete photoisomerization. 
The control wells that were treated with pAPMan, however, also showed decreased bacterial 
binding after irradiation. This suggests that the surface’s integrity had been influenced by the 
exposure with UV light. In this context, it has been reviewed earlier that polystyrene like many 
other polymers degrades when subjected to UV irradiation in the presence of air due to attack 
of free radicals formed in the polymer matrix.141 Degradation of the polystyrene surface is a 
serious issue since it may have resulted in a change of the surface’s functionalization and, thus, 
a decrease in the number of binding partners available for bacterial adhesion. At this point, it 
cannot be precluded that the decreased bacterial binding, which was detected in the wells 
treated with CD conjugate 90, is not due to the collaps of the inclusion complexes after 
photoisomerization but may possibly be a consequence of surface degradation. 
The results from the performed assays demonstrate that experiments involving irradiation 
on microtiter plates require a special setup since all wells must receive the same amount of 
radiation to ensure effective photoisomerization. It was speculated that shadows are casted 
on the wells due to the location of the UV lamp above the plate. Therefore, irradiation from 
under the plate might be a way to solve this problem. However then, transparent microtiter 
plates must be utilized, which, on the other hand, cannot be used for fluorescence 
measurements due to “crosstalk” interference between the wells. Instead, other options 
including HRP conjugated lectins or application of streptavidin/biotin-systems may be 
employed in this case. 
More importantly, however, the material of the microtiter plates must be chosen with caution 
since irradiation with UV light seemed to have degraded the surface and supposedly changed 
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its functionalization. Fine-tuning of the azobenzene’s substitution may be another option 
since certain substituents have been known to shift the wavelength for photoisomerization 
from shorter wavelengths in the UV region to longer wavelengths in the red to near-infrared 
(near-IR) region, which are less aggressive owing to their lower energy.142 
On the basis of these facts, experiments on polymer-based microtiter plates were not further 
pursued. Instead, it was preferred to perform assays with magnetic PEG beads, which will be 
discussed in the following chapter. 
 
5.3.3 Biological Testing on Magnetic PEG Beads 
In further assays, PEG beads, which contain a magnetic core, were used as a replacement for 
the employed polystyrene microtiter plates since, besides their UV light compatibility, they 
offer interesting applications. Carbohydrate-functionalized PEG beads, for example, have 
been efficiently employed in the isolation and removal of bacteria from solution.143 Acting as 
sensitive sensors for detection of E. coli bacteria, antibody-functionalized beads have been 
utilized for capturing bacteria, which subsequently initiated an electric detection mechanism 
by binding of guanine-labeled beads.144 
Prior to bacterial adhesion experiments, the inclusion complex formation on the beads’ 
surface was validated by utilizing the fluorescein-tagged CD 93. Since the beads were 
prefunctionalized with carboxylate groups, the corresponding active esters had to be created 
by treatment with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) and N-hydroxyl 
succinimide (NHS). Then, azobenzene derivatives 82 and 83, respectively, were coupled to 
the beads’ surface by incubation with a 10 mM solution of the respective azobenzene in 
carbonate buffer (pH 9.6). Subsequently, the beads were washed for removal of unreacted 
azobenzene and deactivated with an ethanolamine solution. Inclusion complex formation was 
induced by incubation with an 8 mM solution of fluorescein-tagged CD 93 and excess CD was 
removed by washing. The functionalized beads were then separated into two portions while 
one portion was irradiated with UV light (365 nm) and the other portion was kept in the dark. 
Then, inclusion of the CD derivative 93 as well as the disruption of the complexes was 
quantified by fluorescence detection (Figure 5.14). The obtained results from the fluorescence 
measurement are depicted in Figure 5.15A. 
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Figure 5.14: Outline for a protocol of photo-switchable cell adhesion to functional PEG beads, 
exemplified by beads functionalized with azobenzene 82. Activation of the carboxylate groups on the 
beads’ surface allows for immobilization of azobenzene derivatives 82 and 83, respectively. Treatment 
with fluorescent CD conjugate 93 enables the validation of inclusion complex formation by direct 
fluorescence detection. Photoisomerization of the azobenzene units results in disruption of the 
complexes and, consequently, a decrease in fluorescence intensity. Bacterial adhesion can be 
investigated by treating the photoresponsive beads with CD conjugate 90 and incubating with 
fluorescent E. coli. Decreased bacterial adhesion can be achieved by photoirradiation, expelling the CD 
conjugate 90. 
For investigation of bacterial adhesion, functionalized beads were prepared according to the 
protocol described above. Therefore, the beads were treated with an 8 mM solution of CD 
conjugate 90. Since irradiation with UV light would harm the bacteria and, thus, alter the 
result of the assay, irradiation of the beads was performed prior to incubation with the 
bacteria. For this, the functionalized beads were again separated into two portions while one 
portion was irradiated with UV light (365 nm) and the other portion was kept in the dark. 
Finally, both portions were incubated with GFP-transfected E. coli (PKL1162), subsequently 
washed and fluorescence was measured for quantification of adhesion. The obtained results 
are depicted in Figure 5.15B whereby the highest fluorescence value of each assay (at least 
three independent experiments) was normalized to 1. 
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Figure 5.15: A) Measured fluorescence from inclusion of fluorescein-tagged CD 93 on magnetic PEG 
beads functionalized with azobenzene derivatives 82 (blue) and 83 (green), respectively, and the 
corresponding fluorescence after irradiation at 365 nm. B) Detected fluorescence resulting from 
bacterial adhesion to CD conjugate 90 on beads functionalized with azobenzene derivatives 82 (blue) 
and 83 (green), respectively, and after irradiation at 365 nm. The shown data sets represent average 
values from several (at least three) independent experiments. 
Comparing the results depicted in Figure 5.15A reveals that inclusion complex formation is 
much more pronounced on beads functionalized with azobenzene derivative 82, resulting in 
an almost fivefold higher detected fluorescence value compared to those treated with 83. As 
far as the efficiency of photoinduced complex disruption is concerned, azobenzene 82 shows 
nearly 26% of decrease in fluorescence while in the case of azobenzene 83 no mentionable 
difference between both isomers could be observed. Keeping these results in mind, 
interpretation of the data obtained from bacterial adhesion studies (Figure 5.15B) shows a 
different scenario. Here, adhesion is almost equally efficient on both types of functionalized 
beads. Comparing the efficiency of photoinduced complex disruption, however, reveals that 
prior irradiation prevents bacterial adhesion by 30% for azobenzene 82 and by 74% for 
azobenzene 83. These findings are in accordance with the compounds’ individual E/Z ratio in 
the photostationary state (cf. Experimental Section) whereas azobenzene derivative 83 has a 
higher Z amount than 82. 
The obtained results raise the question why inclusion complex formation with fluorescein-
tagged CD 93 was very low on beads functionalized with azobenzene derivative 83. It could 
be argued that an insufficient immobilization of the azobenzene was the reason for this issue. 
However, the same beads were used in the bacterial adhesion studies, which, on the contrary, 
provided good results. One possible reason for the hampered inclusion can be related to the 
rather bulky fluorescein residue, which is located quite close to the primary face of the CD and 
may have caused steric clash with the azobenzene’s methoxy group.
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6. Conclusions 
Exploration of the Amadori Rearrangement for Bioconjugation of Carbohydrates 
Since it was previously demonstrated that the Amadori rearrangement has potential as a 
selective ligation method for efficient conjugation of unprotected sugars and amines, the aim 
of this project was to further investigate this reaction by employing different substrates. The 
article “Are D-manno-configured Amadori Products Ligands of the Bacterial Lectin FimH?” 
focused on the evaluation of the Amadori rearrangement for the preparation of ligands for the 
bacterial lectin FimH (Figure 6.1). The synthesis of an appropriate heptopyranose as a starting 
material for the synthesis of manno-configured Amadori products was reported. Aniline and 
propargylamine were reacted with this heptose to yield the respective C-glycosyl-type 
hexoses, revealing that Amadori rearrangement of aniline turned out to be less efficient as 
that of propargylamine due to the less nucleophilic, aromatic amino group of aniline. 
Furthermore, molecular docking of both Amadori products was performed in order to 
investigate the influence of the alkyl/aryl aminomethyl group at the β-face of the sugar ring 
on the complexation of the glycoconjugates in the CRD of FimH. The studies suggested a 
reasonable binding mode, however, biological testing of the Amadori products revealed 0.2–
0.4 fold weaker potencies towards inhibition of type 1 fimbriae-mediated bacterial adhesion 
compared to MeMan. 
 
Figure 6.1: Amadori rearrangement of a suitable heptose with different amines results in C-glycosyl 
type D-mannoside analogues. The potency of these compounds for inhibition of type 1 fimbriae-
mediated bacterial adhesion is in the range of MeMan.  
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A possible explanation for this issue may be found in the tilted arrangement of the Amadori 
products while being complexed in the CRD of FimH, resulting in compromised H-bonding, 
which weakens the affinity. Hence, it was shown that the utilization of the Amadori 
rearrangement for the synthesis of FimH ligands is critical since the resulting products have 
a limited fit in the CRD as a consequence of the sterically challenging aglycone. 
The chromatographic purification of Amadori products is quite cumbersome and in some 
cases can be even impossible due to the high polarity of the employed starting materials as 
well as the product itself. Because of this, the second chapter focused on application of the 
CSP methodology on amine substrates as starting materials in the Amadori rearrangement 
(Figure 6.2). A known guaiazulene carbonate was employed to synthesize a guaiazulene-
tagged amine 18 for Amadori rearrangement reactions. Employing two different heptoses 20 
and 21a/b, the corresponding gluco- and manno-configured products were prepared without 
any observable difference in the efficiency of the reaction. However, it turned out that several 
side products had been formed in both cases, which, nevertheless, could be easily removed 
through chromatography facilitated by the guaiazulene moiety. 
 
Figure 6.2: Application of different colored amines in the Amadori rearrangement resulted in 
chromophore-tagged Amadori products 22-25. Utilization according to the CSP methodology revealed 
that guaiazulene-derived compounds 22 and 24 were suited best for this purpose. 
Besides the guaiazulene-tagged amino compound 18, an aminomethylazobenzene 19 was 
applied in the Amadori rearrangement reactions with both heptopyranoses. In both cases, the 
reaction emerged as highly inefficient as only the gluco-configured product 23 was obtained 
in a very low yield while the manno-configured product 25 remained heavily contaminated. 
Since the hydrochloride 20, instead of the free amine, was employed for the reaction, it was 
suspected that the pH value of the solution may have been unfavorable for the reaction, 
resulting in low reactivity of the azobenzene derivative. Additionally, the chromatographic 
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purification did not proceed well enough due to extensive tailing, which significantly affected 
the purity of the obtained products. 
Taken together, it could be demonstrated that the Amadori rearrangement can be efficiently 
employed as a ligation method for conjugation of carbohydrates. This, however, requires that 
the compatibility of the starting materials (especially regarding their reactivity) is provided. 
Although Amadori products did not deliver high potencies towards inhibition of bacterial 
adhesion, the reaction may be used to generate ligands for lectins other than FimH. The 
general applicability of this reaction as a bioconjugation method, however, remains uncertain 
and requires further investigation. Especially concerning the amount of formed side products 
as well as the incomplete conversion, which was observed in some examples described herein, 
points out the necessity of improving the reaction’s efficiency. Solutions to these issues may 
be adjustment of the utilized reactants or, more elegantly, tuning of the reactions conditions. 
Although the Amadori rearrangement may not be generally applicable yet, the Glycogroup at 
the TU Graz successfully investigated different mono- but also multivalent rearrangement 
reactions, demonstrating the potential of this reaction for special applications. 
Bacterial Adhesion to Carbohydrate Scaffold-Based Glycoclusters 
In the first part of this chapter, the manuscript “Synthesis of AB4 Carbohydrate Scaffolds as 
Branching Units in the Glycosciences” was presented. Therein, the synthesis of a carbohydrate 
scaffold bearing an AB4-type functionalization was discussed following a retrosynthetic 
approach. Performance of different pathways revealed that the azido group in the aglycone of 
the scaffold had to be introduced at an advanced stage in order to avoid severe side reactions 
which were observed during most of the examined pathways. Finally, the N3/(NHBoc)4-
functionalized target scaffold could be synthesized in 30% yield over six steps. From this 
compound as well as from a precursor, other valuable molecules were prepared including a 
photoswitchable glycoconjugate and a glycocluster 41 (Figure 6.3). 
 
Figure 6.3: Target molecules that have been prepared in the scope of the manuscript “Synthesis of AB4 
Carbohydrate Scaffolds as Branching Units in the Glycosciences”.  
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In the second part of the chapter the previously synthesized glycocluster 41 was prepared for 
surface functionalization by attachment of a biorepulsive OEG linker 46 through a CuAAC 
cycloaddition reaction. Although the click reaction at first turned out to be unexpectedly 
problematic due to insufficient conversion of the starting material, the target glycocluster 47 
could be finally obtained in a yield of 50% (71%, based on conversion) by employing a 
different Cu(I) catalyst and purification by RP chromatography. Furthermore, tetravalent 
glycocluster 41 was tested as an inhibitor of type 1 fimbriae-mediated bacterial adhesion. An 
RIP value of 25.6 and a valency corrected value of 6.4 was determined, showing that the 
cluster 41 has a small multivalency effect, which, however, is not in the range of previously 
reported clusters containing a carbohydrate core. It was suspected that the geometrical shape 
of the glycocluster in combination with the electronic and conformational properties of the 
thiourea groups, which are connected to the mannose moieties, may negatively influence their 
preorganization as well as the recognition by the lectin. The scaffold compounds and the 
glycocluster 41 described in this chapter give rise to a variety of special applications as topics 
of future research in the Lindhorst group. Glycocluster, for instance, that arise from the 
photoresponsive scaffold (cf. Chapter 4.2) may be immobilized on suitable surfaces by click 
chemistry. Similarly, glycocluster 47, which contains a biorepulsive linker, may be attached 
to surfaces via its amino group. 
 
Figure 6.4: Tetravalent glycocluster 41 has been tested as an inhibitor of type 1 fimbriae-mediated 
bacterial adhesion. Attachment of a biorepulsive OEG linker allows for immobilization onto functional 
surfaces via the amino group (red circle). 
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Since CDs are capable of encapsulating appropriate hydrophobic molecules, such as 
adamantane or azobenzene, an assay system based on this feature was developed. Two 
approaches were investigated, which involved different CD hosts for fabrication of a 
supramolecular surface. Inclusion of different glycoconjugate guest molecules on the surface 
was performed in order to effect switchable bacterial adhesion. The first approach involved 
covalent immobilization of amino-functionalized CD derivatives as a means to create the 
supramolecular surface. However, this approach resulted in unspecific binding of bacteria to 
the surface and was not further pursued. In the second approach, the supramolecular surface 
was fabricated by non-covalent immobilization of amphiphilic CD derivatives. The performed 
ELLA studies, utilizing the lectin Con A and an adamantane glycoconjugate, demonstrated that 
the applied conditions needed adjustment but the approach is feasible. However, this 
approach was also not pursued any longer since a similar assay system was published by 
Jonkheijm and coworkers. Based on the experiences gathered from the previous experiments, 
a reverse variant of this assay system was investigated which involved bacterial adhesion to 
CD complexes on photoresponsive surfaces (Figure 6.5). 
 
Figure 6.5: Magnetic PEG beads functionalized with azobenzene 82 and 83, respectively, were treated 
with CD conjugates 90 or 93. Switching of bacterial adhesion was effected by photoisomerization of 
the azobenzene units.  
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The photoresponsive surfaces were fabricated by immobilization of aminomethylazobenzene 
derivatives 82 and 83, respectively, onto prefunctionalized microtiter plates. UV-light 
irradiation of polystyrene microtiter plates revealed that alteration of the functional surface 
took place so that the solid support was changed to UV-stable magnetic PEG beads. For these 
studies, two CD conjugates 90 and 93 were utilized for inclusion on the photoresponsive 
surface. While the fluorescein-tagged CD conjugate 93 was applied for validation of the 
inclusion complex formation, investigation of switchable cell adhesion was enabled by 
treatment with mannose CD conjugate 90. 
Inclusion of the fluorescein-tagged CD conjugate 93 turned out to be inefficient on beads 
functionalized with azobenzene derivative 83. The performed bacterial adhesion assays, 
however, revealed that adhesion was equally pronounced on both functional surfaces (82 and 
83). Attenuation of bacterial adhesion by photoisomerization of the azobenzene units 
depended greatly on the switching properties of the respective azobenzene. While in the case 
of azobenzene 82, bacterial adhesion was decreased by 30%, photoisomerization of 83 
resulted in a decrease of 74%. This proof of principle paves the way towards many interesting 
applications in research but also in the medical sector. For instance, this system could be 
applied in diagnostic procedures or, in the case of the tested PEG beads, for the extraction and 
accumulation of pathogens from body fluids or other media. 
 
The results presented in this thesis point out that the possibilities for investigation of bacterial 
adhesion can be highly diverse. Especially interdisciplinary studies and combinations of 
complex organic synthesis with biochemical techniques are powerful and promising tools, 
allowing for elucidation of biological processes in many aspects. The findings of this thesis 
contribute to the examination of novel targets as well as techniques for investigation of 
bacterial adhesion and will be topic of future research in the Lindhorst group.  
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7. Experimental Section 
7.1 Materials and Methods 
Reactions, chemicals and solvents 
All reactions were carried out under atmospheric conditions (unless indicated otherwise). 
Moisture-sensitive reactions were carried out under a nitrogen atmosphere in reaction 
vessels that were baked out before use. All chemicals were purchased from abcr, Acros, Alfa 
Aesar, Merck, Sigma-Aldrich or TCI and used without further purification. For extractions and 
column chromatography, technical grade solvents were used, which were purified by 
distillation before use. Dry solvents were either directly purchased from the manufacturer or 
dried by an Inert PureSolv MD5 solvent purification system. 
Thin layer chromatography (TLC) 
TLC was performed on silica gel plates (GF 254, Merck) backed with aluminum. Detection of 
UV-active substances was achieved by a CAMAG UV lamp (λ1 = 254 nm, λ2 = 366 nm). 
Substances that were not UV-active were detected by charring with 10% sulfuric acid in EtOH, 
with a vanillin staining reagent (3.0 g vanillin and 0.5 mL H2SO4 in 100 mL EtOH) or with a 
ninhydrin staining solution followed by heating at ≈ 180 °C. 
Flash- and reverse phase (RP) chromatography 
Flash chromatography was carried out on silica gel 60 (Merck, 230-400 mesh, particle size 
0.040-0.063 mm) or by using an Interchim puriFlash®450 chromatography system with 
distilled solvents. RP chromatography was performed by using the same flash system with 
CHROMABOND® C18ec columns (Macherey Nagel). 
Gel permeation chromatography (GPC) 
GPC was performed on Sephadex® G-15 (Sigma Aldrich) by using a peristaltic pump with DMF 
as the solvent. 
Nuclear magnetic resonance spectroscopy (NMR) 
NMR spectra were recorded on Bruker DRX-500 (500.13 MHz for 1H and 125.75 MHz for 13C) 
and AV-600 (600.13 MHz for 1H and 150.92 MHz for 13C) spectrometers at 300 K. Assignment 
of the peaks was achieved with the aid of 2D NMR techniques (1H,1H-COSY, 1H,13C-HSQC and 
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1H,13C-HMBC). Chemical shifts are referenced to the residual proton or the carbon signal of 
the used deuterated solvent. 
CDCl3  1H 7.26 ppm (s) 
  13C 77.16 ppm (t) 
MeOH-d4 1H 3.31 ppm (quint) 
  13C 49.00 ppm (sept) 
DMSO-d6 1H 2.50 ppm (quint) 
  13C 39.52 ppm (sept) 
Data is presented in the following format: chemical shift (δ), multiplicity (s = singlet, 
d = doublet, t = triplet, q = quartet, m = multiplet and br = broad signal), coupling constant in 
Hertz (Hz) and integration. 
Optical rotations 
Optical rotations were measured on a PerkinElmer 241 polarimeter (sodium D-line: 589 nm, 
cell length: 1 dm) in the solvents indicated. Optical rotations of guaiazulene derivatives could 
not be recorded since their intense color prevents detection. 
Melting points (m.p.) 
Melting points were determined on a BÜCHI Melting Point M-560 apparatus. 
Mass spectrometry (MS) 
ESI mass spectra were recorded on a Bruker Daltonics Esquire-LC instrument. High-
resolution (HR) ESI-MS was performed on an Agilent 6224 ESI-TOF instrument. EI mass 
spectra were recorded on a Jeol AccuTOF 4GCV instrument. MALDI-TOF spectra were 
measured on a Bruker Biflex III instrument with an acceleration voltage of 19 kV and 2,5-
dihydroxybenzoic acid (DHB) as the matrix. 
Purity of compounds 
The purity of synthesized compounds was ensured by validation of the corresponding 1H and 
13C NMR spectra in combination with the respective HR ESI-MS spectra. 
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Infrared (IR) spectroscopy 
IR spectra were recorded on a PerkinElmer FT-IR Paragon 1000 (ATR) spectrometer. 
Absorption bands are presented in cm-1. 
Ultraviolet–visible (UV/Vis) spectroscopy 
UV/Vis spectra were recorded on a Lambda-41 spectrometer from PerkinElmer equipped 
with Büchi thermostat. Samples were measured in fused quartz cuvettes with a diameter of 
1 cm at a temperature of 20 °C ± 1 °C. 
Irradiation experiments 
Irradiation was performed by using an LED (λ = 365 nm) from Nichia Corporation 
(NC4U133A) with a full-width at half maximum (FWHM) of 9 nm and an optical power output 
(PO) of ≈ 1 W. 
Microtiter plates 
Adhesion-inhibition assays were performed on black Nunc MicroWell™ (MaxiSorp™) 96-well 
plates (Thermo Scientific™). Covalent immobilization of compounds was carried out on black 
Nunc Immobilizer™ Amino 96-well plates. For ELLA-type assays, transparent Nunc-Immuno™ 
MicroWell™ (MaxiSorp™) 96-well plates were utilized. Phenol-sulfuric acid assays were 
performed on transparent Nunc Immobilizer™ Amino 96-well plates. 
ELISA reader 
Fluorescence and absorbance was measured on a Tecan infinite® 200 multifunction 
microplate reader. A bandpass filter was used with 485 nm for excitation and 535 nm for 
emission. For the phenol-sulphuric acid assay, absorbance was measured at 492 nm. 
Magnetic PEG beads 
Bacterial adhesion studies were performed on micromod magnetic polystyrene beads 
containing a PEG-COOH coating (micromer®-M, 08-56-203). 
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7.2 General Synthetic Procedures 
7.2.1 General Procedure A (Synthesis of amphiphilic CD derivatives 61-63) 
The preparative procedure was adapted from J. Pharm. Sci. 2002, 91 (5), 1214-1224: 
A solution of heptakisbromo CD 60130 (1.0 eq) in deoxygenated DMF was added to a solution 
of the respective carboxylic acid (14 eq) and Cs2CO3 (7.0 eq) as well in deoxygenated DMF. 
The reaction mixture was stirred at 50 °C for 72 h and was then filtered. The solvent was 
removed under reduced pressure and the residue was washed several times with water. The 
resulting solid was taken up in DMF and precipitated by addition of water. After filtration, the 
solid was washed with water followed by acetone and finally dried at 60 °C, giving the 
respective amphiphilic CD derivative. 
 
7.2.2 General Procedure B (CuAAC reaction with copper(II) sulfate pentahydrate) 
The preparative procedure was adapted from Angew. Chem. 2002, 114 (14), 2708-2711: 
The respective azide (1.0 eq) and alkyne (1.0 eq) were both dissolved in DMF and an aqueous 
solution of CuSO4 . 5 H2O (0.42 eq) was added. After that, an aqueous solution of sodium 
ascorbate (0.85 eq) was added and the reaction mixture was stirred at room temperature for 
16 h. The solvent was removed under reduced pressure and the crude product was purified 
by the method indicated in the corresponding individual procedure. 
 
7.2.3 General Procedure C (NaOMe promoted deacetylation) 
The preparative procedure was adapted from Chem. Ber. 1929, 62 (6), 1613-1614: 
The respective acetyl-protected carbohydrate was dissolved in MeOH. Subsequently, a freshly 
prepared methanolic NaOMe solution (1 M) was added and the reaction mixture was stirred 
for 16 h at room temperature. The solution was then neutralized by addition of Amberlite-
IR120®, the resin was filtered off, and the solvent was removed under reduced pressure to 
yield the pure deacetylated compound. 
  
 Experimental Section 133 
7.3 Individual Synthetic Procedures 
4-(2-Hydroxyethyl)-7-isopropyl-1-methylazulene (16)57 
 
The preparative procedure was adapted from Eur. J. Org. Chem. 2006, 1103-1108: 
An LDA solution (25.2 mL, 50.4 mmol, 1.0 eq; 2 M) was diluted dry Et2O (100 mL) and cooled 
to -35 °C. Then, a solution of guaiazulene 14 (10.0 g, 50.4 mmol, 1.0 eq) in Et2O (30 mL) was 
added dropwise and the reaction mixture was stirred for 40 min at this temperature. 
Paraformaldehyde was added and stirring was continued for 10 min at -35 °C. The mixture 
was then allowed to attain room temperature and stirred for 16 h. The solution was diluted 
with Et2O and the organic phase was washed three times with brine, dried over MgSO4, 
filtered, and the solvent was removed under reduced pressure. The crude mixture was 
purified by flash chromatography (toluene/EtOAc, 6:1), giving product 16 as a blue oil. 
Yield: 6.17 g, 27.0 mmol, 54%. 
The obtained spectroscopic data was according to that reported in the literature.57 
2-(7-Isopropyl-1-methylazulen-4-yl)ethyl N-succinimidyl carbonate (17)59 
 
The preparative procedure was adapted from J. Carbohydr. Chem. 2009, 28 (6), 330-347: 
Pyridine (35.2 µL, 436 µmol, 0.2 eq) and DSC (669 mg, 2.61 mmol, 1.2 eq) were added to a 
solution of alcohol 16 (497 mg, 2.18 mmol, 1.0 eq) in dry DMF (3 mL). The reaction mixture 
was stirred at 40 °C for 16 h and the solvent was removed under reduced pressure. The 
residue was taken up in EtOAc (30 mL) and the organic phase was washed three times with 
brine. After drying over MgSO4, the organic phase was filtered, and the solvent was removed 
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under reduced pressure. The crude product was purified by flash chromatography 
(cyclohexane/EtOAc, 3:1→2:1), giving carbonate 17 as a blue solid. 
Yield: 736 mg, 1.99 mmol, 91%. 
The obtained spectroscopic data was according to that reported in the literature.59 
N-2-[2-(7-Isopropyl-1-methyl-azulen-4-yl)ethoxycarbonylamido]ethylamine (18) 
 
A solution of carbonate 17 (76.4 mg, 207 µmol, 1.0 eq) in CHCl3 (1 mL) was added at 0 °C to a 
solution of ethylene diamine (373 µL, 5.59 mmol, 27 eq) in CHCl3 (3.5 mL). The reaction 
mixture was stirred for 1 h at this temperature and stirring was continued for further 16 h at 
room temperature. The organic phase was washed twice with satd. aq. NaHCO3 solution, 
brine, and water. After drying over MgSO4, the organic phase was filtered and the solvent was 
removed under reduced pressure. The residue was purified by flash chromatography 
(CH2Cl2/MeOH, 10:1 containing 1% of TEA), giving amine 18 as a blue oil. 
Yield: 61.9 mg, 197 µmol, 95%; 
Rf: 0.26 (CH2Cl2/MeOH, 9:1 containing 1% of TEA); 
1H NMR (500 MHz, CDCl3, 300 K): δ = 8.16 (d, J6,8 = 1.6 Hz, 1H, H-8), 7.62 (d, J2,3 = 3.6 Hz, 1H, 
H-2), 7.38 (dd, J5,6 = 10.6 Hz, J6,8 = 1.1 Hz, 1H, H-6), 7.31 (d, J6,8 = 2.9 Hz, 1H, H-3), 6.96 (d, J5,6 = 
10.7 Hz, 1H, H-5), 5.62 (mc, 1H, NHCO), 4.44 (dd~t, OCH,CH-az = 7.3 Hz, 2H, OCH2CH2-az), 4.23 (br 
s, 2H, NH2), 3.42 (dd~t, OCH,CH-az = 7.3 Hz, 2H, OCH2CH2-az), 3.34 (mc, 2H, H2NCH2CH2NHCO), 
3.04 (sept, Jisopropyl = 6.7 Hz, 1H, az-CH(CH3)2), 2.95 (mc, 2H, H2NCH2CH2NHCO), 2.63 (s, 3H, az-
CH3), 1.33 (d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 157.1 (C=O), 143.7 (C-7), 140.4 (C-4), 137.7 (C-10), 
137.0 (C-2), 136.3 (C-9), 135.2 (C-6), 133.6 (C-8), 125.6 (C-1), 124.9 (C-5), 112.7 (C-3), 65.4 
(OCH2CH2-az), 41.6 (H2NCH2CH2NHCO), 41.2 (H2NCH2CH2NHCO), 38.4 (az-CH(CH3)2), 37.9 
(OCH2CH2-az), 24.8 (az-CH(CH3)2), 13.0 (az-CH3) ppm; 
ESI-MS (m/z): [M+H]+ calcd. for C19H27N2O2, 315.207, found, 315.183; 
IR (ATR) ῦ: 3293, 2957, 1700, 1523, 1459, 1387, 1250, 1140, 1024, 921, 823, 779 cm-1. 
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1-{N-2-[2-(7-Isopropyl-1-methyl-azulen-4-yl)ethoxycarbonylamido]ethyl}amino-1-
deoxy α-D-gluco-hept-2-ulose (22) 
 
D-Glycero-D-gulo-heptopyranose (20, 134 mg, 638 µmol, 1.0 eq) was dissolved in a mixture of 
EtOH (4 mL), 1,4-dioxane (0.5 mL), and water (5 drops). Then guaiazulene-tagged amine 18 
(201 mg, 638 µmol, 1.0 eq) and acetic acid (36.5 µL, 638 µmol, 1.0 eq) were added and the 
reaction mixture was stirred at 70 °C for 5 h. The solvent was removed under reduced 
pressure and the crude product was purified by flash chromatography (CHCl3/MeOH, 
5:1→3:1 containing 1% of conc. NH4OH). Amadori product 22 was obtained as a blue syrup. 
Yield: 116 mg, 328 µmol, 52% (66% based on conversion, 14% starting material reisolated). 
Rf: 0.32 (CHCl3/MeOH, 2:1 containing 1% of conc. NH4OH); 
1H NMR (500 MHz, MeOH-d4, 300 K): δ = 8.19 (d~s, 1H, H-8), 7.62 (d, J2,3 = 3.6 Hz, 1H, H-2), 
7.46 (dd~d, J5,6 = 10.6 Hz, 1H, H-6), 7.32 (d, J6,8 = 3.7 Hz, 1H, H-3), 7.06 (d, J5,6 = 10.7 Hz, 1H, H-
5), 4.44 (dd~t, OCH,CH-az = 7.0 Hz, 2H, OCH2CH2-az), 3.82 (dd, J7´a,7´b = 11.6 Hz, J6´,7´a = 2.2 Hz, 1H, 
H-7´a), 3.75-3.72 (m, 1H, H-4´), 3.69-3.65 (m, 2H, H-6´, H-7´b), 3.46 (dd~t, OCH,CH-az = 7.0 Hz, 2H, 
OCH2CH2-az), 3.33-3.27 (m, 4H, HNCH2CH2NHCO, H-3´, H-5´), 3.08 (sept, Jisopropyl = 6.9 Hz, 1H, 
az-CH(CH3)2), 3.02 (s, 2H, H-1´a,b), 2.94 (mc, 2H, HNCH2CH2NHCO), 2.63 (s, 3H, az-CH3), 1.36 
(d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 159.4 (C=O), 144.9 (C-7), 141.4 (C-4), 139.0 (C-10), 
137.9 (C-2), 137.7 (C-9), 136.0 (C-6), 134.0 (C-8), 126.4 (C-1), 125.8 (C-5), 113.4 (C-3), 97.0 
(C-2´), 75.5 (C-6´), 74.4 (C-3´), 74.3 (C-4´), 71.6 (C-5´), 66.5 (OCH2CH2-az), 62.7 (C-7´), 55.1 (C-
1´), 50.1 (HNCH2CH2NHCO), 39.6 (H2NCH2CH2NHCO), 39.4 (az-CH(CH3)2), 38.5 (OCH2CH2-az), 
25.1 (az-CH(CH3)2), 12.9 (az-CH3) ppm; 
λmax (ε): 349 nm (3587 L mol-1 cm-1); 
ESI-MS (m/z): [M+H]+ calcd. for C26H38N2O8, 507.270, found, 507.274; 
IR (ATR) ῦ: 3318, 2960, 1698, 1525, 1456, 1255, 1034, 823 cm-1. 
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1-{N-2-[2-(7-Isopropyl-1-methyl-azulen-4-yl)ethoxycarbonylamido]ethyl}amino-1-
deoxy α-D-manno-hept-2-ulose (24) 
 
D-Glycero-D-galacto/D-talo heptopyranose (21a/b, 142 mg, 677 µmol, 1.0 eq) was dissolved 
in a mixture of EtOH (4 mL), 1,4-dioxane (0.5 mL), and water (5 drops). Then guaiazulene-
tagged amine 18 (213 mg, 677 µmol, 1.0 eq) and acetic acid (38.7 µL, 677 µmol, 1.0 eq) were 
added and the reaction mixture was stirred at 70 °C for 7 h. The solvent was removed under 
reduced pressure and the crude product was purified by flash chromatography (CHCl3/MeOH, 
5:1→3:1 containing 1% of conc. NH4OH). Amadori product 24 was obtained as a blue syrup. 
Yield: 185 mg, 365 µmol, 54% (59% based on conversion, 5% starting material reisolated). 
Rf: 0.35 (CHCl3/MeOH, 2:1 containing 1% of conc. NH4OH); 
1H NMR (600 MHz, CDCl3, 300 K): δ = 8.19 (d~s, 1H, H-8), 7.63 (d, J2,3 = 3.2 Hz, 1H, H-2), 7.47 
(dd~d, J5,6 = 10.5 Hz, 1H, H-6), 7.33 (d, J6,8 = 3.4 Hz, 1H, H-3), 7.07 (d, J5,6 = 10.6 Hz, 1H, H-5), 
4.46 (dd~t, OCH,CH-az = 6.9 Hz, 2H, OCH2CH2-az), 3.85-3.82 (m, 3H, H-3´, H-4´, H-7´a), 3.76 (dd, 
J7´a,7´b = 11.6 Hz, J6´,7´b = 5.3 Hz, 1H, H-7´b), 3.73-3.71 (m, 1H, H-6´), 3.66-3.63 (m, 1H, H-5´), 3.47 
(dd~t, OCH,CH-az = 6.9 Hz, 2H, OCH2CH2-az), 3.37 (mc, 2H, HNCH2CH2NHCO), 3.27 (d, J1´a,1´b = 
12.5 Hz, 1H, H-1´a), 3.12-3.02 (m, 4H, HNCH2CH2NHCO, H-1´b, az-CH(CH3)2), 2.63 (s, 3H, az-
CH3), 1.36 (d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (150.92 MHz, CDCl3, 300 K): δ = 159.6 (C=O), 144.8 (C-7), 141.4 (C-4), 139.1 (C-10), 
137.9 (C-2), 137.7 (C-9), 136.0 (C-6), 134.0 (C-8), 126.5 (C-1), 125.8 (C-5), 113.5 (C-3), 96.2 
(C-2´), 75.1 (C-3´), 75.0 (C-6´), 72.6 (C-4´), 67.8 (C-5´), 66.7 (OCH2CH2-az), 62.6 (C-7´), 55.6 (C-
1´), 49.9 (HNCH2CH2NHCO), 39.4 (az-CH(CH3)2), 38.7 (HNCH2CH2NHCO), 38.5 (OCH2CH2-az), 
25.1 (az-CH(CH3)2), 12.9 (az-CH3) ppm; 
λmax (ε): 349 nm (5352 L mol-1 cm-1); 
ESI-MS (m/z): [M+H]+ calcd. for C26H38N2O8, 507.3, found, 507.2; 
IR (ATR) ῦ: 3280, 2960, 1699, 1540, 1410, 1255, 1052, 1033, 922, 821 cm-1. 
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1-[N-(E)-p-(Phenylazo)benzyl]amino-1-deoxy α-D-gluco-hept-2-ulose (23) 
 
Azobenzene derivative 19 (85 mg, 0.34 mmol, 1.0 eq) was suspended in a mixture of EtOH 
(5 mL) and TEA (47 µL, 0.34 mmol, 1.0 eq). The suspension was stirred for 20 min at room 
temperature before D-glycero-D-gulo-heptopyranose (20, 71 mg, 0.34 mmol, 1.0 eq) as well as 
1,4-dioxane (0.5 mL) and water (5 drops) were added. The reaction mixture was stirred at 
70 °C for 2 h but TLC revealed only little conversion so that another 0.5 eq of azobenzene 
derivative 19 (43 mg, 0.17 mmol) and TEA (24 µL, 0.17 mmol) were added. Stirring was then 
continued for 8 h at 70 °C and the solvent was removed under reduced pressure. The crude 
product was purified by flash chromatography (CHCl3/MeOH, 84:15 containing 1% of conc. 
NH4OH), giving Amadori product 23 as a yellow amorphous solid. 
Yield: 9 mg, 0.02 mmol, 6%; 
Rf: 0.38 (CHCl3/MeOH, 3:1 containing 1% of conc. NH4OH); 
[]
 = +20.6 (c = 0.8, MeOH); 
1H NMR (500 MHz, CDCl3, 300 K): δ = 7.95 (mc, 2H, H-10, H-12), 7.92 (mc, 2H, H-15, H-19), 
7.64 (mc, 2H, H-9, H-13), 7.55 (mc, 2H, H-16, H-18), 7.53 (mc, 1H, H-17), 4.19 (d, JNCH,NCH´ = 
13.7 Hz, 1H, HNCH´H-ar), 4.15 (d, JNCH,NCH´ = 13.7 Hz, 1H, HNCH´H-ar), 3.85 (dd, J7a,7b = 11.5 Hz, 
J6,7a = 2.3 Hz, 1H, H-7a), 3.78-3.74 (m, 1H, H-4), 3.70-3.65 (m, 2H, H-6, H-7b), 3.33-3.27 (m, 2H, 
H-3, H-5), 3.06 (d, JH-1a,H-1b = 12.4 Hz, 1H, H-1a), 3.03 (d, JH-1a,H-1b = 12.3 Hz, 1H, H-1b) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 154.0 (C-14), 153.8 (C-11), 132.5 (C-17), 131.3 (C-9, C-
13), 130.9 (C-8), 130.3 (C-16, C-18), 124.1 (C-10, C-12), 123.9 (C-15, C-19), 97.1 (C-2), 75.5 
(C-6), 74.4 (C-3, C-4), 71.6 (C-5), 62.7 (C-7), 54.6 (C-1), 53.2 (HNCH2-ar) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C20H25N3O6, 426.2, found, 426.1. 
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2-(2-(2-(Prop-2-ynyloxy)ethoxy)ethoxy)ethanol (43)77b 
 
The preparative procedure was adapted from Bioconjugate Chem. 2009, 20 (12), 2364-2370: 
Ground potassium hydroxide (3.04 g, 54.1 mmol, 1.1 eq) was added to neat triethylene glycol 
(42, 19.8 mL, 148 mmol, 3.0 eq) and the reaction mixture was stirred at 40 °C for 30 min. 
Then propargyl bromide solution (4.66 mL, 49.2 mmol, 1.0 eq; 80% in toluene) was added 
and stirring was continued at 60 °C for 3 h. The mixture was then diluted with water (45 mL) 
and acidified to pH 1 with a hydrochloric acid solution (1 M). The aqueous phase was 
extracted three times with EtOAc and the combined organic phases were washed twice with 
brine. The organic phase was then dried over MgSO4, filtered, and the solvent was removed 
under reduced pressure. The crude product was purified by flash chromatography 
(cyclohexane/EtOAc, 1:1), giving alkyne 43 as a colorless oil. 
Yield: 3.14 g, 16.7 mmol, 34%. 
The obtained spectroscopic data was according to that reported in the literature.77b 
2-(2-(2-(Prop-2-ynyloxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (44)77b 
 
The preparative procedure was adapted from Bioconjugate Chem. 2009, 20 (12), 2364-2370: 
Alkyne 43 (1.03 g, 5.47 mmol, 1.0 eq) and tosyl chloride (1.15 g, 6.02 mmol, 1.1 eq) were 
dissolved in CH2Cl2 (6 mL). Ground potassium hydroxide (1.23 g, 21.9 mmol, 4.0 eq) was 
slowly added at 0 °C and the reaction mixture was stirred at this temperature for 3 h. The 
mixture was poured onto ice-cold water and the aqueous phase was extracted three times 
with CH2Cl2. The organic phase was then washed with brine, dried over MgSO4, filtered, and 
the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography (cyclohexane/EtOAc, 2:1), giving tosylate 44 as a colorless oil. 
Yield: 1.57 g, 4.59 mmol, 84%. 
The obtained spectroscopic data was according to that reported in the literature.77b 
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3-(2-(2-(2-Azidoethoxy)ethoxy)ethoxy)prop-1-yne (45)77b 
 
The preparative procedure was adapted from Bioconjugate Chem. 2009, 20 (12), 2364-2370: 
Tosylate 44 (4.94 g, 14.4 mmol, 1.0 eq), sodium azide (7.48 g, 115 mmol, 8.0 eq) and TBAI 
(532 mg, 1.44 mmol, 0.1 eq) were dissolved in DMF (150 mL). The reaction mixture was 
stirred at 70 °C for 4 h. The mixture was then poured onto ice-cold water and the aqueous 
phase was extracted four times with CH2Cl2. The organic phase was dried over MgSO4, filtered, 
and the solvent was removed under reduced pressure. The crude product was purified by 
flash chromatography (cyclohexane/EtOAc, 1:1), giving azide 45 as a colorless oil. 
Yield: 2.34 g, 11.0 mmol, 76%. 
The obtained spectroscopic data was according to that reported in the literature.77b 
2-(2-(2-(Prop-2-ynyloxy)ethoxy)ethoxy)ethylamine (46)77b 
 
The preparative procedure was adapted from Bioconjugate Chem. 2009, 20 (12), 2364-2370: 
PPh3 (4.33 g, 16.5 mmol, 1.5 eq) was added to solution of azide 45 (2.34 g, 11.0 mmol, 1.0 eq) 
in dry THF (50 mL). The reaction mixture was stirred for 16 h at room temperature and conc. 
NH4OH (35%, 5 mL) was added. Stirring was continued for another 16 h at this temperature 
and the solvent was removed under reduced pressure. The residue was purified by flash 
chromatography (CH2Cl2/MeOH, 90:9 containing 1% of conc. NH4OH), giving amine 46 as a 
colorless oil. 
Yield: 1.76 g, 9.40 mmol, 85%. 
The obtained spectroscopic data was according to that reported in the literature.77b 
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2-(4-(2-(2-(2-Ammoniumethoxy)ethoxy)ethoxy)methyltriazolyl)ethyl 2,3,4,6-tetra-O-
[3-N´-(α-D-mannopyranosyl)thioureidopropyl] α-D-mannopyranosyl formate (47) 
 
A stock solution of CuBr (7.03 mg, 49.0 µmol) and PMDETA (10.2 µL, 49.0 µmol) in dry DMF 
(15.8 mL) was prepared. Then, glycocluster 41 (42.2 mg, 31.0 µmol, 1.0 eq) and alkyne 46 
(5.80 mg, 31.0 µmol, 1.0 eq) were dissolved in 2 mL of the stock solution and the reaction 
mixture was stirred for 16 h at room temperature. The solvent was removed under reduced 
pressure and the residue was purified by RP chromatography (ACN/ddH2O containing 0.1% 
of formic acid, cf. Appendix), giving the product as the corresponding formate salt 47. 
Yield: 24.6 mg, 15.4 µmol, 50% (71% based on conversion, 21% starting material reisolated). 
Rf: 0.19 (iPrOH/H2O/EtOAc/NH4OH (conc.), 5:3:1:1); 
[]
 = +20.8 (c = 0.3, H2O); 
1H NMR (500 MHz, D2O, 300 K): δ = 8.38 (s, 1H, C(O)H), 8.08 (s, 1H, Htriazole), 5.64-5.44 (m, 3H, 
3 H-1´), 4.86 (d~s, 1H, H-1), 4.67 (s, 2H, triazole-CH2O), 4.64 (mc, 2H, OCH2CH2-triazole), 4.04-
3.99 (m, 2H, OCH´HCH2-triazole, H-4), 3.93-3.85 (m, 7H, OCH´HCH2-triazole, 4 H-4´, 2 H-6´a), 
3.80-3.77 (m, 4H, H-2, H-5, 2 H-6´a), 3.72-3.44 (m, 45H, triazole-CH2OCH2, triazole-
CH2OCH2CH2, OCH2CH2O, OCH2CH2O, OCH2CH2NH4+, 4 OCH2CH2CH2NH, 4 OCH2CH2CH2NH, 
4 H-2´, 4 H-3´, H-3, 4 H-5´, 4 H-6´b, H-6a,b), 3.16 (mc, 2H, OCH2CH2NH4+), 1.83 (br mc, 8H, 
4 OCH2CH2CH2NH) ppm; 
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13C NMR (125 MHz, D2O, 300 K): δ = 181.6 (C=S), 170.6 (C=O), 143.9 (Cquart, triazole), 125.6 
(Ctriazole), 97.1 (C-1), 82.3, 81.4 (2 C-1´), 78.8 (C-3), 77.4 (C-3´), 75.2 (C-2), 73.6, 73.4 (C-2´), 
70.7, 70.5 (C-5, C-4´), 69.7, 69.5, 68.9, 68.5, 67.6, 66.9, 66.5, 66.4 (triazole-CH2OCH2, triazole-
CH2OCH2CH2, OCH2CH2O, OCH2CH2O, OCH2CH2CH2NH, C-5´, C-6), 65.7 (OCH2CH2-triazole), 
63.1 (triazole-CH2O), 61.0, 60.8 (2 C-6´), 50.2 (OCH2CH2-triazole), 42.3, 42.1 
(2 OCH2CH2CH2NH), 39.1 (OCH2CH2NH4+), 29.0, 28.7, 28.5, 28.2 (4 OCH2CH2CH2NH) ppm; 
ESI-MS (m/z): [M+H]+ calcd. for C57H104N12O29S4, 1549.5993, found, 1549.5971. 
Mono[6A-(p-toluenesulfonyl)-6A-deoxy]cyclomaltoheptaose (49)119a 
 
The preparative procedure was adapted from Org. Synth. 2000, 77, 225: 
β-CD (48, 8.26 g, 7.26 mmol, 4.0 eq) was suspended in water (180 mL) and the suspension 
was brought to 60 °C. The resulting clear solution was cooled to room temperature and 1-(p-
toluenesulfonyl)imidazole (6.46 g, 29.1 mmol, 4.0 eq) was added. The reaction mixture was 
stirred for 2 h at room temperature before aq. NaOH (3.72 g in 10 mL) was slowly added over 
10 min. The suspension was then filtered and the filtrate was neutralized by addition of solid 
NH4Cl (9.95 g). The solution was reduced to half of the initial volume by blowing a gentle 
stream of air over the surface of the solution for 16 h. The precipitate was collected by 
filtration, washed with ice-cold water, followed by acetone, and dried at 60 °C. The solid was 
recrystallized from water and tosylate 49 was obtained as a white solid. 
Yield: 2.96 g, 2.30 mmol, 32%. 
The obtained spectroscopic data was according to that reported in the literature.119a 
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Mono[6A-azido-6A-deoxy]cyclomaltoheptaose (50)117 
 
The preparative procedure was adapted from Analyst 2011, 136, 5017–5024: 
NaN3 (194 mg, 2.98 mmol, 1.2 eq) was added to a solution of tosylate 49 (3.23 g, 2.51 mmol, 
1.0 eq) in DMF (30 mL) and the reaction mixture was stirred at 80 °C for 6 h. After cooling to 
room temperature, the solution was added dropwise to acetone and the precipitate was 
collected by filtration. Washing with acetone and subsequent drying at 60 °C furnished 
azide 50 as a white solid. 
Yield: 2.96 g, 2.30 mmol, 32%. 
The obtained spectroscopic data was according to that reported in the literature.117 
Mono[6A-(4-aminomethyl-triazolyl)-6A-deoxy]cyclomaltoheptaose (51) 
 
CD conjugate 51 was synthesized according to general procedure B with azide 50 (200 mg, 
172 µmol), propargylamine (11.0 μL, 172 µmol), CuSO4 . 5 H2O (18.1 mg, 72.5 µmol), sodium 
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ascorbate (28.7 mg, 145 µmol), DMF (2 mL), and water (0.67 mL). A greenish solid (0.31 g) 
was obtained which was used without further purification. 
2-(4-Aminomethyl-triazolyl)ethyl α-D-mannopyranoside (53) 
 
Mannoside 53 was synthesized according to general procedure B with azide 52 (42.9 mg, 
172 µmol), propargylamine (11.0 μL, 172 µmol), CuSO4 . 5 H2O (18.1 mg, 72.5 µmol), sodium 
ascorbate (28.7 mg, 145 µmol), DMF (2 mL), and water (0.67 mL). A greenish solid (0.11 g) 
was obtained which was used without further purification. 
2-(2-(2-[(E)-p-(p´-Phenylazo)phenyloxy]ethoxy)ethoxy)ethanol (56) 
 
A mixture of p-phenylazophenol 55 (3.25 g, 16.4 mmol, 1.0 eq), potassium hydroxide 
(920 mg, 16.4 mmol, 1.0 eq) and 2-[2-(2-chlorethoxy)ethoxy]ethanol 54 (2.40 mL, 
16.4 mmol, 1.0 eq) in n-Butanol (20 mL) was refluxed for 72 h. Remaining solids were filtered 
off, washed thoroughly with CHCl3, and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography (Et2O/EtOAc, 5:1), giving azobenzene 
derivative 56 as an orange solid. 
Yield: 3.80 g, 11.5 mmol, 70%; 
Rf: 0.23 (Et2O/EtOAc, 5:1); 
m.p.: 56 °C; 
1H NMR (500 MHz, CDCl3, 300 K): δ = 7.84 (mc, 2H, H-3, H-5), 7.78 (mc, 2H, H-8, H-12), 7.47-
7.35 (m, 3H, H-9, H-10, H-11), 6.96 (mc, 2H, H-2, H-6), 4.18-4.13 (m, 2H, Ar-OCH2CH2O), 3.85-
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3.81 (m, 2H, Ar-OCH2CH2O), 3.70-3.61 (m, 6H, OCH2CH2O, OCH2CH2O, OCH2CH2OH), 3.58-3.53 
(m, 2H, OCH2CH2OH) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 161.2 (C-1), 152.7 (C-7), 147.1 (C-4), 130.4 (C-10), 
129.0 (C-9, C-11), 124.7 (C-3, C-5), 122.6 (C-8, C-12), 114.8 (C-2, C-6), 72.5 (OCH2CH2OH), 70.9 
(OCH2CH2O), 70.4 (OCH2CH2O), 69.6 (Ar-OCH2CH2O), 67.7 (Ar-OCH2CH2O), 61.8 (OCH2CH2OH) 
ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C18H22N2O4, 353.148, found, 353.144; 
IR (ATR) ῦ: 3271, 2930, 2877, 1595, 1498, 1453, 1358, 1253, 1234, 1140, 1103, 1060, 1030, 
923, 844, 771 cm-1. 
2-(2-(2-[(E)-p-(p´-Phenylazo)phenyloxy]ethoxy)ethoxy)ethyl 2,3,4,6-tetra-O-acetyl α-
D-mannopyranoside (58) 
 
Trichloroacetimidate 57 (385 mg, 781 µmol, 1.0 eq) and azobenzene derivative 56 (310 mg, 
939 µmol, 1.2 eq) were dissolved in dry CH2Cl2 (6 mL). Then, BF3-etherate (150 µL, 
1.25 mmol, 1.6 eq) was added dropwise at 0 °C and the solution was stirred for 30 min at this 
temperature. After stirring for 16 h at room temperature, the solution was diluted with CH2Cl2 
and the organic phase was washed with satd. aq. NaHCO3 solution until no further gas 
formation was observed. The organic phase was dried over MgSO4, filtered and the filtrate 
was concentrated under reduced pressure. Purification of the crude mixture by flash 
chromatography (cyclohexane/EtOAc, 2:3) gave the product 58 as an orange amorphous 
solid. 
Yield: 217 mg, 328 µmol, 42%; 
Rf: 0.22 (cyclohexane/EtOAc, 2:3); 
[]
 = -0.875 (c = 0.4, CH2Cl2); 
1H NMR (500 MHz, CDCl3, 300 K): δ = 7.91 (mc, 2H, H-9, H-11), 7.87 (mc, 2H, H-14, H-18), 7.49 
(mc, 2H, H-15, H-17), 7.43 (dd~t, J15,16 = 7.4 Hz, J16,17 = 7.4 Hz, 1H, H-16), 7.04 (mc, 2H, H-8, 
H-12), 5.37 (dd, J2,3 = 3.4 Hz, J3,4 = 10.1 Hz, 1H, H-3), 5.30 (d, J3,4 = 10.0 Hz, 1H, H-4), 5.28 (dd, 
J1,2 = 1.8 Hz, J2,3 = 3.5 Hz, 1H, H-2), 4.88 (d, J1,2 = 1.6 Hz, 1H, H-1), 4.29 (dd, J5,6 = 5.0 Hz, J6a,6b = 
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12.2 Hz, 1H, H-6a), 4.23 (m, 2H, OCH2CH2-Ar), 4.10-4.05 (m, 2H, H-5, H-6b), 3.92-3.90 (m, 2H, 
OCH2CH2-Ar), 3.85-3.80 (m, 2H, Man-OCH2CH2O), 3.76-3.74 (m, 2H, Man-OCH2CH2O), 3.70-
3.64 (m, 4H, OCH2CH2O, OCH2CH2O), 2.15, 2.10, 2.02, 1.99 (each s, each 3H, 4 OAc) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 170.7, 170.0, 169.9, 169.7 (4 C=O), 161.3 (C-7), 152.7 
(C-13), 147.1 (C-10), 130.4 (C-16), 129.0 (C-15, C-17), 124.7 (C-9, C-11), 122.6 (C-14, C-18), 
114.9 (C-8, C-12), 97.7 (C-1), 70.9 (Man-OCH2CH2O), 70.8 (OCH2CH2O), 70.0 (OCH2CH2O), 69.7 
(OCH2CH2O-Ar), 69.6 (C-5), 69.1 (C-2), 68.4 (C-4), 67.8 (OCH2CH2O-Ar), 67.4 (Man-
OCH2CH2O), 66.2 (C-3), 62.4 (C-6) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C32H40N2O13, 683.243, found, 683.242; 
2-(2-(2-[(E)-p-(p´-Phenylazo)phenyloxy]ethoxy)ethoxy)ethyl α-D-
mannopyranoside (59) 
 
Deprotected mannoside 59 was synthesized according to general procedure C with acetyl-
protected carbohydrate 58 (217 mg, 328 µmol), NaOMe solution (555 µL, 555 µmol) and 
methanol (5 mL), giving an orange amorphous solid. 
Yield: 149 mg, 303 µmol, 92%; 
Rf: 0.40 (EtOAc/MeOH, 5:1); 
[]
 = 26.5 (c = 0.4, CH2Cl2); 
m.p.: 101 °C; 
1H NMR (500 MHz, D2O, 300 K): δ = 7.46 (mc, 2H, H-9, H-11), 7.42 (mc, 2H, H-14, H-18), 6.96-
6.94 (m, 2H, H-15, H-17), 6.88 (mc, 1H, H-16), 6.50 (mc, 2H, H-8, H-12), 4.70 (d~s, 1H, H-1), 
3.83 (dd, J1,2 = 1.3 Hz, J2,3 = 3.1 Hz, 1H, H-2), 3.72-3.67 (m, 3H, H-3, H-6a,b), 3.63-3.57 (m, 3H, 
H-4, OCH2CH2-Ar), 3.49-3.45 (m, 1H, H-5), 3.38-3.32 (m, 10H, Man-OCH2CH2O, Man-
OCH2CH2O, OCH2CH2O, OCH2CH2O, OCH2CH2-Ar) ppm; 
13C NMR (125 MHz, D2O, 300 K): δ = 160.8 (C-7), 152.1 (C-13), 146.5 (C-10), 128.9 (C-15, C-
17), 124.7 (C-9, C-11), 122.4 (C-14, C-18), 114.6 (C-8, C-12), 99.9 (C-1), 72.7 (C-5), 70.7 (C-3), 
70.1 (C-2), 69.8 (C-4), 69.6, 69.5, 68.8, 67.2 (Man-OCH2CH2O, OCH2CH2O, OCH2CH2O, 
OCH2CH2-Ar), 66.6 (OCH2CH2-Ar), 66.2 (Man-OCH2CH2O), 60.8 (C-6) ppm; 
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HR-ESI-MS (m/z): [M+H]+ calcd. for C24H32N2O9, 493.2186, found, 493.2253; [M+Na]+ calcd. 
for C24H32N2O9, 515.2006, found, 515.2072; 
IR (ATR) ῦ: 3342, 2928, 2873, 1606, 1502, 1448, 1304, 1266, 1141, 1094, 1034, 1055, 
836 cm-1. 
Heptakis(6-bromo-6-deoxy)cyclomaltoheptaose (60)130 
 
The preparative procedure was adapted from Angew. Chem. Int. Ed. Engl. 1991, 30 (1), 78-80: 
To a solution of PPh3 (26.1 g, 99.7 mmol, 15 eq) in dry DMF (100 mL) a solution of NBS (17.7 g, 
99.7 mmol, 15 eq) also in dry DMF (33 mL) was added dropwise so that the temperature did 
not exceed 40 °C. Then, predried β-CD (48, 7.35 g, 6.48 mmol, 1.0 eq) was added and the 
reaction mixture was stirred at 80 °C for 36 h and the solution was subsequently reduced to 
one third of the initial volume. A freshly prepared methanolic NaOMe solution (65.0 mL, 
129 mmol) was added and the mixture was stirred for 2 h at room temperature. Overlaying 
of the solution with MeOH (800 mL) induced the precipitation of a solid, which was filtered 
off and washed with MeOH. Drying at 30 °C furnished bromide 60 as a brownish solid. 
Yield: 9.81 g, 6.23 mmol, 96%. 
The obtained spectroscopic data was according to that reported in the literature.130 
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Heptakis(6-hexanoyl)cyclomaltoheptaose (61)129 
 
Amphiphilic CD 61 was synthesized according to general procedure A with bromide 60 
(1.14 g, 724 µmol) in DMF (6 mL), hexanoic acid (1.17 g, 10.1 mmol), and caesium carbonate 
(1.64 g, 5.06 mmol) in DMF (6 mL), yielding a white solid. 
Yield: 791 mg, 0.434 µmol, 60%. 
The obtained spectroscopic data was according to that reported in the literature.129 
Heptakis(6-dodecanoyl)cyclomaltoheptaose (62) 
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Amphiphilic CD 62 was synthesized according to general procedure A with bromide 60 
(2.00 g, 1.27 mmol) in DMF (10 mL), dodecanoic acid (3.56 g, 17.8 mmol), and caesium 
carbonate (2.88 g, 8.88 mmol) in DMF (10 mL), yielding a white solid. 
Yield: 1.16 g, 482 µmol, 38%; 
1H NMR (500 MHz, DMSO-d6, 300 K): δ = 6.08 (br s, 14H, 7 OH-2, 7 OH-3), 5.00-4.87 (m, 7H, 
7 H-1), 4.34-4.21 (m, 7H, 7 H-6a), 4.09-3.99 (m, 7H, 7 H-6b), 3.80 (m, 7H, 7 H-5), 3.62 (m, 7H, 
7 H-3), 3.32 (m, 14H, 7 H-2, 7 H-4), 2.36-2.12 (m, 28H, 7 CH2CH2CO, 7 CH2CH2CO), 1.46 (mc, 
14H, 7 CH2CH2CH2CO), 1.22 (mc, 98H, 49 CH2), 0.85 (br t, 21H, 7 CH3) ppm; 
13C NMR (125 MHz, DMSO-d6, 300 K): δ = 172.8 (C=O), 102.5 (C-1), 83.2 (C-4), 73.2 (C-3), 72.6 
(C-2), 69.6 (C-5), 63.6 (C-6), 33.8 (CH2CO), 33.5 (CH2CH2CO), 31.8, 29.5, 29.4, 29.2, 29.1, 29.0 
(6 CH2), 24.8 (CH2CH2CH3), 22.5 (CH2CH3), 14.3 (CH3) ppm; 
Heptakis(6-tetradecanoyl)cyclomaltoheptaose (63) 
 
Amphiphilic CD 63 was synthesized according to general procedure A with bromide 60 
(2.00 g, 1.27 mmol) in DMF (10 mL), dodecanoic acid (4.06 g, 17.8 mmol), and caesium 
carbonate (2.88 g, 8.88 mmol) in DMF (10 mL), yielding a white solid. 
Yield: 285 mg, 109 µmol, 9%; 
1H NMR (500 MHz, DMSO-d6, 300 K): δ = 6.50 (br s, 14H, 7 OH-2, 7 OH-3), 4.97-4.86 (m, 7H, 
7 H-1), 4.27 (m, 7H, 7 H-6a), 4.04 (m, 7H, 7 H-6b), 3.81 (m, 7H, 7 H-5), 3.63 (m, 7H, 7 H-3), 
3.33 (m, 14H, 7 H-2, 7 H-4), 2.36-2.10 (m, 28H, 7 CH2CH2CO, 7 CH2CH2CO), 1.46 (m, 14H, 
7 CH2CH2CH2CO), 1.24 (m, 126H, 63 CH2), 0.85 (t, JCH2,CH3 = 6.8 Hz, 21H, 7 CH3) ppm; 
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13C NMR (125 MHz, DMSO-d6, 300 K): δ = 176.3 (C=O), 102.5 (C-1), 83.2 (C-4), 73.2 (C-3), 72.6 
(C-2), 36.2 (CH2CO), 31.8, 29.5, 29.5, 29.4, 29.2 (5 CH2), 24.8 (CH2CH2CH3), 22.6 (CH2CH3), 14.3 
(CH3) ppm; 
(S)-2-[(tert-Butoxycarbonyl)amino]-3-(prop-2-yn-1-yloxy)propanoic acid (69)131 
 
The preparative procedure was adapted from Chem. Sci. 2012, 3 (5), 1640-1644: 
N-Boc-L-serine (68, 500 mg, 2.44 mmol, 1.0 eq) was dissolved in dry DMF (5 mL) and NaH 
(215 mg, 5.37 mmol, 2.2 eq; 60% suspension in mineral oil) was added portion wise at 0 °C. 
The reaction mixture was stirred for 30 min at this temperature and propargyl bromide 
solution (254 µL, 2.68 mmol, 1.1 eq; 80% in toluene) was added. The mixture was stirred for 
30 min at 0 °C and after attaining room temperature stirring was continued for 16 h. Then, 
water (5 mL) was carefully added and the solvent was removed under reduced pressure. The 
residue was taken up in water and the aqueous phase was extracted four times with Et2O. The 
aqueous phase was acidified (pH 2-3) with aq. KHSO4 solution (0.5 M) and extracted three 
times with CH2Cl2. The organic phase was washed three times with aq. KHSO4 solution 
(pH 2-3), dried over MgSO4, filtered, and the solvent was removed under reduced pressure. 
The product 69 was obtained as a yellowish oil. 
Yield: 572 mg, 2.35 mmol, 96%: 
The obtained spectroscopic data was according to that reported in the literature.131 
(S)-2-Amino-3-(prop-2-yn-1-yloxy)propanoic acid hydrochloride (66)131 
 
The preparative procedure was adapted from Chem. Sci. 2012, 3 (5), 1640-1644: 
N-Boc-O-propargyl-L-serine (69, 2.62 g, 10.8 mmol) was dissolved EtOAc (5 mL) and aq. HCl 
solution (7.5 mL, 10 M) was added. The reaction mixture was stirred for 10 min after TLC 
revealed complete consumption of the starting material. The solvent was removed under 
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reduced pressure and the remaining solid was washed with CH2Cl2 and Et2O to furnish 
hydrochloride 66 as a yellowish solid. 
Yield: 1.64 g, 9.11 mmol, 84%. 
The obtained spectroscopic data was according to that reported in the literature.131 
2-[2-(2-Chloroethoxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl α-D-
mannopyranoside (71)134 
 
The preparative procedure was adapted from J. Am. Chem. Soc., 2009, 131 (6), 2110-2112: 
Mannose pentaacetate (70, 4.24 g, 10.9 mmol, 1.0 eq) and 2-(2-(2-chloroethoxy)ethoxy)-
ethanol (54, 4.74 mL, 32.6 mmol, 3.0 eq) were dissolved in dry CH2Cl2 (30 mL). Then, BF3-
etherate (5.46 mL, 43.5 mmol, 4.0 eq) was added dropwise at 0 °C and the solution was stirred 
for 30 min at this temperature. After stirring for 16 h at room temperature, the reaction was 
quenched by addition of triethylamine (6 mL) and the solution was diluted with CH2Cl2. The 
organic phase was washed three times with water, dried over MgSO4, filtered, and the solvent 
was removed under reduced pressure. The crude product was purified by flash 
chromatography (cyclohexane/EtOAc, 1:1), yielding chloride 71 as yellowish syrup. 
Yield: 3.41 g, 6.83 mmol, 63%. 
The obtained spectroscopic data was according to that reported in the literature.134 
2-[2-(2-Azidoethoxy)ethoxy]ethyl 2,3,4,6-tetra-O-acetyl α-D-
mannopyranoside (72)134a 
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The preparative procedure was adapted from J. Chem. Soc., Perkin Trans. 1 2001, 823-831: 
NaN3 (650 mg, 10.0 mmol, 5.0 eq) was added to solution of acetyl-protected mannoside 71 
(1.00 g, 2.00 mmol, 1.0 eq) and TBAI (148 mg, 400 µmol, 0.2 eq) in DMF (20 mL). The reaction 
mixture was stirred at 60 °C for 6 h and after attaining room temperature stirring was 
continued for 16 h. Water (20 mL) was added and the solution was extracted four times with 
CH2Cl2. The organic phase was dried over MgSO4, filtered, and the solvent was removed under 
reduced pressure. The residue was purified by flash chromatography (cyclohexane/EtOAc, 
1:2), giving azide 72 as a colorless syrup. 
Yield: 893 mg, 1.77 mmol, 89%. 
The obtained spectroscopic data was according to that reported in the literature.134a 
2-[2-(2-Azidoethoxy)ethoxy]ethyl α-D-mannopyranoside (65)134a 
 
Deprotected mannoside 65 was synthesized according to general procedure C with acetyl-
protected carbohydrate 72 (879 mg, 1.74 mmol), NaOMe solution (870 µL, 870 µmol), and 
methanol (10 mL), giving a colorless syrup. 
Yield: 562 mg, 1.67 mmol, 96%; 
The obtained spectroscopic data was according to that reported in the literature.134a 
(S)-2-N-[2-(7-Isopropyl-1-methyl-azulen-4-yl)ethoxycarbonylamido]-3-(prop-2-yn-1-
yloxy)propanoic acid (73) 
 
O-Propargyl-L-serine (66, 347 mg, 1.93 mmol, 1.0 eq) was dissolved in a mixture of THF and 
water (1:1, 50 mL) and NaHCO3 was added (648 mg, 7.72 mmol, 4.0 eq). The reaction mixture 
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was stirred for 15 min at room temperature before carbonate 17 (714 mg, 1.93 mmol, 1.0 eq) 
was added and stirring was continued for 16 h. The solution was then diluted with a half-satd. 
aq. NaCl solution and overlaid with EtOAc. The aqueous phase was acidified with aq. HCl 
solution (2 M) and the phases were separated. The organic phase was subsequently washed 
twice with brine, dried over Na2SO4, filtered, and the solvent was removed under reduced 
pressure. The crude mixture was purified by flash chromatography (CHCl3/MeOH, 90:1 
containing 1% of AcOH), yielding the carboxylic acid 73 as a blue oil. 
Yield: 691 mg, 1.74 mmol, 90%; 
Rf: 0.20 (CHCl3/MeOH, 90:1 containing 1% of AcOH); 
1H NMR (500 MHz, MeOH-d4, 300 K): δ = 8.19 (d, J6,8 = 1.6 Hz, 1H, H-8), 7.63 (d, J2,3 = 3.2 Hz, 
1H, H-2), 7.47 (dd, J5,6 = 10.7 Hz, J6,8= 1.7 Hz, 1H, H-6), 7.34 (d, J6,8 = 3.8 Hz, 1H, H-3), 7.07 (d, 
J5,6 = 10.7 Hz, 1H, H-5), 4.45 (mc, 2H, OCH2CH2-az), 4.38 (dd~t, JOCH,CHN = 4.2 Hz, 1H, 
OCH2CHNH), 4.16 (d, JCHO,CH´O = 2.2 Hz, 2H, HC≡CCH2O), 3.89 (dd, JOCH,OCH´ = 9.6 Hz, J6,8= 4.9 Hz, 
1H, OCH´HCHNH), 3.89 (dd, JOCH,OCH´ = 9.6 Hz, J6,8= 4.9 Hz, 1H, OCH´HCHNH), 3.78 (dd, JOCH,OCH´ = 
9.6 Hz, JOCH,CHN= 3.5 Hz, 1H, OCH´HCHNH), 3.47 (mc, 2H, OCH2CH2-az), 3.09 (sept, Jisopropyl = 
6.9 Hz, 1H, az-CH(CH3)2), 2.84 (dd~t, JHC≡,≡CHO = 2.2 Hz, 1H, HC≡CCH2O), 2.63 (s, 3H, az-CH3), 
1.37 (d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (125 MHz, MeOH-d4, 300 K): δ = 173.3 (CO2H), 158.6 (NCO2), 144.8 (C-7), 141.4 (C-
4), 138.9 (C-10), 137.9 (C-2), 137.7 (C-9), 136.0 (C-6), 134.0 (C-8), 126.3 (C-1), 125.9 (C-5), 
113.5 (C-3), 80.1 (HC≡CCH2O), 76.3 (HC≡CCH2O), 70.4 (OCH2CHNH), 66.5 (OCH2CH2-az), 59.2 
(HC≡CCH2O), 55.5 (OCH2CHNH), 39.4 (az-CH(CH3)2), 38.6 (OCH2CH2-az), 25.1 (az-CH(CH3)2), 
12.9 (az-CH3) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C23H27NO5, 420.178, found, 420.171; 
IR (ATR) ῦ: 3286, 2959, 1715, 1518, 1464, 1421, 1388, 1334, 1220, 1103, 1054, 1034, 922, 
823, 777 cm-1. 
(S)-1-Adamantylamino-2-N-[2-(7-isopropyl-1-methyl-azulen-4-yl)ethoxycarbonyl-
amido]-1-oxo-3-(prop-2-yn-1-yloxy)propane (74) 
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Carboxylic acid 73 (559 mg, 1.41 mmol, 1.5 eq), HBTU (534 mg, 1.41 mmol, 1.5 eq) and HOBt 
(190 mg, 1.41 mmol, 1.5 eq) were dissolved in dry DMF (25 mL) and DIPEA (479 µL, 
2.82 mmol, 3.0 eq) was added. The reaction mixture was stirred for 15 min at room 
temperature before adamantylamine 67 (142 mg, 939 µmol, 1.0 eq) was added and stirring 
was continued for 16 h. Then, the solvent was removed under reduced pressure and the 
residue was purified by flash chromatography (toluene/EtOAc, 15:1→8:1), yielding amide 74 
as a blue solid. 
Yield: 444 mg, 836 µmol, 89%; 
Rf: 0.33 (toluene/EtOAc, 9:1); 
m.p.: 71 °C; 
1H NMR (500 MHz, CDCl3, 300 K): δ = 8.19 (d, J6,8 = 1.9 Hz, 1H, H-8), 7.66 (d, J2,3 = 3.7 Hz, 1H, 
H-2), 7.43 (dd, J5,6 = 10.7 Hz, J6,8= 1.8 Hz, 1H, H-6), 7.33 (d, J6,8 = 3.8 Hz, 1H, H-3), 7.02 (d, J5,6 = 
10.7 Hz, 1H, H-5), 6.02, 5.55 (each br s, each 1H, 2 NH), 4.50 (dd~t, OCH,CH-az = 6.9 Hz, 2H, 
OCH2CH2-az), 4.22-4.08 (m, 3H, OCH2CHNH, HC≡CCH2O), 3.85, 3.58 (each mc, each 1H, 
OCH´HCHNH, OCH´HCHNH), 3.47 (dd~t, OCH,CH-az = 7.0 Hz, 2H, OCH2CH2-az), 3.09 (sept, 
Jisopropyl = 6.9 Hz, 1H, az-CH(CH3)2), 2.67 (s, 3H, az-CH3), 2.45 (dd~t, JHC≡,≡CHO = 2.4 Hz, 1H, 
HC≡CCH2O), 2.07 (br mc, 3H, CHadamantyl), 1.99, 1.68 (each br mc, each 6H, CH2, adamantyl), 1.37 (d, 
Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 168.4 (CONH), 143.6 (C-7), 140.5 (C-4), 137.6 (C-10), 
137.1 (C-2), 136.4 (C-9), 135.2 (C-6), 133.6 (C-8), 125.6 (C-1), 124.9 (C-5), 112.6 (C-3), 79.1 
(HC≡CCH2O), 75.3 (HC≡CCH2O), 69.9 (OCH2CHNH), 65.7 (OCH2CH2-az), 58.7 (HC≡CCH2O), 
54.3 (OCH2CHNH), 52.3 (Cquart, adamantyl), 41.6 (CH2, adamantyl), 38.4 (az-CH(CH3)2), 37.8 (OCH2CH2-
az), 36.4 (CH2, adamantyl), 29.6 (CHadamantyl), 24.9 (az-CH(CH3)2), 13.0 (az-CH3) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C33H42N2O4, 553.304, found, 553.301; 
IR (ATR) ῦ: 3293, 2906, 1660, 1518, 1453, 1359, 1233, 1094, 1051, 922, 824, 778 cm-1. 
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(S)-2-(2-(2-(4-(1-Adamantylamino-2-N-(2-(7-isopropyl-1-methyl-azulen-4-
yl)ethoxycarbonylamido)-3-methoxy-1-oxopropyl)triazolyl)ethoxy)ethoxy)-
ethyl 2,3,4,6-tetra-O-acetyl α-D-mannopyranoside (75) 
 
Acetyl-protected mannoside 75 was synthesized according to general procedure B with 
azide 72 (115 mg, 228 µmol), alkyne 74 (110 mg, 207 µmol), CuSO4 . 5 H2O (21.7 mg, 
86.9 µmol), sodium ascorbate (34.9 mg, 176 µmol), DMF (6 mL), and water (2 mL). The crude 
product was purified by flash chromatography (CH2Cl2/MeOH, 30:1), giving the product 75 as 
a blue syrup. 
Yield: 106 mg, 102 µmol, 50% (55% based on conversion, 5% starting material reisolated); 
Rf: 0.26 (CH2Cl2/MeOH, 30:1); 
1H NMR (600 MHz, CDCl3, 300 K): δ = 8.18 (d, J6,8 = 1.4 Hz, 1H, H-8), 7.72 (s, 1H, Htriazole), 7.65 
(d, J2,3 = 3.5 Hz, 1H, H-2), 7.42 (dd, J5,6 = 10.6 Hz, J6,8 = 1.3 Hz, 1H, H-6), 7.32 (d, J2,3 = 3.6 Hz, 1H, 
H-3), 7.01 (d, J5,6 = 10.6 Hz, 1H, H-5), 6.28, 5.70 (each br s, each 1H, 2 NH), 5.34 (dd, J3´,4´ = 
10.1 Hz, J2´,3´ = 3.4 Hz, 1H, H-3´), 5.29 (d~t, J3´,4´ = 10.0 Hz, 1H, H-4´), 5.26-5.25 (m, 1H, H-2´), 
4.87 (d, J1´,2´ = 1.2 Hz, 1H, H-1´), 4.68 (br mc, 2H, triazole-CH2O), 4.55 (mc,2H, OCH2CH2-
triazole), 4.46 (mc, 2H, OCH2CH2-az), 4.27 (dd, J6´a,6´b = 12.2 Hz, J5´,6´a= 5.0 Hz, 1H, H-6´a), 4.17 
(mc, 1H, OCH2CHNH), 4.11 (dd, J6´a,6´b = 12.2 Hz, J5´,6´b= 2.3 Hz, 1H, H-6´b), 4.04 (ddd, J4´,5´ = 
9.8 Hz, J5´,6´a = 5.0 Hz, J5´,6´b= 2.4 Hz, 1H, H-5´), 3.91-3.85 (m, 3H, OCH2CH2-triazole, 
OCH´HCHNH), 3.81-3.78 (m, 1H, Man-OCH´HCH2O), 3.67-3.59 (m, 7H, OCH2CH2O, OCH2CH2O, 
Man-OCH´HCH2O, Man-OCH2CH2O), 3.55 (mc, 1H, OCH´HCHNH), 3.46 (mc, 2H, OCH2CH2-az), 
3.07 (sept, Jisopropyl = 6.9 Hz, 1H, az-CH(CH3)2), 2.65 (s, 3H, az-CH3), 2.14, 2.09 (each s, each 3H, 
2 OAc), 2.05 (br mc, 3H, CHadamantyl), 2.03, 1.98 (each s, each 3H, 2 OAc), 1.95, 1.65 (each br mc, 
each 6H, CH2, adamantyl), 1.36 (d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (150.92 MHz, CDCl3, 300 K): δ = 170.8, 170.2, 170.1, 169.8 (COCH3), 168.6 (CONH), 
156.3 (NHCO2), 144.2 (Cquart, triazole), 143.6 (C-7), 140.4 (C-4), 137.6 (C-10), 137.0 (C-2), 136.4 
(C-9), 135.2 (C-6), 133.6 (C-8), 125.6 (C-1), 124.9 (C-5), 123.9 (Ctriazole), 112.5 (C-3), 97.8 (C-
1´), 70.8, 70.7 (OCH2CH2O, OCH2CH2O), 70.4 (OCH2CHNH), 70.1 (Man-OCH2CH2O), 69.7 (C-2´), 
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69.6 (OCH2CH2-triazole), 69.2 (C-3´), 68.6 (C-5), 67.5 (Man-OCH2CH2O), 66.3 (C-4´), 65.6 
(OCH2CH2-az), 64.5 (triazole-CH2O), 62.5 (C-6´), 54.2 (OCH2CHNH), 52.2 (Cquart, adamantyl), 50.4 
(OCH2CH2-triazole), 41.5 (CH2, adamantyl), 38.4 (az-CH(CH3)2), 37.8 (OCH2CH2-az), 36.4 (CH2, 
adamantyl), 29.5 (CHadamantyl), 24.8 (az-CH(CH3)2), 21.0, 20.9, 20.8 (3 COCH3), 13.0 (az-CH3) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C53H73N5O16, 1058.5, found, 1058.7; 
IR (ATR) ῦ: 2907, 1751, 1676, 1510, 1367, 1218, 1088, 1047, 978, 921, 787 cm-1. 
(S)-2-(2-(2-(4-(1-Adamantylamino-2-N-(2-(7-isopropyl-1-methyl-azulen-4-yl)ethoxy-
carbonylamido)-3-methoxy-1-oxopropyl)triazolyl)ethoxy)ethoxy)ethyl α-D-
mannopyranoside (64) 
 
Deprotected mannoside 64 was synthesized according to general procedure C with acetyl-
protected carbohydrate 75 (75.2 mg, 72.6 µmol), NaOMe solution (50.0 µL, 50.0 µmol), and 
methanol (1 mL), giving a blue amorphous solid. 
Yield: 55.6 mg, 64.1 µmol, 88%; 
Rf: 0.23 (EtOAc/MeOH, 5:1); 
1H NMR (600 MHz, MeOH-d4, 300 K): δ = 8.18 (d~s, 1H, H-8), 7.98 (s, 1H, Htriazole), 7.62 (d, J2,3 = 
3.4 Hz, 1H, H-2), 7.46 (dd~d, J5,6 = 10.5 Hz, 1H, H-6), 7.32 (d~s, 1H, H-3), 7.06 (d, J5,6 = 10.6 Hz, 
1H, H-5), 4.79 (d~s, 1H, H-1´), 4.60 (br mc, 2H, triazole-CH2O), 4.55 (mc,2H, OCH2CH2-triazole), 
4.45 (mc, 2H, OCH2CH2-az), 4.22 (mc, 1H, OCH2CHNH), 3.86-3.78 (m, 5H, H-2´, H-6´a, Man-
OCH´HCH2O, OCH2CH2-triazole), 3.75-3.56 (m, 13H, H-3´, H-4´, H-5´, H-6´b, Man-OCH´HCH2O, 
Man-OCH2CH2O, OCH2CH2O, OCH2CH2O, OCH2CHNH), 3.46 (mc, 2H, OCH2CH2-az), 3.08 (sept, 
Jisopropyl = 6.8 Hz, 1H, az-CH(CH3)2), 2.62 (s, 3H, az-CH3), 2.02 (br mc, 3H, CHadamantyl), 1.96, 1.68 
(each br mc, each 6H, CH2, adamantyl), 1.36 (d, Jisopropyl = 6.9 Hz, 6H, az-CH(CH3)2) ppm; 
13C NMR (150.92 MHz, CDCl3, 300 K): δ = 171.2 (CONH), 158.3 (NHCO2), 145.4 (Cquart, triazole), 
144.8 (C-7), 141.4 (C-4), 139.0 (C-10), 137.9 (C-2), 137.7 (C-9), 136.0 (C-6), 134.0 (C-8), 126.4 
(Ctriazole), 125.8 (C-5), 113.5 (C-3), 101.7 (C-1´), 74.6 (C-3), 72.6 (C-5), 72.1 (C-2), 71.6, 71.5, 
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71.4, 71.3 (OCH2CH2O, OCH2CH2O, Man-OCH2CH2O, OCH2CHNH), 70.4 (OCH2CH2-triazole), 
68.6 (C-4), 67.7 (Man-OCH2CH2O), 66.6 (OCH2CH2-az), 65.0 (triazole-CH2O), 63.0 (C-6´), 56.6 
(OCH2CHNH), 53.1 (Cquart, adamantyl), 51.4 (OCH2CH2-triazole), 42.2 (CH2, adamantyl), 39.4 (az-
CH(CH3)2), 38.5 (OCH2CH2-az), 37.4 (CH2, adamantyl), 30.9 (CHadamantyl), 25.1 (az-CH(CH3)2), 12.9 
(az-CH3) ppm; 
HR-ESI-MS (m/z): [M+H]+ calcd. for C45H65N5O12, 868.4708, found, 868.4742; 
IR (ATR) ῦ: 3338, 2909, 1663, 1528, 1454, 1359, 1255, 1240, 1056, 814 cm-1. 
N-Boc-4-nitrosobenzylamine137 (78) 
 
The preparative procedure was adapted from J. Org. Chem. 2005, 70 (6), 2350-2352: 
A solution of Oxone® (6.33 g 10.3 mmol, 1.5 eq) in water (60 mL) was added to a solution of 
Boc-protected 4-aminobenzylamine 76 (1.53 g, 6.88 mmol, 1.0 eq) in CH2Cl2 (60 mL) and the 
reaction mixture was stirred for 16 h at room temperature. After phase separation, the 
aqueous phase was extracted three times with CH2Cl2. The organic phase was washed first 
with aq. HCl solution (1 M), then with brine, dried over MgSO4, filtered, and the solvent was 
removed under reduced pressure. A crude mixture of the nitroso compound 78 and the 
corresponding nitro compound was obtained as a green solid. 
Yield: 975 mg, 3.30 mmol, 48% (determined by 1H NMR); 
The obtained spectroscopic data was according to that reported in the literature.137 
N-Boc-(E)-p-(p´-methoxyphenylazo)benzylamine (81) 
 
Crude nitroso compound 78 (975 mg) and p-anisidine (79, 406 mg, 1.0 eq) were dissolved in 
DMSO (18 mL) and glacial AcOH (18 mL) was added. The reaction mixture was stirred for 16 h 
at room temperature and subsequently water was added. The precipitated solid was collected 
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by filtration and washed with water. Purification by flash chromatography 
(cyclohexane/EtOAc, 4:1) gave azobenzene derivative 81 as an orange solid. 
Yield: 929 mg, 2.72 mmol, 82%; 
Rf: 0.44 (CH2Cl2); 
m.p.: 117 °C; 
1H NMR (500 MHz, CDCl3, 300 K): δ = 7.91 (mc, 2H, H-3, H-5), 7.84 (mc, 2H, H-8, H-12), 7.41 
(d, J8,9 = 8.4 Hz, 2H, H-9, H-11), 7.01 (mc, 2H, H-2, H-6), 4.90 (br s, 1H, NHBoc), 4.39 (d, JCH,NH = 
5.3 Hz, 2H, CH2NHBoc), 3.89 (s, 3H, OCH3), 1.48 (s, 9H, NHC(O)OC(CH3)3) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 162.2 (C=O), 156.0 (C-1), 152.2 (C-7), 147.2 (C-4), 141.5 
(C-10), 128.2 (C-9, C-11), 124.9 (C-3, C-5), 123.0 (C-8, C-12), 114.4 (C-2, C-6), 55.7 (OCH3), 
44.6 (CH2NHBoc), 28.6 (NHC(O)OC(CH3)3) ppm; 
HR-EI-MS (m/z): [M]+ calcd. for C19H23N3O3, 341.1739, found, 341.1749; 
IR (ATR) ῦ: 3367, 2982, 1681, 1602, 1524, 1501, 1395, 1293, 1247, 1163, 1143, 1104, 1025, 
863, 838 cm-1. 
(E)-p-(p´-Methoxyphenylazo)benzylammonium trifluoroacetate (83) 
 
Azobenzene derivative 81 (924 mg, 2.71 mmol) was dissolved in CH2Cl2 (30 mL) and TFA 
(5 mL) was added. The reaction mixture was stirred for 2 h at room temperature and the 
solvent was removed under reduced pressure. The residue was taken up in MeOH and was 
codistilled with toluene, giving TFA salt 83 as an orange solid. 
Yield: 964 mg, 2.71 mmol, quant.; 
m.p.: 219 °C; 
1H NMR (500 MHz, MeOH-d4, 300 K): δ = 7.92 (mc, 4H, H-3, H-5, H-8, H-12), 7.61 (mc, 2H, H-9, 
H-11), 7.08 (mc, 2H, H-2, H-6), 4.85 (br s, 3H, NH3+), 4.20 (br s, CH2NH3+), 3.90 (s, 3H, OCH3) 
ppm; 
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13C NMR (125 MHz, CDCl3, 300 K): δ = 164.2 (C-1), 154.4 (C-7), 148.2 (C-4), 136.5 (C-10), 
130.9 (C-9, C-11), 126.0 (C-3, C-5), 124.1 (C-8, C-12), 115.5 (C-2, C-6), 56.2 (OCH3), 44.0 
(CH2NH3+) ppm; 
λmax (ε): 349 nm (21705 L mol-1 cm-1); 
HR-EI-MS (m/z): [M]+ calcd. for C14H15N3O, 241.1215, found, 241.1150; 
IR (ATR) ῦ: 2933, 2844, 2638, 1664, 1599, 1580, 1498, 1411, 1255, 1203, 1176, 1126, 1109, 
1035, 985, 840, 800 cm-1. 
N-Boc-(E)-p-(phenylazo)benzylamine (80) 
 
Acetic acid (50 mL) was added to a solution of 4-[N-Boc-aminomethyl]aniline 76 (2.86 g, 
12.9 mmol, 1.0 eq) and nitrosobenzene 77 (1.38 g, 12.9 mmol, 1.0 eq) in DMSO (50 mL). After 
the reaction mixture was stirred for 16 h at room temperature, water (200 mL) was added 
and the precipitated solid was collected by filtration. The crude product was recrystallized 
from a mixture of water and MeOH (4:1), giving the azobenzene derivative 80 as an orange 
solid. 
Yield: 3.05 g, 9.73 mmol, 75%; 
Rf: 0.38 (CH2Cl2); 
m.p.: 119 °C; 
1H NMR (500 MHz, CDCl3, 300 K): δ = 8.14 (mc, 1H, H-1), 7.93-7.90 (m, 2H, H-8, H-12), 7.90-
7.86 (m, 2H, H-3, H-5), 7.55-7.39 (m, 4H, H-2, H-6, H-9, H-11), 4.94 (mc, 1H, NH), 4.40 (d, JCH,NH = 
4.6 Hz, 2H, CH2NHBoc), 1.48 (s, 9H, NHC(O)OC(CH3)3) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 156.1 (C=O), 152.8 (C-4), 152.1 (C-7), 142.2 (C-10), 
131.1 (C-1), 129.2 (C-2, C-6), 128.2 (C-9, C-11), 123.3 (C-8, C-12), 123.0 (C-3, C-5), 79.9 
(NHC(O)OC(CH3)3), 44.5 (CH2NHBoc), 28.6 (NHC(O)OC(CH3)3) ppm; 
EI-MS (m/z): [M]+ calcd. for C18H21N3O2, 311.16, found, 311.12. 
IR (ATR) ῦ: 3321, 2980, 2927, 1683, 1523, 1366, 1285, 1245, 1155, 1135, 930, 846, 764 cm-1. 
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(E)-p-(Phenylazo)benzylammonium trifluoroacetate (82) 
 
Azobenzene derivative 80 (233 mg, 748 µmol) was dissolved in CH2Cl2 (9 mL) and TFA (1 mL) 
was added. The reaction mixture was stirred for 30 min at room temperature and the solvent 
was removed under reduced pressure. The residue was taken up in MeOH and was codistilled 
with toluene, giving TFA salt 82 as an orange solid. 
Yield: 243 mg, 747 µmol, quant.; 
m.p.: 173 °C; 
1H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.37 (br s, 2H, NH2), 8.30 (mc, 1H, H-1), 7.96-7.93 (m, 
2H, H-8, H-12), 7.93-7.88 (m, 2H, H-3, H-5), 7.68 (mc, 2H, H-9, H-11), 7.64-7.56 (m, 2H, H-2, H-
6), 4.16 (s, 2H, CH2NH3+) ppm; 
13C NMR (125 MHz, DMSO-d6, 300 K): δ = 151.9 (C-4), 151.8 (C-7), 137.4 (C-10), 131.8 (C-1), 
130.0 (C-2, C-6), 129.5 (C-9, C-11), 122.7 (C-8, C-12), 122.6 (C-3, C-5), 41.9 (CH2NH3+) ppm; 
λmax (ε): 320 nm (23892 L mol-1 cm-1); 
EI-MS (m/z): [M]+ calcd. for C13H13N3, 211.11, found, 211.09. 
IR (ATR) ῦ: 3005, 2771, 2622, 1662, 1503, 1210, 1173, 1128, 1102, 998, 899, 840, 801 cm-1. 
(E)-p-(Phenylazo)benzylammonium hydrochloride (19) 
 
Azobenzene derivative 80 (175 mg, 562 µmol) was dissolved in CH2Cl2 (10 mL) and conc. aq. 
HCl solution (2 mL) was added. The reaction mixture was stirred for 4 h at room temperature 
and the solvent was removed under reduced pressure, giving hydrochloride salt 19 as an 
orange solid. 
Yield: 139 mg, 561 µmol, quant.; 
160 Experimental Section  
m.p.: 236-240 °C; 
1H NMR (600 MHz, DMSO-d6, 300 K): δ = 8.58 (NH3+), 7.93-7.90 (m, 4H, H-3, H-5, H-8, H-12), 
7.73 (mc, 2H, H-9, H-11), 7.63-7.59 (m, 3H, H-1, H-2, H-6), 4.13 (CH2NH3+) ppm; 
13C NMR (150.92 MHz, CDCl3, 300 K): δ = 151.9 (C-4), 151.7 (C-7), 137.5 (C-10), 131.8 (C-1), 
130.1 (C-9, C-11), 129.5 (C-2, C-6), 122.6 (C-3, C-5, C-8, C-12), 41.8 (CH2NH3+) ppm; 
HR-EI-MS (m/z): [M]+ calcd. for C13H13N3, 211.1109, found, 211.1118; 
IR (ATR) ῦ: 3276, 2873, 1592, 1522, 1486, 1442, 1384, 1214, 1154, 1074, 976, 851, 773 cm-1. 
p-Hydroxyphenyl 2,3,4,6-tetra-O-acetyl α-D-mannopyranoside (87) 
 
Mannose pentaacetate (70, 1.02 g, 2.62 mmol, 1.0 eq) and hydroquinone (86, 1.16 g, 
10.5 mmol, 4.0 eq) were dissolved in a mixture of dry CH2Cl2 (80 mL) and dry acetonitrile 
(30 mL). Then, BF3∙etherate (610 µL, 4.97 mmol, 1.9 eq) was added dropwise at 0 °C and the 
mixture was stirred for 48 h at room temperature. After dilution with CH2Cl2, the organic 
phase was washed with satd. aq. NaHCO3 solution and water. The organic phase was then 
dried over MgSO4, filtered and the solvent was removed under reduced pressure. The crude 
product was then purified by flash chromatography (2:1→1:2), yielding mannoside 87 as a 
colorless syrup. 
Yield: 822 mg, 1.87 mmol, 71%; 
Rf: 0.27 (cyclohexane/EtOAc, 2:1); 
[]
 = 67.8 (c = 0.7, CH2Cl2); 
1H NMR (500 MHz, CDCl3, 300 K): δ = 6.95 (m, 2H, Ar-H), 6.75 (m, 2H, Ar-H), 5.54 (dd, J2,3 = 
10.0 Hz, J3,4 = 3.5 Hz, 1H, H-3), 5.42 (dd, J1,2 = 1.7 Hz, J2,3 = 3.5 Hz, 1H, H-2), 5.38 (d, J1,2 = 1.8 Hz, 
1H, H-1), 5.35 (dd~t, J4,5 = 10.0 Hz, J3,4 = 10.0 Hz, 1H, H-4), 4.27 (dd, J6a,6b = 12.0 Hz, J5,6a = 
5.2 Hz, 1H, H-6a), 4.14 (ddd, J4,5 = 9.9 Hz, J5,6a = 5.3 Hz, J5,6b = 2.4 Hz, 1H, H-5), 4.10 (dd, J6a,6b = 
12.0 Hz, J5,6b = 2.4 Hz, 1H, H-6b), 2.19, 2.06, 2.05, 2.03 (each s, each 3H, 4 OAc) ppm; 
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13C NMR (125 MHz, CDCl3, 300 K): δ = 170.8, 170.3, 170.2, 170.0 (4 C=O), 151.7, 149.8 (2 Ar-
Cquart), 118.0, 116.2 (2 Ar-C), 96.8 (C-1), 69.7 (C-2), 69.2 (C-5), 69.1 (C-3), 66.2 (C-4), 62.4 (C-
6), 21.6, 21.0, 20.8 (3 COCH3) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C20H24O11, 463.12, found, 463.08. 
IR (ATR) ῦ: 3448, 2960, 1742, 1509, 1368, 1203, 1125, 1034, 979, 832, 808, 756 cm-1. 
p-(Prop-2-yn-1-yloxy)phenyl 2,3,4,6-tetra-O-acetyl α-D-mannopyranoside (88) 
 
Potassium carbonate (189 mg, 1.37 mmol, 1.5 eq) was added to a solution of mannoside 87 
(400 mg, 910 μmol, 1.0 eq) in DMF (20 mL). The reaction mixture was stirred for 30 min at 
room temperature and propargyl bromide solution (100 µL, 1.06 mmol, 1.2 eq; 80% in 
toluene) was added. The mixture was stirred at 100 °C for 12 h and subsequently for 24 h at 
room temperature. The solvent was removed under reduced pressure and the crude product 
was purified by flash chromatography (cyclohexane/EtOAc, 2:1), giving alkyne 88 as a white 
solid. 
Yield: 284 mg, 594 µmol, 65%; 
Rf: 0.26 (cyclohexane/EtOAc, 2:1); 
m.p.: 63 °C; 
[]
 = 60.1 (c = 0.5, CH2Cl2); 
1H NMR (500 MHz, CDCl3, 300 K): δ = 7.05-7.00 (m, 2H, Ar-H), 6.94-6.88 (m, 2H, Ar-H), 5.54 
(dd, J2,3 = 3.4 Hz, J3,4 = 10.0 Hz, 1H, H-3), 5.43 (dd, J1,2 = 1.9 Hz, J2,3 = 3.4 Hz, 1H, H-2), 5.42 (d, 
J1,2 = 1.9 Hz, 1H, H-1), 5.35 (dd~t, J4,5 = 10.0 Hz, J3,4 = 10.0 Hz, 1H, H-4), 4.65 (d, JOCH2,C≡CH = 
2.4 Hz, 2H, OCH2C≡CH), 4.27 (dd, J6a,6b = 11.9 Hz, J5,6a = 5.2 Hz, 1H, H-6a), 4.15-4.09 (m, 2H, H-
5, H-6b), 2.50 (t, JOCH2,C≡CH = 2.5 Hz, 1H, OCH2C≡CH), 2.19, 2.05, 2.04, 2.03 (each s, each 3H, 
4 OAc) ppm; 
13C NMR (125 MHz, CDCl3, 300 K): δ = 170.7, 170.1, 170.1, 169.9 (4 C=O), 153.5, 150.5 (2 Ar-
Cquart), 117.9, 116.1 (2 Ar-C), 96.7 (C-1), 78.7 (OCH2C≡CH), 75.7 (OCH2C≡CH), 69.6 (C-2), 69.2 
(C-5), 69.1 (C-3), 66.2 (C-4), 62.4 (C-6), 56.5 (OCH2C≡CH), 21.2, 21.0, 20.8 (3 COCH3) ppm; 
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ESI-MS (m/z): [M+Na]+ calcd. for C23H26O11, 501.1, found, 501.5. 
IR (ATR) ῦ: 3274, 2957, 1739, 1508, 1367, 1211, 1125, 1027, 974, 912, 831, 807 cm-1. 
p-(Prop-2-yn-1-yloxy)phenyl α-D-mannopyranoside (89) 
 
Deprotected mannoside 89 was synthesized according to general procedure C with acetyl-
protected carbohydrate 88 (152 mg, 318 µmol), NaOMe solution (100 µL, 100 µmol) and 
methanol (10 mL), giving a white solid. 
Yield: 80.2 mg, 258 µmol, 81%; 
Rf: 0.15 (CH2Cl2/MeOH, 9:1); 
[]
 = 65.2 (c = 0.3, MeOH); 
1H NMR (500 MHz, MeOH-d4, 300 K): δ = 7.09-7.04 (m, 2H, Ar-H), 6.96-6.90 (m, 2H, Ar-H), 
5.37 (d, J1,2 = 1.4 Hz, 1H, H-1), 4.68 (d, JOCH2,C≡CH = 2.1 Hz, 2H, OCH2C≡CH), 4.00 (dd, J1,2 = 1.8 Hz, 
J2,3 = 3.3 Hz, 1H, H-2), 3.89 (dd, J2,3 = 3.4 Hz, J3,4 = 9.4 Hz, 1H, H-3), 3.79 (dd, J6a,6b = 11.9 Hz, 
J5,6a = 2.4 Hz, 1H, H-6a), 3.76-3.70 (m, 2H, H-4, H-6b), 3.66 (ddd, J4,5 = 9.7 Hz, J5,6b = 5.3 Hz, J5,6a = 
2.3 Hz, 1H, H-5), 2.92 (t, JOCH2,C≡CH = 2.4 Hz, 1H, OCH2C≡CH) ppm; 
13C NMR (125 MHz, MeOH-d4, 300 K): δ = 154.2, 152.6 (2 Ar-Cquart), 119.1, 117.0 (2 Ar-C), 
101.1 (C-1), 80.0 (OCH2C≡CH), 76.6 (OCH2C≡CH), 75.3 (C-5), 72.4 (C-3), 72.1 (C-2), 68.4 (C-
4), 62.7 (C-6), 57.2 (OCH2C≡CH) ppm; 
ESI-MS (m/z): [M+Na]+ calcd. for C15H18O7, 333.1, found, 333.4. 
IR (ATR) ῦ: 3558, 3413, 3274, 2940, 2889, 1739, 1506, 1367, 1213, 1124, 1012, 806 cm-1. 
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Mono(6A-(4-((α-D-mannopyranosyl)methyloxy)triazolyl))cyclomaltoheptaose (85) 
 
CD conjugate 85 was synthesized according to general procedure B with azide 50 (292 mg, 
251 μmol), alkyne 84 (54.8 mg, 251 μmol), CuSO4 . 5 H2O (26.5 mg, 106 μmol), sodium 
ascorbate (42.3 mg, 214 μmol), DMF (7 mL), and water (2 mL). The crude product was 
purified by GPC with DMF as the eluent, giving the product 85 as a white solid. 
Yield: 318 mg, 231 μmol, 92%; 
Rf: 0.37 (iPrOH/H2O/EtOAc/NH4OH (conc.), 5:3:1:1); 
[]
 = +128.9 (c = 0.4, H2O); 
m.p.: decomposition at 165 °C; 
1H NMR (600 MHz, DMSO-d6, 300 K): δ = 8.02 (s, 1H, Htriazole), 5.94-5.50 (m, 17H, 7 OH-2CD, 
7 OH-3CD, OH-2Man, OH-3Man, OH-4Man), 5.05 (d, J1,2 = 3.4 Hz, 1H, H-1ACD), 4.92-4.38 (m, 15H, 6 H-
1CD, 6 OH-6CD, 2 H-6ACD, H-1Man), 4.24 (dd~t, J6,OH = 5.7 Hz, 1H, OH-6Man), 3.99 (dd~t, J4,5 = 
8.7 Hz, 1H, H-4Man), 3.76-3.20 (m, 47H, 7 H-2CD, 7 H-3CD, 7 H-4CD, 7 H-5CD, 12 H-6CD, H-2Man, H-
3Man, H-5Man, 2 H-6Man, OCH2-triazole, overlap with HDO) ppm; 
13C NMR (150.92 MHz, DMSO-d6, 300 K): δ = 143.4 (C-4triazole), 124.9 (C-3triazole), 102.0 (C-1CD), 
99.0 (C-1Man), 81.6 (C-4CD), 74.1, 70.9, 70.2 (C-2Man, C-3Man, C-5Man) 73.07, 72.4, 72,1 (C-2CD, C-
3CD, C-5CD), 67.0 (C-4Man), 61.3, 59.9 (C-6Man, C-6CD), 58.7 (OCH2-triazole) 50.2 (C-6ACD) ppm; 
MALDI-MS (m/z): [M+Na]+ calcd. for C51H83N3O40, 1400.445, found, 1401.159; 
IR (ATR) ῦ: 3306, 2938, 1654, 1366, 1249, 1153, 1078, 1019, 999, 948, 846 cm-1. 
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Mono(6A-(4-(4-(α-D-mannopyranosyloxo)methoxyphenyl)triazolyl))-
cyclomaltoheptaose (90) 
 
CD conjugate 90 was synthesized according to general procedure B with azide 50 (1.25 g, 
1.08 mmol), alkyne 89 (334 mg, 1.08 mmol), CuSO4 . 5 H2O (113 mg, 454 μmol), sodium 
ascorbate (182 mg, 918 μmol), DMF (24 mL), and water (8 mL). The crude product was 
purified by RP chromatography (ACN/ddH2O, cf. Appendix), giving the product 90 as a white 
solid. 
Yield: 1.23 g, 837 μmol, 78%; 
Rf: 0.43 (iPrOH/H2O/EtOAc/NH4OH (conc.), 5:3:1:1); 
[]
 = +139.4 (c = 1.5, H2O); 
m.p.: decomposition at 280 °C; 
1H NMR (500 MHz, DMSO-d6, 300 K): δ = 8.13 (s, 1H, Htriazole), 7.03 (mc, 2H, Ar-H), 6.95 (mc, 2H, 
Ar-H), 5.87 (d, JOH,CH = 6.6 Hz, 1H, OH-4Man), 5.77-5.63 (m, 14H, 7 OH-2CD, 7 OH-3CD), 5.22 (d, 
J1,2 = 1.7 Hz, 1H, H-1Man), 5.03 (mc, 3H, H-1ACD, OCH2-triazole), 4.94 (d, JOH,CH = 4.4 Hz, 1H, OH-
2Man), 4.90 (mc, 1H, H-6aACD), 4.85-4.77 (m, 7H, 6 H-1CD), 4.69 (d, JOH,CH = 6.1 Hz, 1H, OH-3Man), 
4.59 (dd, J6a,6b = 14.5 Hz, J5,6a = 8.4 Hz, 1H, H-6bACD), 4.52-4.43 (m, 6H, OH-6CD), 4.28 (mc, 1H, 
OH-6Man), 3.99 (mc, 1H, H-5ACD), 3.81 (mc, 1H, H-2Man), 3.76-3.24 (m, 42H, H-2ACD, 6 H-2CD, H-
3ACD, 6 H-3CD, H-4ACD, 6 H-4CD, 6 H-5CD, 12 H-6CD, H-3Man, H-4Man, H-5Man, overlap with HDO), 
3.14-3.10 (m, 1H, H-6aMan), 2.92-2.89 (m, 1H, H-6bMan) ppm;13C NMR (125 MHz, DMSO-d6, 
300 K): δ = 153.4, 150.7 (2 Ar-Cquart), 142.7 (Cquart, triazole), 125.4 (Ctriazole), 118.3, 115.5 (2 Ar-C), 
102.2, 102.1, 102.0, 101.9, 101.3 (C-1ACD, C-1CD), 99.9 (C-1Man), 83.5, 82.1, 81.6, 81.5, 81.4, 81.0 
(C-3Man, C-3ACD, C-3CD), 74.8, 73.2, 73.1, 73.0, 72.9, 72.7, 72.5, 72.5, 72.4, 72.3, 72.3, 72.2, 72.1, 
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71.8, 70.7 (C-2ACD, C-2CD, C-4ACD, C-4CD, C-5CD, C-5Man), 70.2 (C-2Man), 70.0 (C-5ACD), 66.8 (C-4AMan), 
61.4 (OCH2-triazole), 61.1, 60.2, 60.0, 59.9, 59.0 (C-6CD), 50.4 (C-6ACD) ppm; 
HR-ESI-MS (m/z): [M+H]+ calcd. for C57H87N3O41, 1470.4893, found, 1470.4878; 
IR (ATR) ῦ: 3306, 2938, 1504, 1334, 1203, 1152, 1079, 1024, 1002, 946, 832 cm-1. 
Mono(6A-amino-6A-deoxy)cyclomaltoheptaose (91)139 
 
The preparative procedure was adapted from J. Chromatogr. A 2005, 1094 (1–2), 187-191: 
PPh3 (196 mg, 748 µmol, 1.1 eq) was added to a solution of azido-β-CD 50 (789 mg, 680 µmol, 
1.0 eq) in DMF (10 mL). The reaction mixture was stirred for 2 h at room temperature and 
water (1 mL) was added subsequently. The mixture was then stirred at 90 °C for 3 h and after 
cooling to room temperature was poured onto acetone. The precipitated solid was collected 
by filtration, washed with acetone, and dried at 60 °C, yielding amino-β-CD 91 as a white solid. 
Yield: 725 mg, 639 μmol, 94%; 
The obtained spectroscopic data was according to that reported in the literature.140 
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Mono(6A-N´-(3´,6´-dihydroxy-3H-spiro[2-benzofuran-1,9´-xanthen]-3-one-5-
yl)thioureido-6A-deoxy)cyclomaltoheptaose (93) 
 
Amino-β-CD 91 (100 mg, 88.2 µmol, 1.0 eq) and fluorescein isothiocyanate isomer I (92, 
37.8 mg, 97.0 µmol, 1.1 eq) were dissolved in dry DMF (20 mL). Then, DIPEA (15.0 µL, 
88.2 µmol, 1.0 eq) was added and the mixture was stirred for 16 h at room temperature. The 
solution was poured onto Et2O and the precipitated solid was collected by filtration, washed 
thoroughly with Et2O, and dried at 60 °C. The fluorescein-tagged CD 93 was obtained as an 
orange solid. 
Yield: 86.4 mg, 56.7 µmol, 64%; 
Rf: 0.60 (iPrOH/H2O/EtOAc/NH4OH (conc.), 5:3:1:1); 
[]
 = +94.1 (c = 1.0, DMSO); 
1H NMR (500 MHz, DMSO-d6, 300 K): δ = 10.0 (br s, 1H, Ar-OH), 8.31 (d~s, 1H, H-4), 7.94 (br 
s, 1H, NH), 7.78 (d, J6,7 = 8.1 Hz, 1H, H-6), 7.15 (d, J6,7 = 8.3 Hz, 1H, H-7), 6.65-6.62 (m, 4H, H-1´, 
H-4´, H-5´, H-8´), 6.54 (mc, 2H, H-2´, H-7´), 5.89-5.66 (m, 14H, 7 OH-2, 7 OH-3CD), 4.89-4.82 (m, 
7H, 7 H-1CD), 4.55-4.37 (m, 6H, 6 OH-6CD), 4.16 (mc, 1H, H-6AaCD), 3.82-3.24 (m, 41H, 7 H-2CD, 
7 H-3CD, 7 H-4CD, 7 H-5CD, H-6AbCD, 6 H-6a,bCD, overlap with HDO) ppm; 
13C NMR (125 MHz, DMSO-d6, 300 K): δ = 180.6 (C=S), 168.6 (C=O), 152.4 (C-10´, C-11´), 141.3 
(C-8), 129.2 (C-1´, C-8´), 128.4 (C-6), 124.5 (C-7), 117.1 (C-4), 113.7 (C-2´, C-7´), 110.1 (C-9´, 
C-12´), 102.5, 102.3, 102.1, 102.0, 101.8, 101.7 (C-4´, C-5´, C-1ACD, C-1CD), 83.8 (C-1), 81.8, 81.5, 
81.2 (C-3ACD, C-3CD), 73.1, 73.0, 72.8, 72.5, 72.4, 72.3, 72.1, 72.0, 69.7, 69.6, 69.5, 68.5 (C-2ACD, 
C-2CD, C-4ACD, C-4CD, C-5ACD, C-5CD), 59.9, 59.7 (C-6CD), 44.8 (C-6ACD) ppm; 
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HR-ESI-MS (m/z): [M+H]+ calcd. for C63H82N2O39S, 1523.4294, found, 1523.4298; 
IR (ATR) ῦ: 3305, 2939, 1577, 1460, 1317, 1209, 1153, 1109, 1078, 1024, 946, 916, 847 cm-1. 
 
7.4 Photoirradiation Experiments 
Photoirradiation experiments were performed by A. Müller (for azobenzene derivative 82) 
and myself (for azobenzene derivative 83). 
E/Z ratios were determined by irradiating a sample of the respective azobenzene derivative 
and subsequent measurement by 1H NMR spectroscopy. Therefore, an NMR tube containing 
the azobenzene sample (≈10 mg dissolved in 500 µL MeOH-d6) was set up at a distance of 
approx. 5 cm to the LED and was irradiated at 365 nm for 15 min when the photostationary 
state (PSS) was reached. Afterwards, the sample was immediately measured by 1H NMR 
spectroscopy in order to prevent back-isomerization. The respective PSS was calculated by 
integration of an isolated proton signal (OCH3 or CH2NH3+) of the corresponding azobenzene 
derivative. 
Kinetics of the thermal Z→E relaxation were determined by 1H NMR spectroscopy. For this, 
1H NMR spectra were recorded in regular intervals of 3-4 h over a period of 5-6 d. The half-
life was determined by integration of isolated Z and E isomer proton signals (OCH3 or 
CH2NH3+). Both the decrease of the Z isomer integral and the increase of the E isomer integral 
were plotted and the data was fitted by a first order exponential decay. The half-life τ1/2 was 
calculated by the formula: τ1/2 = ln 2/k. 
For UV/Vis spectroscopy, a UV cuvette containing a sample of the respective azobenzene 
derivative was set up at a distance of approx. 5 cm to the LED and was irradiated at 365 nm 
for 15 min. Afterwards, UV/Vis spectra (cf. Appendix) were immediately recorded, revealing 
the formation of the respective Z isomer by an increase of the n-π* transition absorbance and 
a decrease of the π-π* transition absorbance. Extinction coefficients (ε) were calculated 
through linear regression of absorbance maxima deduced from UV/Vis spectra measured at 
different concentrations (5 µM, 10 µM, 20 µM, 40 µM, 60 µM and 80 µM). 
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Table 7.1: Characterization of the E and Z isomers of azobenzene derivatives 82 and 83. 
Azobenzene 
derivative 
E/Z (PSS)[a] λmax (E and Z) [nm] half-life, τ1/2 [h] 
82 58:42 
320 
320, 440 
680 
83 3:97 
349 
311, 438 
146 
[a] Determined by the integration ratio of OCH3 or CH2NH3+ moieties in the 1H NMR spectra. 
 
 
7.5 Bacterial Adhesion Assays 
7.5.1 Media and Buffer Solutions 
LB medium: tryptone (10.0 g), sodium chloride (10.0 g) and yeast extract (5.00 g) were 
dissolved in distilled deionized water (1.00 L) and after autoclavation chloramphenicol 
(50.0 mg) and ampicillin (100 mg) were added. 
PBS buffer solution (pH 7.2): sodium chloride (8.00 g), potassium chloride (200 mg), 
sodium hydrogen phosphate dihydrate (1.44 g) and potassium dihydrogen phosphate 
(200 mg) were dissolved in distilled deionized water (1.00 L). 
PBST buffer solution (pH 7.2): PBS buffer + Tween® 20 (0.05% v/v). 
Carbonate buffer solution (pH 9.6): sodium carbonate (1.59 g) and sodium hydrogen 
carbonate (2.52 g) were dissolved in distilled deionized water (1.00 L). 
MES buffer (0.5 M, pH 6.3): 2-(N-Morpholino)ethanesulfonic acid (9.76 g) were dissolved in 
distilled deionized water (1.00 L) and the pH value was adjusted to 6.3 with sodium carbonate 
solution (2.5 M). 
Reagent solution for activation of magnetic PEG beads: EDC (32 mg) and NHS (64 mg) 
were dissolved in MES buffer (1 mL). 
Adjustment of pH values: The buffer pH values were adjusted with aqueous 0.1 M HCl or 
0.1 M NaOH solution 
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7.5.2 Cultivation of Bacteria 
GFP-expressing E. coli bacteria (strain pPKL1162)145 were cultured from a frozen stock in LB 
medium and incubated overnight at 37 °C. After centrifugation, the bacteria pellet was 
washed twice with PBS buffer (2.00 mL) and then resuspended in PBS buffer. Finally, the 
suspension was adjusted to OD600 = 0.4 (2 mg/mL) with PBS. 
 
7.5.3 Adhesion-inhibition Assay with GFP-expressing E. coli 
Black 96-well microtiter plates (Nunc™, MaxiSorp™) were incubated with a solution of 
mannan from Saccharomyces cerevisiae (1.2 mg/mL in carbonate buffer, 120 μL/well) and 
desiccated overnight at 37 °C and 100 rpm. The plates were washed three times with PBST 
(150 μL/well) and subsequently blocked by incubation with a PVA solution (1% in PBS, 
120 μL/well) for 4 h at 4 °C. The plates were then washed twice with PBST (150 μL/well) and 
once with PBS (150 μL/well). Serial dilutions (1:1) of the respective inhibitor in PBS were 
prepared on the plates (100 µL/well; start concentrations are indicated at the corresponding 
inhibition curves). The bacterial suspension (OD600 = 0.4, 50 µL/well) was then added and the 
plates were incubated for 1 h at 37 °C and 100 rpm. Subsequently, the plates were washed 
twice with PBS (150 μL), the wells were filled with PBS (100 μL/well), and fluorescence 
(485 nm/535 nm) was measured.146 Each inhibitor was tested at least in triplicate and with 
the standard inhibitor MeMan on the same plate. 
The percentage of inhibition was calculated: 
ℎ


 (%) =
 − 

∙ 100 
where I0 = intensity of fluorescence without inhibitor; I = intensity of fluorescence with 
inhibitor. 
 
7.5.4 Covalent Functionalization of Polystyrene Microtiter Plates 
Black 96-well microtiter plates (Nunc Immobilizer™ Amino) were incubated with solutions of 
the respective amino functionalized compound in carbonate buffer (100 µL/well; 
concentrations are indicated at the corresponding binding curves) overnight at room 
temperature and 100 rpm. The plates were washed three times with PBST (150 μL/well) and 
subsequently blocked by incubation with an ethanolamine solution (10 mM in carbonate 
buffer, 120 μL/well) for 2 h at room temperature and 100 rpm. Finally, the microtiter plates 
were washed twice with PBST (150 µL/well) and once with PBS (150 µL/well).146 
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7.5.5 Non-covalent Functionalization of Polystyrene Microtiter Plates 
Transparent 96-well microtiter plates (Nunc-Immuno™ MicroWell™ MaxiSorp™) were 
incubated with a solution of the respective amphiphilic CD (5 µM in ddH2O, diluted from stock 
solution containing 1% DMSO, 100 µL/well) overnight at room temperature. The plates were 
washed twice with PBS (200 µL/well) and blocked by incubation with a BSA solution (1% 
m/v in PBS, 150 µL/well) for 1 h at 37 °C. Finally, the microtiter plates were washed twice 
with PBS (200 µL/well). 
 
7.5.6 Binding Assay with GFP-expressing E. coli and Cyclodextrin Inclusion 
Complexes on Polystyrene Microtiter Plates 
Covalently functionalized microtiter plates were prepared according to 7.5.4 either by 
incubation with an azobenzene solution of static concentration or by preparation of serial 
dilutions (1:1, concentrations are indicated at the corresponding binding curves). Then, 
solutions of the respective CD conjugate (100 µL/well, static concentration or serially diluted, 
concentrations are indicated at the corresponding binding curves) were added and the plates 
were incubated for 1 h at 37 °C and 100 rpm. After washing once with PBS (150 µL/well), one 
half of the plates was covered while the other half was irradiated with 365 nm for 15 min. 
Subsequently, the plates were washed once with PBS (150 µL/well), the bacterial suspension 
(OD600 = 0.4, 100 µL/well) was added and the plates were incubated for 1 h at 37 °C and 
100 rpm. Finally, the plates were washed three times with PBS (150 µL/well), PBS was added 
to the wells (100 µL/well) and fluorescence (485 nm/535 nm) was measured. 
On each plate pAPMan (10 mM in static concentration or serially diluted) was covalently 
immobilized as a reference. 
 
7.5.7 Binding Assay with Magnetic PEG Beads 
Assays with magnetic PEG beads were performed by A. Müller and myself. 
Magnetic PEG beads (2x 450 µL, micromod, PEG-COOH coating micromer®-M) were 
incubated with a freshly-prepared activation reagent solution (112.5 µL) for 16 h at room 
temperature and 600 rpm. After washing twice with PBS (1 mL) by using a magnetic rack, the 
two portions were combined in an Eppendorf tube®, the supernatant was removed, and the 
beads were resuspended in PBS (600 µL). 
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Taken from this stock suspension, the activated beads (100 µL) were then incubated with 
azobenzene derivatives 82 and 83, respectively, (15 mM in carbonate buffer containing 10% 
of DMSO and 1% of TEA, 1 mL) for 4 h at room temperature and 600 rpm. After washing twice 
with PBS (1 mL), the beads were blocked by incubation with an ethanolamine solution (10 mM 
in carbonate buffer, 1 mL) for 1 h at room temperature and 600 rpm. Then, the beads were 
washed twice with PBS (1 mL) and resuspended in PBS (1 mL). 
The azobenzene functionalized beads (50 µL) were incubated with CD conjugate 90 (8 mM in 
PBS, 100 µL) for 2 h at room temperature and 600 rpm. After washing twice with PBS 
(100 µL), the beads were resuspended in PBS (50 µL), transferred to a small plastic bowl and 
PBS (450 µL) was added. One portion of the beads was irradiated for 10 min with UV light 
(365 nm) and agitated at 600 rpm while the other portion was agitated and kept in the dark. 
Subsequently, the beads were transferred to an Eppendorf tube®, washed with PBS (400 µL), 
and resuspended in PBS (400 µL). A bacterial suspension (OD600 = 0.6, 100 µL) was added and 
the beads were incubated for 30 min at room temperature and 600 rpm. After washing with 
PBS (500 µL) and transfer to a new Eppendorf tube®, the beads were taken up in PBS (100 µL), 
transferred to a black 96-well microtiter plate (Nunc™, MaxiSorp™), and fluorescence 
(485 nm/535 nm) was measured. 
Each type of azobenzene functionalized beads (azobenzene 82 or 83) was tested in duplicate 
and unfunctionalized beads provided the blank fluorescence value. 
 
7.5.8 Enzyme Activity Test (for ELLA) 
This assay as well as the one described in 7.5.9 was performed at the CSIC – University of 
Seville under supervision of Jose Manuel García Fernández. 
Transparent 96-well microtiter plates (Nunc-Immuno™ MicroWell™ MaxiSorp™) were 
incubated with a solution of mannan from Saccharomyces cerevisiae (10 µg/mL in PBS 
containing 0.1 mM of Ca2+ and 0.1 mM of Mn2+, 100 μL/well) overnight at room temperature. 
The plates were subsequently washed three times with PBST (200 µL/well) and blocked by 
incubation with a BSA solution (1% m/v in PBS, 150 µL/well) for 1 h at 37 °C. After washing 
three times with PBST (200 µL/well), the wells were filled with serial dilutions of Con A-HRP 
(10-1-10-5 mg/mL in PBS, 100 µL/well) and incubated for 1 h at 37 °C. The plates were again 
washed three times with PBST (200 µl/well) and a solution of ABTS (0.25 mg/mL in citrate-
phosphate buffer with 0.015% H2O2, 50 µL/well) was added, resulting in a color reaction. 
After 20 min, the reaction was stopped by addition of H2SO4 (1 M, 50 µL/well) and the 
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absorbance at 415 nm was measured. The concentration of Con A-HRP which gave 
absorbance values between 0.8 and 1.0 was used for surface binding assays.147 
 
7.5.9 Enzyme-linked Lectin Assay (ELLA) with Cyclodextrin Inclusion Complexes 
Non-covalently functionalized microtiter plates were prepared according to 7.5.5. Then, serial 
dilutions (1:1) of the respective guest molecules were prepared on the plates (start 
concentration: 40 µM) and the plates were incubated for 1 h at 37 °C. After washing twice with 
PBS (200 µL/well), a Con A-HRP solution (concentration determined by enzyme activity test) 
was added, the microtiter plates were incubated for 1 h at 37 °C, and subsequently washed 
twice with PBS (200 µL/well). Then, a solution of ABTS (0.25 mg/mL in citrate-phosphate 
buffer with 0.015% H2O2, 50 µL/well) was added, the reaction was stopped after 20 min by 
addition of H2SO4 (1 M, 50 µL/well) and the absorbance at 415 nm was measured. 
 
7.5.10 Phenol-Sulfuric Acid Assay 
Covalently functionalized microtiter plates (transparent 96-well Nunc Immobilizer™ Amino) 
were prepared according to 7.5.4 by incubation with solutions of the respective amino 
functionalized compound (10 mM in carbonate buffer). Serial dilutions (1:1) of azido-β-CD 50 
(start concentration: 5 mM in PBS) and mannoside 52 (start concentration: 10 mM in PBS) 
were prepared in a separate area on the same plates and subsequently desiccated overnight 
at 37 °C. Then, every well was incubated with a phenol solution (5% in ddH2O, 25 µL/well) 
and conc. sulfuric acid (125 µL/well) for 30 min at room temperature and 100 rpm, followed 
by determination of the absorbance at 490 nm.148
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Appendix 
UV/Vis Spectra of Selected Compounds 
 
Figure A1: UV/Vis spectrum of azobenzene derivative 82. 
 
Figure A2: UV/Vis spectrum of azobenzene derivative 83.  
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Figure A3: UV/Vis spectrum of Amadori product 21. 
 
Figure A4: UV/Vis spectrum of Amadori product 24.  
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Chromatograms of Selected Compounds 
 
Figure A5: Chromatogram of the RP purification of CD conjugate 90. Left y-axis: absorbance [mAU], 
right y-axis: amount of ACN in percent; x-axis: time [min]. Rt = 13.12 min. 
 
Figure A6: Chromatogram of the RP purification of glycocluster 47. Left y-axis: absorbance [mAU], right 
y-axis: amount of ACN in percent; x-axis: time [min]. Rt = 12.46 min 
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Abbreviations 
9-BBN   9-borabicyclo[3.3.1]nonane 
ABTS   2,2´-azino-bis(3-ethylbenzo-thiazoline-6-sulphonic acid 
ACN   acetonitrile 
Asn   asparagine 
Asp   aspartic acid 
Boc   tert-butyloxycarbonyl 
br   broad signal 
BSA   bovine serum albumin 
CD   cyclodextrin 
Con A   concanavalin A 
CRD   carbohydrate recognition domain 
CSP   chromophore-supported purification 
CuAAC   copper(I)-catalyzed azide alkyne cycloaddition 
d   doublet 
DIPEA   N,N-diisopropylethylamine 
DMF   N,N-dimethylformamide 
DMSO   dimethyl sulfoxide 
DSC   N,N´-disuccinimidyl carbonate 
E. coli   Escherichia coli 
EDC   1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EE   ethyl acetate 
EI   electron ionization 
ELLA   enzyme-linked lectin assay 
ER   endoplasmic reticulum 
ESI   electrospray ionization 
Gal   galactose 
GalNAc   N-acetylgalactosamine 
GC   gas chromatography 
GFP   green fluorescent protein 
GlcNAc   N-acetylglucosamine 
Gln   glutamine 
HBTU   2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexaﬂuorophosphate 
HMEC   human mammary epithelial cells 
HOBt   hydroxybenzotriazole 
HPLC   high performance liquid chromatography 
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HR   high resolution, high-resolution 
HRP   horseradish peroxidase 
IC50   half maximal inhibitory concentration 
IR   infrared 
LDA   lithium diisopropylamide 
LED   light-emitting diode 
m   multiplet 
m.p.   melting point 
MALDI   matrix-assisted laser desorption ionization 
Man   mannose 
m-CPBA   m-chloroperoxybenzoic acid 
MeMan   methyl α-D-mannoside 
MS   mass spectrometry 
NBS   N-bromosuccinimide 
Neu5Ac   N-acetylneuraminic acid 
NHS   N-hydroxyl succinimide 
NMR   nuclear magnetic resonance spectroscopy 
OD   optical density 
OEG   oligo ethylene glycol 
PBS   phosphate buffered saline 
PBST   phosphate buffered saline with Tween® 
PEG   polyethylene glycol 
pH   potentia Hydrogenii 
Phe   phenylalanine 
PMDTA   N,N,N′,N′′,N′′-pentamethyldiethylenetriamine 
PNA   peanut agglutinin 
pNPMan   p-nitrophenyl α-D-mannoside 
PSS   photostationary state 
PVA   polyvinyl alcohol 
q   quartet 
Rf   retardation factor 
RIP   relative inhibitory potency 
RIT   relative inhibition titre 
ROESY   rotating-frame nuclear Overhauser effect correlation spectroscopy 
RP   reverse phase 
rt   room temperature 
s   singlet 
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SAM   self assembled monolayer 
SD   standard deviation 
Ser   serine 
t   triplet 
TBABr   tetra-n-butylammonium bromide 
TBAI   tetra-n-butylammonium iodide 
TEA   triethylamine 
TEM   transmission electron microscopy 
TFA   trifluoroacetic acid 
THF   tetrahydrofuran 
Thr   threonine 
TLC   thin layer chromatography 
Tyr   tyrosine 
UV   ultraviolet 
Y   tyrosine 
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Figures 
Figure 1.1: A) Schematic illustration of a cellular membrane with various incorporated 
proteins and lipids, which are functionalized with glycans at particular glycosylation sites. B) 
Electron microscopic view of the glycocalyx of an endothelial cell. ..................................................... 3 
Figure 1.2: Types of N-glycans: high-mannose, complex and hybrid. Each N-glycan contains 
the common core Man3GlcNAc2Asn (blue square: GlcNAc; green circle: Man; yellow circle: Gal; 
purple square: Neu5Ac; purple triangle: fucose). ........................................................................................ 4 
Figure 1.3: (A) TEM image of an E. coli cell, showing fimbriae on the cell surface. (B) Assembly 
of type 1 fimbriae according to the chaperone-usher pathway inside the periplasm. IM: inner 
membrane; OM: outer membrane; FimH: fimbrial lectin; FimC: periplasmic chaperone; FimD: 
fimbrial usher protein; FimA, FimD, FimF, and FimG: other fimbrial subunits. .............................. 7 
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